<SEC-DOCUMENT>0001193125-23-090874.txt : 20230404
<SEC-HEADER>0001193125-23-090874.hdr.sgml : 20230404
<ACCEPTANCE-DATETIME>20230404161621
ACCESSION NUMBER:		0001193125-23-090874
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20230404
DATE AS OF CHANGE:		20230404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XOMA Corp
		CENTRAL INDEX KEY:			0000791908
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				522154066
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39801
		FILM NUMBER:		23797684

	BUSINESS ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		510-204-7239

	MAIL ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA LTD /DE/
		DATE OF NAME CHANGE:	19990107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA CORP /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d344283ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:xoma="http://www.xoma.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>DEF 14A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="">
 <div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden73597816" contextRef="P01_01_2022To12_31_2022">DEF 14A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2022To12_31_2022">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2022To12_31_2022">0000791908</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="xoma-20221231.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="P01_01_2022To12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:PeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis" >ecd:NonPeoNeoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis" >xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD" > <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">UNITED STATES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Washington, D.C. 20549 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 18pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><span style="-sec-ix-hidden:hidden73597816">SCHEDULE 14A</span> INFORMATION </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Proxy Statement Pursuant to Section&#160;14(a) of the </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities Exchange Act of 1934 </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed by a Party other than the Registrant&#160;&#160;&#9744; </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:4%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:95%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Preliminary Proxy Statement</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Confidential, for Use of the Commission Only (as p<div style="display:inline;">erm</div>itte<div style="display:inline;">d</div> by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">14a-6(e)(2))</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Definitive Proxy Statement</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Definitive Additional Materials</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Soliciting Material Pursuant to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#167;240.14a-12</div></td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 22pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2022To12_31_2022">XOMA CORPORATION</ix:nonNumeric> </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Registrant as Specified In Its Charter) </div></div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Name of Person(s) Filing Proxy Statement if other than the Registrant) </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:4%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td colspan="4" style="height:12pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="3" style="vertical-align:top">No fee required</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td colspan="4" style="height:12pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="3" style="vertical-align:top">Fee paid previously with preliminary materials</td></tr>
<tr style="font-size:1pt">
<td style="height:18pt"></td>
<td colspan="4" style="height:18pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="3" style="vertical-align:top">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">14a-6(i)(1)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0-11</div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div></div></div></div></div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div></div></div></div> <div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g344283g02g01.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">XOMA CORPORATION </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2200 Powell Street, Suite 310 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Emeryville, California 94608 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(510) <span style="white-space:nowrap">204-7200</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Our Stockholders: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the annual meeting of stockholders of XOMA Corporation on May&#160;17, 2023, which will be held virtually via live webcast at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span> at 9:00 a.m. Pacific Time. The meeting will be held online only. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Details of the business to be conducted at the annual meeting are provided in the Notice of Annual Meeting of Stockholders and proxy statement. Also, for your information, we are making available a copy of our Annual Report on Form <span style="white-space:nowrap">10-K</span> to stockholders for the fiscal year ended on December&#160;31, 2022. We are providing our stockholders access to all of these materials via the internet, reducing the amount of paper necessary to produce these materials, as well as costs associated with mailing all of these materials to all stockholders. Accordingly, on or about April&#160;4, 2023, we will begin mailing a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;), to all stockholders of record as of March&#160;20, 2023, and will have posted our proxy materials on the website referenced in the Notice (<span style="font-weight:bold">www.virtualshareholdermeeting.com/XOMA2023</span>). As more fully described in the Notice, all stockholders may choose to access our proxy materials on that website, and any stockholder may request a printed set of such materials. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hope that you will attend the online annual meeting. In any event, please promptly vote your proxy by accessing the internet, via the toll-free telephone number in the Notice or, if you have elected to receive a paper copy of the proxy materials, by completing, signing and returning the proxy card that is provided. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:100%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely yours,</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt;margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<img src="g344283g02g02.jpg" alt="LOGO" />
</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Owen Hughes</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Executive Chairman and Interim Chief Executive Officer</p></td></tr>
</table></div> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">XOMA CORPORATION </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2200 Powell Street, Suite 310 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Emeryville, California 94608 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(510) <span style="white-space:nowrap">204-7200</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO BE HELD AT 9:00 A.M. PACIFIC TIME ON MAY&#160;17, 2023 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders of XOMA Corporation: </p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The annual meeting of stockholders of XOMA Corporation (the &#8220;Company&#8221;) will be held virtually via live webcast at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span> on May&#160;17, 2023, at 9:00 a.m. Pacific Time, for the following purposes: </p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect our nominees for director; </p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to the XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 709,000 shares; </p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify the appointment of Deloitte&#160;&amp; Touche LLP to act as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2023; </p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">4.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in this proxy statement; </p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">5.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers; and </p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">6.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To consider and transact such other business as may properly come before the meeting or any adjournment or postponement thereof. </p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These items of business are more fully described in the proxy statement accompanying this notice. </p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors has fixed the close of business on March&#160;20, 2023 as the record date for the determination of stockholders entitled to notice of, and to vote at, this meeting and at any adjournment or postponement thereof. On March&#160;20, 2023, the Company had 11,460,968 shares of common stock issued and outstanding. The proxy materials prepared in connection with the annual meeting are being made available at <span style="font-weight:bold">www.virtualshareholdermeeting.com/XOMA2023</span>. </p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap">


<img src="g344283g04g51.jpg" alt="LOGO" />
 <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Thomas Burns</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Senior Vice President, Finance and Chief Financial Officer</td></tr>
</table></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">This proxy statement and the related proxy card are being sent or made available </span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">on or about April&#160;4, 2023. </span></p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">You are cordially invited to attend the meeting online. Whether or not you expect to attend the meeting, please complete, date, sign and return the proxy mailed to you, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote online if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">XOMA CORPORATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROXY STATEMENT </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">TO THE STOCKHOLDERS: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The enclosed proxy is solicited on behalf of the Board of Directors (the &#8220;Board&#8221;) of XOMA Corporation, a Delaware corporation (&#8220;XOMA&#8221; or the &#8220;Company&#8221;), for use at the annual meeting of stockholders to be held virtually via live webcast at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span> at 9:00 a.m. Pacific Time on May&#160;17, 2023, or any adjournment or postponement thereof, at which stockholders of record holding shares of common stock on March&#160;20, 2023 will be entitled to vote. On March&#160;20, 2023, the Company had issued and outstanding 11,460,968 shares of common stock, par value $0.0075 per share (&#8220;Common Stock&#8221;). Holders of Common Stock are entitled to one vote for each share held. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why did I receive a notice regarding the availability of proxy materials on the internet? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#8220;SEC&#8221;), instead of mailing a printed copy of our proxy materials, including our Annual Report on Form <span style="white-space:nowrap">10-K,</span> to each stockholder of record, we have decided to provide access to these materials via the internet to all of our stockholders. This method reduces the amount of paper necessary to produce these materials, as well as the costs associated with mailing these materials to all stockholders. Accordingly, on or about April&#160;4, 2023, we will begin mailing a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;) to stockholders of record as of March&#160;20, 2023, and will have posted our proxy materials on the website referenced in the Notice (<span style="font-weight:bold">www.virtualshareholdermeeting.com/XOMA2023</span>). All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will I receive any other proxy materials by mail? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may send you a proxy card, along with a second Notice, on or after April&#160;14, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I attend the annual meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The meeting will be held virtually on May&#160;17, 2023 at 9:00 a.m. Pacific Time via live webcast at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span>. You are entitled to attend the annual meeting if you were a stockholder as of the close of business on March&#160;20, 2023, the record date, or hold a valid proxy for the meeting. To be admitted to the annual meeting, you will need the <span style="white-space:nowrap">16-digit</span> control number included in the Notice, on your proxy card or on the instructions that accompanied your proxy materials. If you are a beneficial stockholder, you should contact the bank, broker or other institution where you hold your account well in advance of the meeting if you have questions about obtaining your control number or proxy to vote. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We encourage you to access the annual meeting before it begins. Online <span style="white-space:nowrap">check-in</span> will begin at 8:45 a.m. Pacific Time and you should allow ample time for the <span style="white-space:nowrap">check-in</span> procedures. The virtual meeting has been designed to provide the same rights to participate as you would have at an <span style="white-space:nowrap">in-person</span> meeting. Information on how to vote before and during the annual meeting is discussed below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I ask questions at the annual meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the annual meeting, you may only submit questions in the question box provided at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span>. We will respond to as many inquiries at the annual meeting as time allows. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I have technical difficulties or trouble accessing the virtual meeting website? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you encounter any difficulties accessing the virtual annual meeting webcast during the <span style="white-space:nowrap">check-in</span> or meeting time, please call the technical support number that will be posted on the annual meeting website <span style="white-space:nowrap">log-in</span> page. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I cannot virtually attend the annual meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote your shares electronically before the meeting by internet, by proxy or by telephone as described below. You do not need to access the annual meeting webcast to vote if you submitted your vote via proxy, by internet or by telephone in advance of the annual meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will a list of record stockholders as of the record date be available? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the ten days ending <span style="font-style:italic">the day prior to</span> the annual meeting, a list of our record stockholders as of the close of business on the record date will be available for examination by any stockholder of record for a legally valid purpose. For access to the stockholder list, please contact us at InvestorRelations@xoma.com. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I vote my shares? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may either vote &#8220;For&#8221; all the nominees to the Board or you may &#8220;Withhold&#8221; your vote for any nominee you specify. With regard to your advisory vote on how frequently we solicit stockholder advisory approval of executive compensation, you may vote for any one of the following: one year, two years or three years, or you may abstain from voting on that matter. For each of the other matters to be voted on, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The procedures for voting are fairly simple: </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Stockholder of Record: Shares Registered in Your Name </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, you may vote online at the annual meeting, vote by proxy over the telephone, vote by proxy through the internet or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote at the meeting even if you have already voted by proxy. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To vote using the proxy card, simply complete, sign, and date the proxy card, that may be delivered and return it promptly in the envelope provided. If you return your signed proxy card to us before the annual meeting, we will vote your shares as you direct us to. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To vote over the telephone, dial toll-free<span style="font-weight:bold"> <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903</span></span></span></span> and follow the recorded instructions. You will be asked to provide the company number and control number from the Notice. Your telephone vote must be received by 11:59 p.m. Eastern Time on May&#160;16, 2023 to be counted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To vote through the internet <span style="font-weight:bold"><span style="font-style:italic">prior</span></span> to the annual meeting, you may vote via the internet at<span style="font-weight:bold"> www.proxyvote.com</span> by following the <span style="white-space:nowrap">on-screen</span> instructions. You will be asked to provide the company number and control number from the Notice. Your internet vote must be received by 11:59 p.m., Eastern Time on May&#160;16, 2023 to be counted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To vote through the internet <span style="font-weight:bold"><span style="font-style:italic">during</span></span> the annual meeting, if you are a stockholder of record as of the record date, please follow the instructions at<span style="font-weight:bold"> www.virtualshareholdermeeting.com/XOMA2023</span>. You will need to enter the <span style="white-space:nowrap">16-digit</span> control number included on your Notice, proxy card or notice you receive or in the email sending you the Proxy Statement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Beneficial Owner: Shares Registered in the Name of Broker or Bank </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from the Company. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote <span style="font-style:italic">prior to the meeting</span>, simply following the voting instructions in the Notice to ensure that your vote is counted. To vote through the internet during the annual meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy form. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I return a proxy card or otherwise vote but do not make specific choices? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All shares represented by a valid proxy to the annual meeting will be voted, and, if you provide specific instructions, your shares will be voted as you instruct. If you sign your proxy card with no further instruction and do not hold your shares beneficially thorough a broker, bank or other nominee, your shares will be voted: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">FOR each of the nominees for the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">FOR the approval of an amendment to the XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan to increase the aggregate number of shares of Common Stock authorized for issuance thereunder by 709,000 shares; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">FOR the appointment of Deloitte&#160;&amp; Touche LLP to act as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2023; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">FOR the approval of the compensation of the Company&#8217;s named executive officers, as disclosed in this proxy statement in accordance with SEC rules; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Three Years as the preferred frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Can I revoke my proxy? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder of Record: Shares Registered in Your Name </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may send a timely written notice of such revocation to the Secretary of the Company at the Company&#8217;s principal office, 2200 Powell Street, Suite 310, Emeryville, California 94608. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may attend the annual meeting and vote online. Simply attending the meeting will not, by itself, revoke your proxy. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may submit a properly completed proxy card with a later date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">You may grant a subsequent proxy by telephone or through the internet. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most current proxy card or telephone or internet proxy is the one that is counted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Owner: Shares Registered in the Name of Broker or Bank </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What does it mean if I receive more than one Notice? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Notices to ensure that all of your shares are voted. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How are votes counted? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Votes will be counted by the inspector of election appointed for the meeting, who will separately count, for the proposal to elect directors, votes &#8220;For,&#8221; &#8220;Withhold&#8221; and broker <span style="white-space:nowrap">non-votes;</span> with respect to the proposal regarding frequency of stockholder advisory votes to approve executive compensation, votes for frequencies of one year, two years or three years, abstentions and broker <span style="white-space:nowrap">non-votes;</span> and, with respect to the other proposals, votes &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and, if applicable, broker <span style="white-space:nowrap">non-votes.</span> Abstentions will be counted towards the vote total for each of Proposals 2, 3 and 4, and will have the same effect as &#8220;Against&#8221; votes. For Proposal 5, abstentions will be counted towards the vote total, and will have the same effect as votes against each of the proposed voting frequencies. Broker <span style="white-space:nowrap">non-votes</span> on Proposals 1, 2, 4 and 5 will have no effect and will not be counted towards the vote total for any of those proposals. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What are &#8220;broker <span style="white-space:nowrap">non-votes&#8221;?</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed above, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under NYSE rules, the broker, bank or other such agent cannot vote the shares. These <span style="white-space:nowrap">un-voted</span> shares are counted as &#8220;broker <span style="white-space:nowrap">non-votes.&#8221;</span> Proposals 1, 2, 4 and 5 are considered to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under NYSE rules and we therefore expect broker <span style="white-space:nowrap">non-votes</span> to exist in connection with those proposals. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you <span style="text-decoration:underline">must</span> provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many votes are needed to approve each proposal? </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 1 &#8211; For the election of directors, the seven nominees receiving the most &#8220;For&#8221; votes from the holders of shares present virtually or represented by proxy and entitled to vote on the election of directors will be elected. Only votes &#8220;For&#8221; will affect the outcome. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 2 &#8211; To approve an amendment to the XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan to increase the aggregate number of shares of Common Stock authorized for issuance thereunder by 709,000 shares, the proposal must receive &#8220;For&#8221; votes from the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter. If you<span style="font-weight:bold"> </span>mark your proxy to &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote. Broker <span style="white-space:nowrap">non-votes</span> will have no effect. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 3 &#8211; To ratify the selection of Deloitte&#160;&amp; Touche LLP as our independent registered public accounting firm for the year ending December&#160;31, 2023, the proposal must receive &#8220;For&#8221; votes from the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter. If you &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 4 &#8211; To provide advisory approval of the compensation of the Company&#8217;s named executive officers, the proposal must receive &#8220;For&#8221; votes from the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter. If you mark your proxy to &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote. Broker <span style="white-space:nowrap">non-votes</span> will have no effect. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 5 &#8211; For the advisory vote on the frequency of stockholder advisory votes on executive compensation, the frequency receiving the votes of the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter at the annual meeting will be considered the frequency preferred by the stockholders. If you mark your proxy to &#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote on each of the proposed voting frequencies. Broker <span style="white-space:nowrap">non-votes</span> will have no effect. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is the quorum requirement? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid meeting. The presence, virtually or by proxy, of at least a majority of the shares of Common Stock outstanding on the record date will constitute a quorum. On the record date, there were 11,460,968 shares<span style="font-weight:bold"> </span>outstanding and entitled to vote.<sup style="font-size:75%; vertical-align:top"> </sup>Thus, the holders of 5,730,485 shares must be present virtually or represented by proxy at the meeting to have a quorum. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote online at the meeting. Abstentions and broker <span style="white-space:nowrap">non-votes</span> will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting or represented by proxy may adjourn the meeting to another date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who is paying for this proxy solicitation? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will bear the entire cost of solicitation of stockholder votes, including preparation, assembly, printing, and delivery of this proxy statement, the proxy card, and any additional solicitation material furnished to stockholders. Copies of solicitation material will be furnished to brokerage houses, fiduciaries, and custodians holding in their names shares of Common Stock that are beneficially owned by others to forward to such beneficial owners. The solicitation of proxies may be supplemented by telephone, electronic or personal solicitation by directors, officers, or employees of the Company for no additional compensation. Stockholders appointing a proxy through the internet should understand that there may be costs associated with electronic access, such as usage charges from internet access providers, which will be borne by the stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How can I find out the results of the voting at the annual meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at the annual meeting. In addition, final voting results will be published in a current report on Form <span style="white-space:nowrap">8-K</span> that we expect to file within four business days after the annual meeting. If final voting results are not available to us in time to file a Form <span style="white-space:nowrap">8-K</span> within four business days after the meeting, we intend to file a Form <span style="white-space:nowrap">8-K</span> to publish preliminary results and, within four business days after the final results are known to us, file an additional Form <span style="white-space:nowrap">8-K</span> to publish the final results. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROPOSAL 1&#8212;ELECTION OF DIRECTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board presently consists of eight directors. W. Denman Van Ness<span style="font-style:italic"> </span>is transitioning from the Board effective immediately prior to the annual meeting, and, effective as of the date of the annual meeting, the Board size will be seven directors. Each director to be elected and qualified will hold office until the next annual meeting of stockholders and until their successors are elected, or, if sooner, until their death, resignation or removal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nominees for the Board nominated for election by our Nominating&#160;&amp; Governance Committee are set forth below. Each person nominated for election has been previously elected by our stockholders, except for Owen Hughes, who was appointed to our Board in January 2023 upon recommendation by our Nominating&#160;&amp; Governance Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes of the holders of shares present virtually or represented by proxy and entitled to vote on the election of directors. Accordingly, the seven nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the seven nominees named below. Each person nominated for election has agreed to serve if elected, and the Company&#8217;s management has no reason to believe that any of the nominees listed below will be unable to serve. Unless otherwise instructed, the proxy holders will vote all proxies received by them on the accompanying form for the nominees for director listed below. In the event any nominee should become unavailable for election due to an unexpected occurrence, the proxies will be voted for any such substitute nominee as may be designated by the present Board to fill the vacancy. In the event that additional persons are nominated for election as directors, the proxy holders intend to vote all proxies received by them for the nominees listed below. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Nominees to the Board </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:34%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:58%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Title</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owen Hughes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Executive Chairman of the Board and Interim Chief Executive Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">48</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Franklin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">57</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natasha Hernday</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">51</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Kosacz</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">65</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph M. Limber</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">70</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Perry</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">50</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jack L. Wyszomierski</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">67</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Owen</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Hughes</span> has been our Executive Chairman of the Board and Interim Chief Executive Officer since January&#160;2023. Mr.&#160;Hughes has served as the Chief Executive Officer of Sail Bio, Inc., a private biotechnology company focused on addressing toxic proteinopathies, since February 2022 and served as the Chief Executive Officer <span style="white-space:nowrap">and&#160;co-founder&#160;of</span> Cullinan Oncology, Inc., a publicly-traded oncology company, from September 2017 to October 2021. Previously, Mr.&#160;Hughes served as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, Inc., a biotechnology company focused on type II diabetes, from February 2013 to August 2017. Prior to his operating roles, Mr.&#160;Hughes spent 16 years on Wall Street in various capacities, including roles at Brookside Capital, an operating division of Bain Capital and Pyramis Global Advisors, a Fidelity Investments Company. Mr.&#160;Hughes has served on the board of directors of Ikena Oncology, Inc., a publicly-traded oncology company, since December 2022. Mr.&#160;Hughes served on the board of directors of Radius Health, Inc., a publicly-traded biopharmaceutical company, from April 2013 to August 2022 until its sale to Gurnet Point Capital and Patient Square Capital; Translate Bio, Inc., a messenger RNA therapeutics company, from July 2016 until its acquisition by Sanofi in September 2021; and FS Development Corp. II, a special </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purpose acquisition company sponsored by Foresite Capital, from February 2021 to December 2021. Mr.&#160;Hughes received a B.A. in History from Dartmouth College. Mr.&#160;Hughes has significant experience with biopharmaceutical companies and brings the unique perspective of the Interim Chief Executive Officer of the Company to the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Heather L. Franklin</span> has been a director since August 2021. Ms.&#160;Franklin has over 20 years of broad biotechnology expertise. She founded Blaze Bioscience, Inc. in 2011 and has led the company from its infancy to become a clinical-stage company. Prior to establishing Blaze and serving as its President and CEO, Ms.&#160;Franklin spent 10 years at ZymoGenetics in positions of increasing responsibility, ultimately serving as senior vice president, business development, where she was a member of the executive management team and was responsible for business development, alliance management, strategic planning, portfolio management and pipeline marketing. Earlier in her career, she held roles in program management at Amgen and Targeted Genetics. Ms.&#160;Franklin received her MBA from The Wharton School of the University of Pennsylvania, her M.S. from the University of Washington and her B.S. from University of North Carolina at Chapel Hill. Ms.&#160;Franklin brings to the Board extensive executive management experience in the biotechnology industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Natasha Hernday</span> has been a director since July 2020. Ms.&#160;Hernday is the Chief Business Officer and a member of the Executive Committee for the publicly traded biotechnology company Seagen, Inc. She has worked for Seagen since 2011. From 1994 through 2010, after starting her career in molecular and mammalian cell biology, Ms.&#160;Hernday served in various roles of increasing responsibility at Amgen Inc., including as Director, Mergers&#160;&amp; Acquisitions and as Director, <span style="white-space:nowrap">Out-Partnering.</span> She serves on the Board of Directors for Alpine Immune Sciences, Inc. and on the Knight Campus External Advisory Board for the University of Oregon. Ms.&#160;Hernday previously served on the Board of Directors of PDL BioPharma, Inc. Ms.&#160;Hernday received her BA in microbiology from the University of California at Santa Barbara and MBA from Pepperdine University. Ms.&#160;Hernday brings to the Board extensive experience in advising biotechnology companies on matters of corporate strategy and partnership. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Barbara Kosacz</span> has been a director since January 2019. Ms.&#160;Kosacz has been Chief Operating Officer and General Counsel at Kronos Bio, Inc. since July 2020. Ms.&#160;Kosacz was previously a partner at Cooley LLP since 2002 and has more than 25 years of experience in counseling clients in the life sciences arena, ranging from early stage startups to larger public companies, venture funds, investment banks and <span style="white-space:nowrap">non-profit</span> institutions. She serves on the board of directors of Phoenix Biotech Acquisition Corp., a blank-check company formed for the purpose of acquiring or merging with one or more businesses, the board of directors of Athira Pharma, Inc., has served as a member of the BIO Emerging Companies&#8217; Section Governing Board, is a member of the Board of Trustees of the Keck Graduate Institute, an advisory board member of Locust Walk Partners, and has been a speaker at multiple life sciences-related conferences, as well as guest lecturer at the University of California, Berkeley (Boalt Hall), Stanford University, the University of Pennsylvania and Columbia University on biotechnology law, biotech business models, corporate partnering negotiations and deal structures and bioethics. Recognized by<span style="font-style:italic"> Best Lawyers</span> in America since 2008, Ms.&#160;Kosacz and was listed as a &#8220;leading lawyer&#8221; for healthcare and life sciences in the 2018<span style="font-style:italic"> Legal 500</span>, as a &#8220;Band 1&#8221; attorney in the 2018 edition of<span style="font-style:italic"> Chambers USA: America&#8217;s Leading Lawyers for Business</span> and recognized as a &#8220;highly recommended transactions&#8221; lawyer by<span style="font-style:italic"> IAM Patent 1000</span> for her &#8220;nearly three decades advising diverse companies in the industry at a deeply strategic and commercial level and overseeing their most complex and profitable deals.&#8221; She received her Juris Doctor degree from the University of California, Berkeley School of Law, and her bachelor&#8217;s degree from Stanford University. Ms.&#160;Kosacz brings extensive experience in advising biotechnology companies to the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Joseph M. Limber</span> has been a director since December 2012. Mr.&#160;Limber currently serves as President and Chief Executive Officer and a member of the Board of Directors of Secura Bio, Inc., a position he has held since February 2019. Prior to that, Mr.&#160;Limber served as President and Chief Executive Officer of Genoptix, Inc. from March 2017 through December 2018. Mr.&#160;Limber served as Executive Chairman of ImaginAb from January 2016 through November 2017. Mr.&#160;Limber served as President and Chief Executive Officer of Gradalis, Inc. from July 2013 through April 2015. Mr.&#160;Limber served as President and Chief Executive Officer of Prometheus </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Laboratories Inc., a subsidiary of Nestl&#233; Health Science, from December 2003 through April 2013 and as a member of its Board of Directors from January 2004 through April 2013. From January 2003 to July 2003, Mr.&#160;Limber was a consultant and interim Chief Executive Officer for Deltagen, Inc., a provider of drug discovery tools and services to the biopharmaceutical industry. From April 1998 to December 2002, Mr.&#160;Limber was the President and Chief Executive Officer of ACLARA BioSciences, Inc. (now Monogram Biosciences, Inc.), a developer of assay technologies and <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">lab-on-a-chip</span></span></span> systems for life science research. From 1996 to 1998, he was the President and Chief Operating Officer of Praecis Pharmaceuticals, Inc. (acquired by GlaxoSmithKline plc), a biotechnology company focused on the discovery and development of pharmaceutical products. Prior to Praecis, Mr.&#160;Limber served as Executive Vice President of SEQUUS Pharmaceuticals, Inc. (acquired by Alza Corporation and now part of the Johnson&#160;&amp; Johnson family of companies). He also held management positions in marketing and sales with Syntex Corporation (now F. <span style="white-space:nowrap">Hoffmann-La</span> Roche Ltd.) and with Ciba-Geigy Corporation (now Novartis AG). Mr.&#160;Limber holds a B.A. from Duquesne University. Mr.&#160;Limber brings to the Board his experience in successfully developing markets for specialty pharmaceutical products and managing the critical transition from research organization to commercial entity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Matthew Perry</span> has been a director since February 2017. Mr.&#160;Perry is the President of Biotechnology Value Fund Partners L.P. (&#8220;BVF&#8221;) and portfolio manager for the underlying funds managed by the firm. BVF Partners is a private investment partnership that has focused on <span style="white-space:nowrap">small-cap,</span> value-oriented investment opportunities for more than 20 years. Mr.&#160;Perry joined BVF Partners in December 1996 and has been a successful lead investor in dozens of transactions. He has positively influenced corporate direction for numerous biotechnology companies during the course of his career. In January 2016, Mr.&#160;Perry was named to CTI BioPharma Corp.&#8217;s Board of Directors and is a member of its Compensation Committee. Mr.&#160;Perry is also a <span style="white-space:nowrap">co-founder</span> and director of Nordic Biotech Advisors ApS, a venture capital firm based in Copenhagen, Denmark. He holds a B.S. degree from the Biology Department at the College of William and Mary. Mr.&#160;Perry brings extensive management consulting experience and experience investing in biotechnology companies to the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Jack L. Wyszomierski</span> has been a director since August 2010. From 2004 until his retirement in 2009, Mr.&#160;Wyszomierski was Executive Vice President and Chief Financial Officer of VWR International, LLC, a global laboratory supply, equipment and distribution business that serves the world&#8217;s pharmaceutical and biotechnology companies, as well as industrial and governmental organizations. At Schering-Plough, a global health care company which had worldwide sales of over $8&#160;billion in 2004, Mr.&#160;Wyszomierski held positions of increasing responsibility from 1982 to 2004 culminating in his appointment as Executive Vice President and Chief Financial Officer. Mr.&#160;Wyszomierski also serves on the Board of Directors of Athersys, Inc., Exelixis, Inc. and SiteOne Landscape Supply, Inc., and served on the Board of Directors of Unigene Laboratories, Inc. from 2012 to 2013. He holds an M.S. in Industrial Administration and a B.S. in Administration, Management Science and Economics from Carnegie Mellon University. Mr.&#160;Wyszomierski brings his considerable financial expertise to the Board, the Audit Committee and the Compensation Committee. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">T<small>HE</small> B<small>OARD</small> R<small>ECOMMENDS</small> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">A V<small>OTE</small> I<small>N</small> F<small>AVOR</small> O<small>F</small> E<small>ACH</small> N<small>AMED</small> N<small>OMINEE</small>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Board Diversity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the global and complex nature of our business, the Board believes it is important to consider diversity of race, ethnicity, gender, sexual orientation, age, education, cultural background and professional experiences in evaluating board candidates in order to provide practical insights and diverse perspectives. Below is an overview of our director nominee diversity. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:62%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td></tr>
<tr style="font-size:1pt">
<td colspan="9" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="9" align="center" style="BORDER-LEFT:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:bottom"><span style="font-weight:bold">Board Diversity Matrix (As of April&#160;4, 2023)</span></td></tr>


<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Number of Directors</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom">8</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;vertical-align:top">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000;vertical-align:top"><span style="font-weight:bold">Female</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000;vertical-align:top"><span style="font-weight:bold">Male</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000;vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-</span></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Binary</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:top"><span style="font-weight:bold">Did Not<br />Disclose<br />Gender</span></td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Part I: Gender Identity</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">3</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">5</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Part II: Demographic Background</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">African American or Black</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alaskan Native or Native American</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asian</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hispanic or Latinx</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">1</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Native Hawaiian or Pacific Islander</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">White</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">2</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">5</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two or More Races or Ethnicities</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
<tr style="font-size:1pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LGBTQ+</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom">1</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:3pt">&#160;</td>
<td colspan="8" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Did Not Disclose Demographic Background</p></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" align="center" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap">&#8212;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Please refer to our definitive proxy statement filed with the SEC on April&#160;7, 2022 for the Board Diversity Matrix as of April&#160;6, 2022. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Board Leadership Structure and Risk Oversight </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board is currently chaired by the Executive Chairman of the Board and Interim Chief Executive Officer of the Company, Owen Hughes. W. Denman Van Ness<span style="font-style:italic"> </span>has served as our Lead Independent Director since January 2008. After the annual meeting, Jack L. Wyszomierski will assume the role of the Lead Independent Director. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Combining the positions of Chief Executive Officer and Executive Chairman helps to ensure that the Board and management act with a common purpose, while separating the positions of Chief Executive Officer and Executive Chairman has the potential to give rise to divided leadership, which could interfere with good decision-making or weaken the Company&#8217;s ability to develop and implement strategy. Combining the positions of Chief Executive Officer and Executive Chairman provides a single, clear chain of command to execute the Company&#8217;s strategic initiatives and business plans. In addition, a combined Chief Executive Officer/Executive Chairman acts as a bridge between management and the Board, facilitating the regular flow of information. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board appointed Mr.&#160;Wyszomierski as the Lead Independent Director to help reinforce the independence of the Board as a whole. The position of Lead Independent Director has been structured to serve as an effective balance to a combined Chief Executive Officer/Executive Chairman of the Board: the Lead Independent Director is empowered to, among other duties and responsibilities, approve agendas and meeting schedules for regular Board meetings, preside over Board meetings in the absence of the Executive Chairman, preside over and establish the agendas for meetings of the independent directors, act as liaison between the Executive Chairman and the independent directors, approve information sent to the Board, preside over any portions of Board meetings at which the evaluation or compensation of the Chief Executive Officer is presented or discussed and, as appropriate upon request, act as a liaison to stockholders. In addition, it is the responsibility of the Lead Independent Director to coordinate between the Board and management with regard to the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determination and implementation of responses to any problematic risk management issues. As a result, the Company believes that the Lead Independent Director can help ensure the effective independent functioning of the Board in its oversight responsibilities. In addition, the Company believes that the Lead Independent Director is better positioned to build a consensus among directors and to serve as a conduit between the other independent directors and the Executive Chairman, for example, by facilitating the inclusion on meeting agendas of matters of concern to the independent directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the Board&#8217;s key functions is informed oversight of the Company&#8217;s risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As set forth in the Audit Committee charter, the Audit Committee oversees the accounting and financial reporting policies and practices of the Company, the effectiveness of the Company&#8217;s internal controls over financial reporting and, as appropriate, the internal controls of certain service providers. In addition, the Audit Committee oversees the quality and objectivity of the financial statements of the Company and the independent audit thereof and acts as a liaison between the Company&#8217;s independent registered public accountant and the Board. While the Audit Committee has the general function of oversight, the management of the Company has the responsibility to maintain appropriate systems for accounting and internal control and the independent registered public account has the responsibility to plan and carry out a proper audit. In order to carry out its purposes, the Audit Committee meets periodically with management in order to review the Company&#8217;s major financial exposures and the steps management has taken to monitor and control such exposures. In fulfilling this role, the Audit Committee conducts periodic risk assessments and reports its findings to the full Board. The Audit Committee also oversees related-party transactions. As part of its oversight, the Compensation Committee reviews the Company&#8217;s practices and policies of employee compensation to determine whether there is a risk of a material adverse effect on the Company. To fulfill its role, the Compensation Committee makes regular reports to the Board. The Nominating&#160;&amp; Governance Committee has the primary responsibility for evaluating nominees to the Board, the organization and composition of the Board and the potential risks therein. In fulfilling its role, the Nominating&#160;&amp; Governance Committee makes regular reports to the Board. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Independence of the Board of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under the Nasdaq Stock Market (&#8220;Nasdaq&#8221;) listing standards, a majority of the members of a listed company&#8217;s board of directors must qualify as &#8220;independent,&#8221; as affirmatively determined by the board of directors. The Board consults with the Company&#8217;s counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating committees be independent within the meaning of Nasdaq rules. Audit committee members must also satisfy the independence criteria set forth in Rule <span style="white-space:nowrap">10A-3</span> under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board undertook a review of the independence of each director and considered whether any director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. As a result of this review, our Board has affirmatively determined that each of Ms.&#160;Franklin, Ms.&#160;Hernday, Ms.&#160;Kosacz, Mr.&#160;Limber, Mr.&#160;Perry and Mr.&#160;Wyszomierski qualifies as an &#8220;independent&#8221; director within the meaning of the applicable Nasdaq listing standards. Accordingly, a majority of our directors are independent, as required under Nasdaq rules. Our Board has affirmatively determined that Mr.&#160;Hughes is not considered independent given his position as our Interim Chief Executive Officer. In addition, our Board previously determined that Mr.&#160;Neal, who served as a director during 2022 and does not stand <span style="white-space:nowrap">for&#160;re-election&#160;at</span> the annual meeting was not independent given his former position as our Chief Executive Officer. Our <span style="white-space:nowrap">non-employee</span> directors have been meeting, and we anticipate that they will continue to meet, in regularly scheduled executive sessions at which only <span style="white-space:nowrap">non-employee</span> directors are present. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the members of the Compensation Committee are &#8220;independent,&#8221; as required by Nasdaq Rules 5605(a)(2) and 5605(d)(2). In determining independence within the meaning of Nasdaq Rules pertaining to membership of the Compensation Committee, our Board determined, based on its consideration of factors specifically relevant to determining whether any such director has a relationship to us that is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, that no member of the Compensation Committee has a relationship that would impair that member&#8217;s ability to make independent judgments about our executive compensation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Board Meetings </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&#160;31, 2022, the Board held six meetings. All directors attended at least 75% of the aggregate number of meetings of the Board and the committees of the Board on which he or she served that were held during the portion of the last fiscal year for which he or she was a director or committee member, respectively. Directors are encouraged to attend the Company&#8217;s annual meeting of stockholders where practicable. All directors serving at the time of the 2022 annual meeting attended last year&#8217;s annual meeting of stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has standing compensation, nominating&#160;&amp; governance and audit committees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for recommending and reviewing the compensation, including options and perquisites, of the Company&#8217;s officers and other employees generally, but only reviews and individually approves the compensation for our executive officers, including the named executive officers (other than our Interim Chief Executive Officer). With respect to the compensation of our Interim Chief Executive Officer, final decisions are made by the independent members of our Board, upon the recommendations of the Compensation Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In making its executive compensation determinations, the Compensation Committee receives input from its compensation consultant, Compensia, Inc., a national compensation consulting firm that specializes in executive compensation matters (&#8220;Compensia&#8221;) as well as recommendations from our Interim Chief Executive Officer, although no member of management is present for, or participates in, decisions regarding his or her own compensation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In discharging its responsibilities, the Compensation Committee works with members of our management team, including our Interim Chief Executive Officer. The management team assists the Compensation Committee by providing information on Company and individual performance, market data, and management&#8217;s perspective and recommendations on compensation matters. The Compensation Committee solicits and reviews our Interim Chief Executive Officer&#8217;s recommendations and proposals with respect to adjustments to base salaries, cash incentive compensation, long-term incentive compensation opportunities, program structures, and other compensation-related matters for our executive officers (other than with respect to his own compensation). The Compensation Committee reviews and discusses these recommendations and proposals with our Interim Chief Executive Officer and uses them as one factor in determining and approving the compensation for our executive officers (other than our Interim Chief Executive Officer). Our Interim Chief Executive Officer recuses himself from all discussions and recommendations regarding his own compensation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under its charter, the Compensation Committee has the authority to engage the services of outside advisors, experts, and others to assist it in the discharge of its responsibilities. In accordance with this authority, the Compensation Committee has retained the services of Compensia to assist it in evaluating our executive compensation program, gathering and analyzing data on the competitive market for executive talent, and formulating and assessing potential changes to our executive compensation program. Compensia serves at the discretion of the Compensation Committee, which reviews Compensia&#8217;s engagement annually. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee regularly reviews the objectivity and independence of the advice provided by Compensia on executive compensation matters. In 2022, the Compensation Committee considered the six specific independence factors adopted by the SEC and Nasdaq and determined that Compensia was independent and that its work did not raise any conflicts of interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2022, the Compensation Committee held three meetings and consisted of Mr.&#160;Wyszomierski (former Chair), Mr.&#160;Perry, Mr.&#160;Van Ness and Ms.&#160;Franklin. In February 2023, Ms.&#160;Franklin was appointed Chair of the Compensation Committee. The Board has adopted a written charter for the Compensation Committee, a copy of which is available on the Company&#8217;s website at<span style="font-style:italic"> https://investors.xoma.com/corporate-governance/governance-documents</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nominating&#160;&amp; Governance Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating&#160;&amp; Governance Committee assists the Board by identifying individuals qualified to become Board members, recommends to the Board the director nominees for the next annual meeting of stockholders, recommends to the Board the director nominees for each committee and develops, recommends to the Board and oversees the governance principles applicable to the Company. The Nominating&#160;&amp; Governance Committee held three meetings in 2022. During 2022, the Nominating&#160;&amp; Governance Committee consisted of Ms.&#160;Kosacz (former Chair), Ms.&#160;Hernday (current Chair), Mr.&#160;Van Ness and Mr.&#160;Wyszomierski. In February 2022, Mr.&#160;Wyszomierski stepped down from the Nominating&#160;&amp; Governance Committee and Ms.&#160;Hernday was appointed as the Chair. Since February 2022, the Nominating&#160;&amp; Governance Committee has consisted of Ms.&#160;Hernday (Chair), Ms.&#160;Kosacz and Mr.&#160;Van Ness. Each member of the Nominating&#160;&amp; Governance Committee is &#8220;independent&#8221; as defined in Rule 5605(a)(2) of the Nasdaq listing standards. The Board has adopted a written charter for the Nominating&#160;&amp; Governance Committee, a copy of which is available on the Company&#8217;s website at<span style="font-style:italic"> https://investors.xoma.com/corporate-governance/governance-documents</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating&#160;&amp; Governance Committee&#8217;s charter provides that the committee will, on behalf of the Board, review letters from stockholders regarding the Company&#8217;s annual meeting and governance process. Beyond this review, the committee has no formal policy regarding consideration of director candidates recommended by stockholders, in large part because the Company has never received from any of its stockholders a recommendation of a director nominee with reasonably adequate qualifications. The need for a more formal policy was considered and determined to be unnecessary by the committee. The committee will consider candidates recommended by stockholders, and a stockholder wishing to submit a recommendation should send a letter to the Secretary of the Company at 2200 Powell Street, Suite 310, Emeryville, California 94608. The mailing envelope must contain a clear notation indicating that the enclosed letter is a &#8220;Director Nominee Recommendation.&#8221; The letter must identify the author as a stockholder and provide a complete listing of the candidate&#8217;s qualifications to serve on the Board, the candidate&#8217;s current principal occupation, most recent five-year employment history and current directorships and a statement that the proposed nominee has consented to the nomination, as well as contact information for both the candidate and the author of the letter. Stockholders may also nominate candidates who are not first recommended to the Nominating&#160;&amp; Governance Committee by following the procedures set forth in our <span style="white-space:nowrap">By-laws.</span> The Nominating&#160;&amp; Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered by the Nominating&#160;&amp; Governance Committee, a director nominee must have experience as a board member or senior officer of a company, have a strong financial background, be a leading participant in a field relevant to the Company&#8217;s business or have achieved national prominence in a relevant field as a faculty member, professional or government official. In addition to these minimum requirements, the committee seeks director candidates based on a number of qualifications, including their independence, knowledge, judgment, leadership skills, education, experience, financial literacy, standing in the community and ability to foster a diversity of backgrounds and views and complement the Board&#8217;s existing strengths. The Board believes that diversity with respect to all of these factors, including diversity of personal background, business and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
professional background, perspective, experience and other characteristics, such as gender, gender identity, ethnicity, sexual orientation and age, is an important consideration in appropriate Board composition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board and the Nominating&#160;&amp; Governance Committee continues the process of identifying and evaluating director nominees by seeking recommendations from a wide variety of contacts, which may include current executive officers and directors and industry, academic and community leaders. The Board or the committee may retain search firms to identify and screen candidates, conduct reference checks, prepare biographies for review by the committee and the Board and assist in setting up interviews. The Nominating&#160;&amp; Governance Committee, and one or more of the Company&#8217;s other directors, interview candidates, and the committee selects and recommends to the full Board nominees that best suit the Company&#8217;s needs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board was established by the Board in accordance with Section&#160;3(a)(58)(A) of the Exchange Act to oversee the Company&#8217;s corporate accounting and financial reporting processes and audits of its financial statements. The Audit Committee is primarily responsible for approving the services performed by the Company&#8217;s independent registered public accounting firm and reviewing the Company&#8217;s accounting practices and systems of internal accounting controls. The Audit Committee held four meetings in 2022. Until February 2022, the Audit Committee consisted of Mr.&#160;Limber (Chair), Ms.&#160;Hernday, Mr.&#160;Van Ness and Mr.&#160;Wyszomierski. In February 2022, Ms.&#160;Hernday stepped down from the Audit Committee. From February 2022 onwards, the Audit Committee consisted of Mr.&#160;Limber (Chair), Mr.&#160;Van Ness and Mr.&#160;Wyszomierski. At the time of the annual meeting, Ms.&#160;Hernday will join the Audit Committee to fill the vacancy after Mr.&#160;Van Ness completes his term and service on the Board and the Audit Committee. Each member of the Audit Committee is &#8220;independent&#8221; as defined in the listing standards of Nasdaq. The Board has determined that each of Mr.&#160;Limber, Mr.&#160;Van Ness and Mr.&#160;Wyszomierski is an &#8220;audit committee financial expert&#8221; as defined by the rules of the SEC. The Board has adopted a written charter for the Audit Committee, a copy of which is available on the Company&#8217;s website at<span style="font-style:italic"> https://investors.xoma.com/corporate-governance/governance-documents</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Report of the Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with rules established by the SEC, the Audit Committee has prepared the following report for inclusion in this proxy statement: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of its ongoing activities, the Audit Committee has: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">met with management periodically to consider the adequacy of the Company&#8217;s internal controls and the objectivity of its financial reporting and discussed these matters with the Company&#8217;s independent registered public accounting firm and with appropriate Company financial personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">regularly met privately with the independent registered public accounting firm, who have unrestricted access to the Audit Committee; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">recommended the appointment of the independent registered public accounting firm and reviewed periodically its performance and independence from management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewed and discussed with management the Company&#8217;s audited consolidated financial statements for the year ended December&#160;31, 2022; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">discussed with the independent auditors the matters required to be discussed by the auditing standards adopted by the Public Company Accounting Oversight Board, and other SEC rules, as currently in effect; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">received the written disclosures and the letter from the independent auditors required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent auditor&#8217;s communications with the Audit Committee concerning independence and has discussed with the independent auditors their independence. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the review and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">AUDIT COMMITTEE OF </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">THE BOARD OF DIRECTORS </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Joseph M. Limber, Chair </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">W. Denman Van Ness </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Jack L. Wyszomierski </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This Section is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Prohibitions on Derivative, Hedging, Monetization and Other Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain an insider trading compliance policy that applies to all directors and employees, including our executive officers, which prohibits certain transactions in our Common Stock, including short sales, puts, calls or other transactions involving derivative securities, hedging or monetization transactions, purchases of our Common Stock on margin or borrowing against an account in which our Common Stock is held, or pledging our Common Stock as collateral for a loan. Our management team oversees compliance with our insider trading compliance program and any material updates to the insider trading compliance program are subject to approval by our Board. Our Chief Financial Officer serves as our insider trading compliance officer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Information about our Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name and age as of April&#160;4, 2023, position and biographical summary of each of our executive officers who is not also a nominee for ongoing membership on our Board is included below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Thomas Burns</span>, age 49, has been our Senior Vice President, Finance and Chief Financial Officer since March 2017. He joined the Company in August 2006 and since then has held various senior finance and accounting roles, most recently as Vice President, Finance and Chief Financial Officer. Mr.&#160;Burns has over twenty-five years of experience in accounting and finance in both biotechnology and high-technology companies. Prior to his employment with the Company, he held multiple senior financial management positions at high-tech companies including Mattson Technology, IntruVert Networks (acquired by McAfee), Niku Corporation (acquired by Computer Associates) and Conner Technology. Mr.&#160;Burns received his Bachelor&#8217;s degree from Santa Clara University and his Masters of Business Administration from Golden Gate University. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Bradley Sitko</span>, age 42, has been our Chief Investment Officer since January 2023. Mr.&#160;Sitko served as the Managing Director, Strategic Finance, at RTW Investments, LP from November 2019 to January 2023 and also served as a member of the board of directors of such firm&#8217;s Irish collective asset-management vehicle (ICAV), RTW Investments ICAV, and was Chief Financial Officer of Ji Xing Pharmaceuticals Limited, a Shanghai-based biopharmaceutical company, incubated by RTW Investments, LP. From March 2015 to November 2019, Mr.&#160;Sitko served as Vice President, Finance, Operations and Corporate Development of DNAnexus, Inc., a genetic data management company. Mr.&#160;Sitko also served as a Director at MTS Health Partners, an investment bank, from October 2008 to March 2015. Mr.&#160;Sitko received a B.A. in History and Sociology of Science from the University of Pennsylvania and an M.B.A. from Columbia Business School. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROPOSAL 2&#8212;APPROVAL OF AMENDMENT TO THE AMENDED AND RESTATED 2010 LONG TERM INCENTIVE AND STOCK AWARD PLAN </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s 2010 Long Term Incentive and Stock Award Plan (the &#8220;Long Term Incentive Plan&#8221;) became effective on July&#160;21, 2010, the date of approval by the Company&#8217;s stockholders. The stockholders approved prior amendments to the Long Term Incentive Plan in May 2014, May 2016 and May 2017, and an amendment and restatement of the Long Term Incentive Plan in May 2019 and May 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this Proposal 2, the Board is asking the stockholders to approve the amendment to the Long Term Incentive Plan (the &#8220;Amendment&#8221;) in order to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Increase the number of shares of Common Stock authorized for issuance under the Long Term Incentive Plan by an additional 709,000 shares; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Increase the number of shares of Common Stock issuable under the Long Term Incentive Plan as incentive stock options (&#8220;ISOs&#8221;) by an additional 709,000 shares; </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why we are Requesting Stockholder Approval of the Amendment to the Long Term Incentive Plan? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that it is in the best interest of the stockholders and the Company to increase the aggregate number of shares authorized for issuance under the Long Term Incentive Plan. We compete with many biotechnology and royalty aggregator companies to attract and retain talented employees at all levels, and equity awards are a critical component of our compensation philosophy and our annual compensation structure. Having the ability to grant equity awards, including stock options, performance units, and other types of stock awards, is essential for us to be able to attract, motivate and retain a talented workforce. If we exhaust our remaining share reserve, we will be unable to issue new equity awards, including stock options, performance units, and other types of stock awards, to our new and existing employees, consultants, officers and directors, and this would seriously hamper our ability to provide a competitive pay package to current and prospective employees. Approval of the Amendment will allow us to continue to grant equity awards, including stock options, performance units, and other types of stock awards, at levels the Board or Compensation Committee determines to be appropriate in order to attract new employees, consultants and directors, retain our existing employees, consultants and directors and to provide incentives for such persons to exert maximum efforts for our success and ultimately increase stockholder value. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Board believes that the Company needs to maintain the flexibility to grant options under the Long Term Incentive Plan as ISOs and thus has increased, subject to stockholder of this Proposal 2, the number of shares that may be issued pursuant to the exercise of ISOs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why You Should Vote to Approve the Amendment to the Long Term Incentive Plan. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we recognize that equity awards may have a dilutive impact on existing stockholders, we believe that we have managed our existing equity reserves carefully, and that our current level of dilution and &#8220;burn rate&#8221; is reasonable, as demonstrated in the tables below.<sup style="font-size:75%; vertical-align:top"> </sup> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Overhang </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain additional information regarding our equity incentive program, which includes grants made under the Long Term Incentive Plan as well as grants made outside the Long Term Incentive Plan as an inducement to persons not previously employed by us to enter into employment with us. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:79%"></td>

<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As&#160;of&#160;March&#160;20,&#160;2023<br />(Record Date)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding stock options</p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">2,003,710</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average exercise price of outstanding stock options</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">19.35</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining term of outstanding stock options (years)</p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">5.74 years</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding full value awards</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under the Long Term Incentive Plan</p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">214,796</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under other equity incentive plans</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock outstanding</p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">11,460,968</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Per-share</span> closing price of common stock as reported on Nasdaq Capital Market</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">19.64</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Burn Rate </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides detailed information regarding the activity related to our equity incentive plans, which includes grants made under the Long Term Incentive Plan for fiscal year 2022. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:83%"></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fiscal&#160;Year&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to stock options granted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">292,972</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to full value awards granted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to stock options cancelled</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">49,796</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to full value awards cancelled</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common stock outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">11,412,854</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Description of the Long Term Incentive Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of the Long Term Incentive Plan is qualified in its entirety by reference to the Long Term Incentive Plan, a copy of which, as proposed to be amended as set forth in this Proposal 2, is attached as Appendix A to this proxy statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">General </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Long Term Incentive Plan is intended to provide incentives to attract, retain and motivate employees, consultants and directors and to provide for competitive compensation opportunities, to encourage long term service, to recognize individual contributions and reward achievement of performance goals, and to promote the creation of long term value for stockholders by aligning the interests of such persons with those of stockholders. The Long Term Incentive Plan provides for the grant to eligible employees, consultants and directors of stock options, SARs, restricted shares, restricted stock units (RSUs), performance shares, performance units, dividend equivalents, and other stock-based awards (the &#8220;Awards&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&#160;20, 2023, of the 3,304,062 shares of Common Stock currently authorized for issuance under the Long Term Incentive Plan: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">737,939 shares have been issued on the exercise of option awards; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">374,748 shares have been issued in connection with vesting of RSUs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">2,003,710 shares were subject to outstanding options; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">214,796 shares were available for issuance for future awards. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expiration dates for all such outstanding options range from May&#160;23, 2023 to November&#160;8, 2032 (at the latest). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Amendment of the Long Term Incentive Plan as proposed in this proxy statement, 709,000 additional shares will be available for issuance under the Long Term Incentive Plan. However, for each restricted share, RSU, performance share, performance unit, dividend equivalent or other stock-based award issued, the number of shares available under the Long Term Incentive Plan will be reduced by 1.08 shares. Forfeiture of Awards that were counted as greater than 1.0 shares under the provisions described above will result in the addition to shares available under the Long Term Incentive Plan of 1.08 shares per share forfeited. If any Awards granted under the Long Term Incentive Plan are forfeited, canceled, terminated, exchanged or surrendered or such Award is settled in cash or otherwise terminates without a distribution of shares to the participant, any shares counted against the number of shares reserved and available under the Long Term Incentive Plan with respect to such Award shall, to the extent of any such forfeiture, repurchase, settlement, termination, cancellation, exchange or surrender, again be available for Awards under the Long Term Incentive Plan. However, if any shares subject to an Award are not delivered to a participant because the Award is exercised through a reduction of shares subject to the Award (i.e., &#8220;net exercised&#8221;), the number of shares that are not delivered to the participant shall not remain available for issuance under the Long Term Incentive Plan. Also, any shares withheld or reacquired by the Company pursuant to the exercise of an option or SAR or as consideration for the exercise of an option or SAR, and any shares withheld or reacquired by the Company in satisfaction of the Company&#8217;s tax withholding obligation on an Award, shall not again become available for issuance under the Long Term Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Common Stock issuable over the term of the Long Term Incentive Plan will be made available from authorized but unissued shares of Common Stock. Each option will have an exercise price per share of not less than 100% of the fair market value per share of Common Stock on the date of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, no more than 4,013,062 shares of Common Stock may be issued as ISOs under the Long Term Incentive Plan following the Amendment. As of March&#160;20, 2023, the Company has issued options to purchase 77,103 shares of Common Stock under the Long Term Incentive Plan as ISOs. This limitation has no effect, however, on the number of shares available under the Long Term Incentive Plan. These Common Stock amounts are subject to anti-dilution adjustments in the event of certain changes in the Company&#8217;s capital structure, as described below. Shares of Common Stock issued pursuant to the Long Term Incentive Plan may consist, in whole or in part, of authorized but unissued shares of Common Stock or treasury shares including shares of Common Stock acquired by purchase in the open market or in private transactions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Eligibility and Administration </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Officers and other employees of, and consultants to, the Company and its subsidiaries and affiliates and directors of the Company are eligible to receive Awards under the Long Term Incentive Plan. Approximately twenty officers, other employees and directors are currently eligible to participate in the Long Term Incentive Plan.<sup style="font-size:75%; vertical-align:top"> </sup>Although the Company utilizes the services of a number of consultants who are or would be eligible to be granted Awards under the Long Term Incentive Plan from time to time, it has seldom granted options or shares under its equity-based plans to consultants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Long Term Incentive Plan provides that the maximum number of shares subject to stock awards that may be granted during any calendar year to any of our <span style="white-space:nowrap">non-employee</span> directors, taken together with any cash fees paid by the Company to such <span style="white-space:nowrap">non-employee</span> director during such calendar year, may not exceed $750,000 in total </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
value (calculating the value of any such stock awards based on the grant date fair value of the stock awards for financial reporting purposes). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Long Term Incentive Plan is administered by the Compensation Committee or such other Board committee or committees (or the entire Board) as may be designated by the Board. Different committees (including the entire Board) may administer the Long Term Incentive Plan with respect to different groups of eligible participants, but in this proxy statement we refer to all of them together as the &#8220;LTIP Administrator.&#8221; Unless otherwise determined by the Board, the LTIP Administrator consists of two or more members of the Board who are <span style="white-space:nowrap">non-employee</span> directors within the meaning of Rule <span style="white-space:nowrap">16b-3</span> of the Exchange Act. The LTIP Administrator determines which eligible employees, consultants and directors receive Awards, the types of Awards to be received and the amounts, terms, and conditions thereof. The LTIP Administrator has authority to waive conditions relating to an Award or to accelerate vesting of Awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The LTIP Administrator may delegate to other members of the Board or to officers or managers of the Company or any subsidiary or affiliate the authority, subject to such terms as the LTIP Administrator shall determine, to perform administrative functions and, with respect to Awards granted to persons not subject to Section&#160;16 of the Exchange Act, to perform such other functions as the LTIP Administrator may determine to the extent permitted under Rule <span style="white-space:nowrap">16b-3</span> and applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for certain anti-dilution adjustments, unless the approval of stockholders of the Company is obtained, options and SARs issued under the Long Term Incentive Plan will not be amended to lower their exercise price or exchanged for other options or SARs with lower exercise prices, options and SARs with an exercise price in excess of the fair market value of the underlying shares of Common Stock will not be exchanged for cash or other property, and no other action will be taken with respect to options or SARs that would be treated as a repricing under the rules of the principal stock exchange on which the shares of Common Stock are listed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ISOs intended to qualify for special tax treatment in accordance with the Code and nonqualified stock options not intended to qualify for special tax treatment under the Code may be granted for such number of shares of Common Stock as the LTIP Administrator determines. The LTIP Administrator will be authorized to set the terms relating to an option, including exercise price and the time and method of exercise. However, the exercise price of options will not be less than the fair market value of the shares of Common Stock on the date of grant, and the term will not be longer than ten years from the date of grant of the options. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An SAR will entitle the holder thereof to receive with respect to each share subject thereto, an amount equal to the excess of the fair market value of one share of Common Stock on the date of exercise over the exercise price of the SAR set by the LTIP Administrator as of the date of grant. However, the exercise price of the SARs will not be less than the fair market value of the shares of Common Stock on the date of grant, and the term will not be longer than ten years from the date of grant of the SARs. Payment with respect to SARs may be made in cash or shares of Common Stock as determined by the LTIP Administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards of restricted shares will be subject to such restrictions on transferability and other restrictions, if any, as the LTIP Administrator may impose. Such restrictions will lapse under circumstances that the LTIP Administrator shall determine, including based upon a specified period of continued employment or upon the achievement of performance criteria referred to below. Except as otherwise determined by the LTIP Administrator, eligible employees granted restricted shares will have all of the rights of a stockholder, including the right to vote restricted shares and receive dividends thereon, and unvested restricted shares will be forfeited upon termination of employment during the applicable restriction period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An RSU will entitle the holder thereof to receive shares of Common Stock or cash at the end of a specified deferral period. RSUs will also be subject to such restrictions as the LTIP Administrator may impose. Such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
restrictions will lapse under circumstances that the LTIP Administrator shall determine, including based upon a specified period of continued employment or upon the achievement of performance criteria referred to below. Except as otherwise determined by the LTIP Administrator, RSUs subject to restriction will be forfeited upon termination of employment during any applicable restriction period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance shares and performance units will provide for the future issuance of shares of Common Stock or payment of cash, respectively, to the recipient upon the attainment of performance objectives over specified performance periods. Except as otherwise determined by the LTIP Administrator, performance shares and performance units will be forfeited upon termination of employment during any applicable performance period. Performance objectives may vary from person to person and grant to grant and will be based upon such performance criteria as the LTIP Administrator may deem appropriate. The LTIP Administrator may revise performance objectives if significant events occur during the performance period which the LTIP Administrator expects to have a substantial effect on such objectives. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The LTIP Administrator may also grant dividend equivalent rights and it is authorized, subject to limitations under applicable law, to grant such other Awards as may be denominated in, valued in, or otherwise based on, shares of Common Stock, as deemed by the LTIP Administrator to be consistent with the purposes of the Long Term Incentive Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nontransferability </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise set forth by the LTIP Administrator in an award agreement, Awards (except for vested shares) will generally not be transferable by the participant other than by will or the laws of descent and distribution and will be exercisable during the lifetime of the participant only by such participant or his or her guardian or legal representative. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Change in Control </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a change in control (as defined in the Long Term Incentive Plan), unless otherwise provided by the LTIP Administrator at the time of the Award grant, each outstanding Award shall either be assumed by the successor company or parent thereof or to be replaced with comparable awards with respect to capital stock of the successor company or parent thereof, such comparability to be determined by the Compensation Committee, or if an Award is not so assumed or replaced, then such outstanding Award shall become fully exercisable at the time of the change in control, and all restrictions or limitations (including risks of forfeiture and deferrals) on such outstanding Award shall lapse, and all performance criteria and other conditions to payment of such Award shall be deemed to be achieved or fulfilled at target (if applicable) and shall be waived by the Company at the time of the change in control. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Capital Structure Changes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the LTIP Administrator determines that any dividend in shares, recapitalization, share split, reverse split, reorganization, merger, consolidation, <span style="white-space:nowrap">spin-off,</span> combination, repurchase, share exchange, extraordinary distribution or other similar corporate transaction or event affects the shares such that an adjustment is appropriate in order to prevent dilution or enlargement of the rights of eligible participants under the Long Term Incentive Plan, then the LTIP Administrator shall make such equitable changes or adjustments as it deems appropriate, including adjustments to (i)&#160;the number and kind of shares that may thereafter be issued under the Long Term Incentive Plan, (ii)&#160;the number and kind of shares, other securities or other consideration to be issued or become issuable in respect of outstanding Awards, and (iii)&#160;the exercise price, grant price or purchase price relating to any Award. Under such circumstances, the LTIP Administrator also has the authority to provide for a distribution of cash or property in respect of any Award. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Amendment and Termination </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Long Term Incentive Plan may be amended, altered, suspended or terminated by the Board at any time, in whole or in part, without the consent of stockholders or plan participants. However, any amendment for which stockholder approval is required under the rules of any stock exchange or automated quotation system on which the shares of Common Stock may then be listed or quoted will not be effective until such stockholder approval has been obtained. In addition, no amendment, suspension, or termination of the Long Term Incentive Plan may materially and adversely affect the rights of a participant under any Award theretofore granted to him or her without the consent of the affected participant. The LTIP Administrator may waive any conditions or rights, amend any terms, or amend, suspend or terminate, any Award granted, provided that, without participant consent, such amendment, suspension or termination may not materially and adversely affect the rights of such participant under any Award previously granted to him or her. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Effective Date and Term </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Long Term Incentive Plan became effective on July&#160;21, 2010, the date of approval by our stockholders, and it was amended in May 2014, May 2016, May 2017 and May 2019. Unless earlier terminated or extended, the Long Term Incentive Plan, as proposed to be amended, will expire on April&#160;1, 2029 (unless sooner terminated by the Board), and no further awards may be granted thereunder after such date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">U.S. Federal Income Tax Consequences Associated with the Long Term Incentive Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the federal income tax consequences of the Long Term Incentive Plan, based upon current provisions of the Code, the Treasury regulations promulgated thereunder and administrative and judicial interpretations thereof, and does not address the consequences under any state, local or foreign tax laws. This information is not and should not be considered tax advice. The Company assumes no liability whatever for any taxes, fees, penalties, investment losses, or other damages incurred by participants in the Long Term Incentive Plan who rely on this information. Participants are strongly urged to consult with their tax advisors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, the grant of an option will not be a taxable event to the recipient, and it will not result in a deduction to the Company. The tax consequences associated with the exercise of an option and the subsequent disposition of shares of Common Stock acquired on the exercise of such option depend on whether the option is a nonqualified stock option or an ISO. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the exercise of a nonqualified stock option, the participant will recognize ordinary taxable income equal to the excess of the fair market value of the shares of Common Stock received upon exercise over the exercise price. The Company or a subsidiary that employs the participant will generally be able to claim a deduction in an equivalent amount. Any gain or loss upon a subsequent sale or exchange of the shares of Common Stock will be capital gain or loss, long-term or short-term, depending on the holding period for the shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, a participant will not recognize ordinary taxable income at the time of exercise of an ISO, and no deduction will be available to the Company or a subsidiary that employs the participant, provided the option is exercised while the participant is an employee or within three months following termination of employment (longer, in the case of disability or death). If an ISO granted under the Long Term Incentive Plan is exercised after these periods, the exercise will be treated for federal income tax purposes as the exercise of a nonqualified stock option. Also, an ISO granted under the Long Term Incentive Plan will be treated as a nonqualified stock option to the extent it (together with other ISOs granted to the participant by the Company) first becomes exercisable in any calendar year for shares of Common Stock having a fair market value, determined as of the date of grant, in excess of $100,000. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If shares of Common Stock acquired upon exercise of an ISO are sold or exchanged more than one year after the date of exercise and more than two years after the date of grant of the option, any gain or loss will be long-term capital gain or loss. If shares of Common Stock acquired upon exercise of an ISO are disposed of prior to the expiration of these <span style="white-space:nowrap">one-year</span> or <span style="white-space:nowrap">two-year</span> holding periods (a &#8220;Disqualifying Disposition&#8221;), the participant will recognize ordinary income at the time of disposition, and the Company or a subsidiary that employs the participant will generally be entitled to a deduction, in an amount equal to the excess of the fair market value of the shares of Common Stock at the date of exercise over the exercise price. Any additional gain will be treated as capital gain, long-term or short-term, depending on how long the shares of Common Stock have been held. Where shares of Common Stock are sold or exchanged in a Disqualifying Disposition (other than certain related party transactions) for an amount less than their fair market value at the date of exercise, any ordinary income recognized in connection with the Disqualifying Disposition will be limited to the amount of gain, if any, recognized in the sale or exchange, and any loss will be a long-term or short-term capital loss, depending on how long the shares of Common Stock have been held. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an option is exercised through the use of shares of Common Stock previously owned by the participant, such exercise generally will not be considered a taxable disposition of the previously owned shares of Common Stock, and thus, no gain or loss will be recognized with respect to such previously owned shares of Common Stock upon such exercise. The amount of any <span style="white-space:nowrap">built-in</span> gain on the previously owned shares of Common Stock generally will not be recognized until the new shares of Common Stock acquired on the option exercise are disposed of in a sale or other taxable transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the exercise of an ISO as described above would not produce ordinary taxable income to the participant, it would result in an increase in the participant&#8217;s alternative minimum taxable income and may result in an alternative minimum tax liability. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restricted Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant who receives restricted shares of Common Stock will generally recognize ordinary income at the time that they &#8220;vest&#8221;, i.e., when they are no longer subject to a substantial risk of forfeiture. The amount of ordinary income so recognized will generally be the fair market value of the shares of Common Stock at the time the shares of Common Stock vest, less the amount, if any, paid for the shares of Common Stock. This amount is generally deductible for federal income tax purposes by the Company or a subsidiary that employs the participant. Dividends paid with respect to shares of Common Stock that are not vested will be ordinary compensation income to the participant (and generally deductible by the Company or a subsidiary that employs the participant). Any gain or loss upon a subsequent sale or exchange of the shares of Common Stock, measured by the difference between the sale price and the fair market value on the date the shares of Common Stock vest, will be capital gain or loss, long-term or short-term, depending on the holding period for the shares of Common Stock. The holding period for this purpose will begin on the date following the date the shares of Common Stock vest. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In lieu of the treatment described above, a participant may elect immediate recognition of income under Section&#160;83(b) of the Code. In such event, the participant will recognize as income the fair market value of the restricted shares at the time of grant (determined without regard to any restrictions other than restrictions which by their terms will never lapse), and the Company or a subsidiary that employs the participant will generally be entitled to a corresponding deduction. Dividends paid with respect to shares of Common Stock as to which a proper Section&#160;83(b) election has been made will not be deductible to the Company or a subsidiary that employs the participant. If a Section&#160;83(b) election is made and the restricted shares are subsequently forfeited, the participant will not be entitled to any offsetting tax deduction. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">SARs, RSUs and Other Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to SARs, RSUs, performance shares, performance units, dividend equivalents and other Awards under the Long Term Incentive Plan not described above, generally, when a participant receives payment with respect to any such Award granted to him or her under the Long Term Incentive Plan, the amount of cash and the fair market value of any other property received will be ordinary income to such participant and will be allowed as a deduction for federal income tax purposes to the Company or a subsidiary that employs the participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, the recipient of an RSU or performance unit structured to conform to the requirements of Section&#160;409A of the Code or an exception to Section&#160;409A of the Code will recognize ordinary income at the time the shares are delivered to the participant in an amount equal to the excess, if any, of the fair market value of the shares received over any amount paid by the recipient in exchange for the shares. If an RSU or performance unit award is subject to Section&#160;409A of the Code, the shares subject to the RSU or performance unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability, or a change in control. If delivery occurs on another date, unless the RSU or performance unit awards otherwise comply with or qualify for an exception to the requirements of Section&#160;409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from an RSU or performance unit award will be the amount paid, if any, for shares plus any ordinary income recognized when the stock is delivered. Subject to the requirement of reasonableness, the provisions and limitations of Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to an income tax deduction equal to the amount of ordinary income realized by the participant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Payment of Withholding Taxes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may withhold, or require a participant to remit to it, an amount sufficient to satisfy any federal, state, local or foreign withholding tax requirements associated with Awards under the Long Term Incentive Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Deductibility Limit on Compensation in Excess of $1 Million </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation of persons who are &#8220;covered employees&#8221; of the Company is subject to the tax deduction limits of Section&#160;162(m) of the Code. The exemption from Section&#160;162(m)&#8217;s deduction limit for performance-based compensation has been repealed, effective for taxable years beginning after December&#160;31, 2017, such that compensation paid to our covered employees in excess of $1&#160;million will not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November&#160;2, 2017 and not modified in any material respect on or after such date. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">New Plan Benefits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:67%"></td>

<td style="vertical-align:bottom;width:12%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:12%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;shares&#160;subject&#160;to&#160;stock<br />awards</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Neal, former Chief Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Burns, Senior Vice President, Finance and Chief Financial Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current Executive Officers as a Group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current <span style="white-space:nowrap">Non-Executive</span> Directors as a Group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current and Former Employees as a Group (including all current <span style="white-space:nowrap">non-executive</span> officers)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Nominees for Director</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each Associate of any Director, Executive Officer or Nominee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each Other Current and Former 5% Holder or Future 5% Recipient</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards granted under the Long Term Incentive Plan to our executive officers and other employees are discretionary and are not subject to set benefits or amounts under the terms of the Long Term Incentive Plan, and our Board and our Compensation Committee have not granted any awards under the Long Term Incentive Plan subject to stockholder approval of this Proposal 2. Each <span style="white-space:nowrap">non-employee</span> director is entitled to receive an annual option grant valued at $100,000 using the Black-Scholes Model in accordance with the <span style="white-space:nowrap">non-employee</span> director compensation policy. Accordingly, the benefits or amounts that will be received by or allocated to our executive officers and other employees and <span style="white-space:nowrap">non-employee</span> directors under the amended Long Term Incentive Plan, as well as the benefits or amounts which would have been received by or allocated to our executive officers and other employees and <span style="white-space:nowrap">non-employee</span> directors for fiscal year 2022 if the Amendment had been in effect, are not determinable. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Long Term Incentive Plan Benefits </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows, for each of the individuals and the various groups indicated, the number of stock options and restricted stock units underlying shares of our Common Stock that have been granted (even if not currently outstanding) under the Long Term Incentive Plan since its amendment and restatement on May&#160;18, 2022 through March&#160;20, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Long Term Incentive Plan </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:73%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:25%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Number&#160;of&#160;shares&#160;subject&#160;to&#160;stock<br />awards</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Neal, former Chief Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&#8212;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Burns, Senior Vice President, Finance and Chief Financial Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">11,000</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current Executive Officers as a Group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">11,000</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current <span style="white-space:nowrap">Non-Executive</span> Directors as a Group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">62,972</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current and Former Employees as a Group (including all current <span style="white-space:nowrap">non-executive</span> officers)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">70,000</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Nominees for Director</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&#8212;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each Associate of any Director, Executive Officer or Nominee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&#8212;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each Other Current and Former 5% Holder or Future 5% Recipient</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&#8212;</p></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Vote Required </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has already approved the Amendment to the Long Term Incentive Plan subject to approval of the Company&#8217;s stockholders. If this Proposal 2 is approved by the stockholders, the Amendment to the Long Term Incentive Plan will become effective upon the date of the annual meeting. In the event the stockholders do not approve this Proposal 2, the Amendment will not become effective and the Long Term Incentive Plan will continue in its current form. The affirmative vote of the holders of a majority of the shares present virtually or represented by proxy and entitled to vote on the matter will be required to approve the Amendment to the Long Term Incentive Plan. Abstentions have the same effect as negative votes. Broker <span style="white-space:nowrap">non-votes</span> are counted towards a quorum but are not counted for any purpose in determining whether this Proposal 2 has been approved. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">T<small>HE</small> B<small>OARD</small> R<small>ECOMMENDS</small> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">A V<small>OTE</small> I<small>N</small> F<small>AVOR</small> O<small>F</small> P<small>ROPOSAL</small> 2. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EQUITY COMPENSATION PLAN INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information with respect to our equity compensation plans in effect as of December&#160;31, 2022. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:42%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Plan Category</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Number of securities</span><br /><span style="font-weight:bold">to be issued upon<br />exercise of outstanding<br />options, warrants and<br />rights (a)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Weighted-</span><br /><span style="font-weight:bold">average exercise<br />price&#160;of&#160;outstanding<br />options, warrants<br />and rights&#160;(b)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Number of securities<br />remaining available<br />for&#160;issuance&#160;under&#160;equity<br />compensation plans<br />(excluding securities<br />reflected&#160;in&#160;column&#160;(a))&#160;(c)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders:<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,025,542</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;20.24</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;423,901</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom" align="right">&#8212;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">2,025,542</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">20.24</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">423,901</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes securities issuable under the Long Term Incentive Plan and the 2015 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes (i) 192,964 shares of Common Stock available for issuance under our Long Term Incentive Plan and (ii) 230,937 shares of Common Stock available for issuance under our ESPP. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROPOSAL 3&#8212;RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board has selected Deloitte&#160;&amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2023, and has directed that management submit the selection of the independent registered public accounting firm for ratification by our stockholders at the annual meeting. Representatives of Deloitte&#160;&amp; Touche LLP are expected to be present at the annual meeting, will have an opportunity to make a statement if they so desire, and will be available to respond to appropriate questions from stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been informed by Deloitte&#160;&amp; Touche LLP that, to the best of their knowledge, neither the firm nor any of its members or their associates has any direct financial interest or material indirect financial interest in XOMA or our affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder ratification of the selection of Deloitte&#160;&amp; Touche LLP as our independent registered public accounting firm is not required by our <span style="white-space:nowrap">By-laws</span> or otherwise. However, the Board is submitting the selection of Deloitte&#160;&amp; Touche LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to ratify the selection, the Audit Committee and the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee and the Board in their discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if they determine that such a change would be in the best interests of XOMA and our stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the shares present (either in person or by proxy) and entitled to vote on the matter at the annual meeting will be required to ratify the selection of Deloitte&#160;&amp; Touche LLP. Abstentions have the same effect as negative votes. Broker <span style="white-space:nowrap">non-votes</span> are counted towards a quorum but are not counted for any purpose in determining whether this matter has been approved; however, we believe that Proposal 3 will be considered a &#8220;routine&#8221; matter, and therefore no broker <span style="white-space:nowrap">non-votes</span> are expected in connection with this Proposal 3. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">T<small>HE</small> B<small>OARD</small> R<small>ECOMMENDS</small> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">A V<small>OTE</small> I<small>N</small> F<small>AVOR</small> O<small>F</small> P<small>ROPOSAL</small> 3. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Fees Billed by Deloitte&#160;&amp; Touche LLP during 2021 and 2022 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total fees paid to Deloitte&#160;&amp; Touche LLP, our current independent registered public accounting firm, for the last two fiscal years are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:78%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fiscal Year Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;659,895</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;710,040</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Related Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,895</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,895</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">661,790</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">711,935</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Audit Fees include the audit of annual financial statements included in the Annual Report on Form <span style="white-space:nowrap">10-K,</span> reviews of quarterly financial statements included in Quarterly Reports on Form <span style="white-space:nowrap">10-Q,</span> consultations on matters addressed during the audit or quarterly reviews, and services provided in connection with SEC filings, including consents and comfort letters. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">All Other Fees include fees for a technical research tool subscription service. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Pre-Approval</span> Policies and Procedures </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee&#8217;s policy is to <span style="white-space:nowrap">pre-approve</span> all audit and permissible <span style="white-space:nowrap">non-audit</span> services provided by the Company&#8217;s independent accountants. <span style="white-space:nowrap">Pre-approval</span> generally is provided for up to one year, is detailed as to the particular service or category of services and generally is subject to a specific budget. The Audit Committee may also <span style="white-space:nowrap">pre-approve</span> particular services on a <span style="white-space:nowrap"><span style="white-space:nowrap">case-by-case</span></span> basis. In assessing requests for services by the independent accountants, the Audit Committee considers whether such services are consistent with the auditor&#8217;s independence, whether the independent accountants are likely to provide the most effective and efficient service based on their familiarity with the Company, and whether the services could enhance the Company&#8217;s ability to manage or control risk or improve audit quality. The Audit Committee has delegated <span style="white-space:nowrap">pre-approval</span> authority to its Chair, who must report any decisions to the Audit Committee at its next scheduled meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee <span style="white-space:nowrap">pre-approved</span> 100% of all audit and other services provided by Deloitte&#160;&amp; Touche LLP, our current independent registered public accounting firm, in 2021 and 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROPOSAL 4&#8212;ADVISORY VOTE ON EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required by the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) to provide stockholders the opportunity to cast an advisory <span style="white-space:nowrap">(non-binding)</span> vote on the executive compensation of our named executive officers as disclosed in this proxy statement in accordance with the compensation disclosure rules of the SEC. This <span style="white-space:nowrap">non-binding</span> advisory vote is commonly referred to as the <span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;say-on-pay&#8221;</span></span> vote. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our 2017 annual meeting, our stockholders indicated their preference that we solicit a <span style="white-space:nowrap">non-binding</span> <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> vote every three years and our Board has adopted a policy that is consistent with that preference. At our 2020 annual meeting, the stockholders also overwhelmingly approved our <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> proposal, with approximately 97% of the total votes cast voting in favor of the proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This year, we are again asking our stockholders to vote &#8220;FOR&#8221; the advisory approval of the compensation of our named executive officers as disclosed in the compensation tables and the related narrative disclosure contained in this proxy statement. As discussed in those disclosures, our philosophy in setting compensation policies for executive officers has two fundamental objectives: (1)&#160;to enable the Company to attract, motivate and retain outstanding individuals and (2)&#160;to align their success with that of the Company&#8217;s stockholders through the creation of stockholder value and achievement of strategic corporate objectives. The Compensation Committee believes that executive compensation should be directly linked both to continuous improvements in corporate performance <span style="white-space:nowrap">(so-called</span> &#8220;pay for performance&#8221;) and accomplishments that are expected to increase stockholder value. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our executive officers and the philosophy, policies and practices described in this proxy statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders will be asked at the annual meeting to approve the following resolution pursuant to this Proposal 4: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; margin-right:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that the stockholders of XOMA Corporation (the &#8220;Company&#8221;) approve, on an advisory basis, the compensation of the Company&#8217;s &#8220;named executive officers&#8221; as such compensation is described in the tabular disclosure regarding such compensation, and the accompanying narrative disclosure, set forth in the Company&#8217;s definitive proxy statement for the 2023 annual meeting of stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of this advisory proposal requires the affirmative vote of the holders of a majority of shares present (either in person or by proxy) and entitled to vote on the matter at the annual meeting. Abstentions have the same effect as negative votes. Broker <span style="white-space:nowrap">non-votes</span> are counted towards a quorum but are not counted for any purpose in determining whether this Proposal 4 has been approved. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">T<small>HE</small> B<small>OARD</small> R<small>ECOMMENDS</small> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">A V<small>OTE</small> I<small>N</small> F<small>AVOR</small> O<small>F</small> P<small>ROPOSAL</small> 4. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROPOSAL 5&#8212;ADVISORY VOTE ON THE FREQUENCY OF SOLICITATION OF ADVISORY STOCKHOLDER APPROVAL OF EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dodd-Frank Wall Street Reform and Consumer Protection Act and Section&#160;14A of the Exchange Act enable the Company&#8217;s stockholders, at least once every six years, to indicate their preference regarding how frequently the Company should solicit a <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> <span style="white-space:nowrap">vote/non-binding</span> advisory vote on the compensation of the Company&#8217;s named executive officers as disclosed in the Company&#8217;s proxy statement. Currently, consistent with the preference expressed by the stockholders at the Company&#8217;s 2017 annual meeting the policy of the Board is to solicit a <span style="white-space:nowrap"><span style="white-space:nowrap">say-on-pay</span></span> vote/ <span style="white-space:nowrap">non-binding</span> advisory vote on the compensation of the named executive officers every three years. Accordingly, the Company is again asking stockholders to indicate whether they would prefer an advisory vote every year, every other year or every three years. Alternatively, stockholders may abstain from casting a vote. For the reasons described below, the Board recommends that the stockholders select a frequency of three years. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After considering the benefits and consequences of each alternative, the Board recommends that the advisory vote on the compensation of the Company&#8217;s named executive officers be submitted to the stockholders once every three years. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that a triennial advisory vote on the compensation of the Company&#8217;s named executive officers is the most appropriate frequency for us at this time. Accordingly, the Board is asking stockholders to indicate their preferred voting frequency by voting for one, two or three years or abstaining from voting on this proposal. The alternative among one year, two years or three years that receives the votes of the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter at the annual meeting will be deemed to be the frequency preferred by the stockholders and will be the alternative selected in the following resolution to be submitted to the stockholders for a vote at the annual meeting: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; margin-right:4%; font-size:10pt; font-family:Times New Roman">&#8220;RESOLVED, that the frequency of every [one year][two years][three years] is hereby APPROVED as the frequency preferred by stockholders for the solicitation of advisory stockholder approval of the compensation paid to the Company&#8217;s named executive officers.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of any of the options of this advisory proposal requires the affirmative vote of the holders of a majority of shares present (either in person or by proxy) and entitled to vote on the matter at the annual meeting. Abstentions will be counted towards the vote total but will not be counted as a vote in favor of any of the frequency options, and thus will have the effect of reducing the likelihood that any frequency receives a majority vote. Broker <span style="white-space:nowrap">non-votes</span> are counted towards a quorum but are not counted for any purpose in determining whether this Proposal 5 has been approved. The Board and the Compensation Committee value the opinions of the stockholders in this matter and, to the extent there is any significant vote in favor of one frequency over the other options, even if less than a majority, the Board will consider the stockholders&#8217; concerns and evaluate any appropriate next steps. However, because this vote is advisory and, therefore, not binding on the Board or the Company, the Board may decide that it is in the best interests of the stockholders that the Company hold an advisory vote on executive compensation more or less frequently than the option preferred by the stockholders. The vote will not be construed to create or imply any change or addition to the fiduciary duties of the Company or the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">T<small>HE</small> B<small>OARD</small> R<small>ECOMMENDS</small> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">A V<small>OTE</small> I<small>N</small> F<small>AVOR</small> O<small>F</small> &#8220;T<small>HREE</small> Y<small>EARS</small>&#8221; O<small>N</small> P<small>ROPOSAL</small> 5. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">COMMON STOCK OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information regarding all stockholders known by the Company to be the beneficial owners of more than 5% of the Company&#8217;s issued and outstanding shares of Common Stock and regarding each director, each of our named executive officers and all directors and executive officers as a group, together with the approximate percentages of issued and outstanding shares of Common Stock owned by each of them. Percentages are calculated based upon shares issued and outstanding plus shares that the holder has the right to acquire under stock options, warrants exercisable and restricted stock units releasable within 60 days from February&#160;15, 2023. The percentages in the table below are based on an aggregate of 11,460,968 shares of Common Stock issued and outstanding as of February&#160;15, 2023. Except for information based on Schedules 13G and 13D, as indicated in the footnotes, amounts are as of February&#160;15, 2023, and each of the stockholders has sole voting and investment power with respect to the shares of Common Stock beneficially owned, subject to community property laws where applicable. An individual&#8217;s presence on this or any other table presented herein is not intended to be reflective of such person&#8217;s status as a &#8220;reporting person&#8221; under Section&#160;16(a) of the Exchange Act. The address for each director and executive officer listed in the table below is c/o XOMA Corporation, 2200 Powell Street, Suite 310, Emeryville, California 94608. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:122pt"></td>
<td></td>
<td></td>
<td style="width:122pt"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:41pt"></td>
<td></td>
<td></td>
<td style="width:41pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; text-indent:0.62em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of<br />Shares&#160;of&#160;Common&#160;Stock<br />Beneficially Owned</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percentage&#160;of<br />Common&#160;Stock<br />Beneficially&#160;Owned&#160;(%)</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5% Stockholders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BVF Inc.<sup style="font-size:75%; vertical-align:top">(1) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3,633,743</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">31.7%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FMR LLC<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,246,686</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">10.9%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named Executive Officers and Directors:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Neal<sup style="font-size:75%; vertical-align:top">(3) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">778,773</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">6.8%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Burns<sup style="font-size:75%; vertical-align:top">(4) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">255,023</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2.2%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew D. Perry<sup style="font-size:75%; vertical-align:top">(5) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">58,990</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">W. Denman Van Ness<sup style="font-size:75%; vertical-align:top">(6) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">51,109</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jack L. Wyszomierski<sup style="font-size:75%; vertical-align:top">(7) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">55,179</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph M. Limber<sup style="font-size:75%; vertical-align:top">(8) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">54,924</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara A. Kosacz<sup style="font-size:75%; vertical-align:top">(9) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">46,896</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natasha Hernday<sup style="font-size:75%; vertical-align:top">(10) </sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">24,745</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Franklin<sup style="font-size:75%; vertical-align:top">(11) </sup></p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">18,941</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owen Hughes<sup style="font-size:75%; vertical-align:top">(12)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">31,250</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;background-color:#cceeff"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and current executive officers as a group as of the record date (10 persons)</p></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">597,057</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"></td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff">&#160;</td>
<td style="vertical-align:bottom;background-color:#cceeff" align="right">5.2%</td>
<td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Indicates less than 1%. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Based on the Form 4 filed January&#160;9, 2023, as of that date, BVF Inc. and its related entities beneficially held 3,633,743 shares of Common Stock, which excludes 5,003,000 shares of Common Stock issuable upon conversion of Series X preferred stock. BVF Partners L.P., or Partners, is the general partner of BVF, and Biotechnology Value Fund II, L.P., or BVF II, is the investment manager of Biotechnology Value Trading Fund OS LP, or Trading Fund OS, and the sole member of BVF Partners OS Ltd., or Partners OS. BVF Inc. is the general partner of Partners, and Mark N. Lampert is the sole officer and director of BVF Inc. Partners OS disclaims beneficial ownership of the shares of Common Stock beneficially owned by Trading Fund OS. Each of Partners, BVF Inc. and Mr.&#160;Lampert disclaims beneficial ownership of the shares of Common Stock beneficially owned by BVF, BVF II, Trading Fund OS, and certain Partners management accounts. Series X preferred stock shall not be converted if, after such conversion, its holding group would beneficially own more than 50% of the number of shares of Common Stock then issued and outstanding. The address of the principal business and office of BVF Inc. and its affiliates is 44 Montgomery Street, 40th Floor, San Francisco, California 94104. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Based on the Schedule 13G/A filed February&#160;9, 2023 by FMR LLC (&#8220;FMR LLC&#8221;) and Abigail P. Johnson, Director, Chairman and Chief Executive Officer of FMR LLC. FMR LLC has the sole power to dispose or direct the disposition of an aggregate of 1,246,686 shares of Common Stock. Ms.&#160;Johnson has the sole power to dispose or direct the disposition of an aggregate of 1,246,686 shares of Common Stock. Fidelity Management&#160;&amp; Research Company LLC, a wholly owned subsidiary of FMR LLC (&#8220;FMR Co.&#8221;) beneficially owns the shares of Common Stock held by certain of FMR LLC&#8217;s subsidiaries and affiliates. FMR Co. beneficially owns 5% or greater of our Common Stock. Members of the Johnson family, including Ms.&#160;Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B stockholders have entered into a stockholders&#8217; voting agreement under which all Series B voting common shares will be voted in accordance with the majority. The address of the principal business and office of FMR LLC, FMR Co. and Ms.&#160;Johnson is 245 Summer Street, Boston, Massachusetts 02210. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 760,628 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023, and 6,323, shares of Common Stock that have been deposited pursuant to the Company&#8217;s Deferred Savings Plan. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 243,540 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023, and 4,928 shares of Common Stock that have been deposited pursuant to the Company&#8217;s Deferred Savings Plan. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 47,191 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 35,466 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 48,714 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 48,714 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 46,896 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 24,745 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 18,941 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 31,250 shares of Common Stock issuable upon the exercise of options exercisable within 60 days after February&#160;15, 2023. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">COMPENSATION OF EXECUTIVE OFFICERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain summary information for the years indicated concerning the compensation earned by the named executive officers. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:36%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name and Principal<br />Position</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Salary<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Awards<br />($)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Equity</span><br />Incentive Plan<br />Compensation<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other<br />Compensation<br />($)<sup style="font-size:75%; vertical-align:top">(2)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total<br />($)</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">James Neal</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">$725,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$435,000</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$1,184,168</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$2,344,168</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">Former Chief Executive Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">$593,166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$2,633,242</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$260,993</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$&#160;&#160;&#160;&#160;&#160;23,394</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$3,510,795</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Thomas Burns</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">$424,950</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(3)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$&#160;&#160;&#160;470,850</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$101,988</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$&#160;&#160;&#160;&#160;&#160;11,510</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$1,009,298</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Senior Vice President, Finance and Chief Financial Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">$397,753</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$&#160;&#160;&#160;599,719</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$127,281</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$&#160;&#160;&#160;&#160;&#160;10,955</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$1,135,708</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts in this column do not reflect compensation actually received by the named executive officers but represent the aggregate grant date fair value for option awards calculated in accordance with FASB ASC Topic 718. See Note 10 of the consolidated financial statements in the Company&#8217;s 2022 Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022 filed on March&#160;9, 2023 regarding assumptions underlying valuation of equity awards. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Amounts for 2022 in this column include: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Neal&#8212;(a) a continuity incentive earned upon Mr.&#160;Neal&#8217;s retirement effective December&#160;31, 2022 of $1,160,000 to be paid in 2023; (b) 763 shares of our common stock contributed to an account under the Company&#8217;s Deferred Savings Plan; and (c)&#160;group term life insurance premiums in the amount of $10,668. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Burns&#8212;(a) 579 shares of our common stock contributed to an account under the Company&#8217;s Deferred Savings Plan; and (b)&#160;group term life insurance premiums in the amount of $1,260. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Effective January&#160;1, 2022, Mr.&#160;Burns&#8217; base salary was $417,641. Effective July&#160;1, 2022, his salary was increased to $432,258 as part of a company-wide retention effort. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Outstanding Equity Awards as of December&#160;31, 2022 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information as of December&#160;31, 2022, regarding unexercised options held by each of our named executive officers. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:88%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="18" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option Awards<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Option<br />Grant</span><br /><span style="font-weight:bold">Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Exercisable<br />(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Unexercisable<br />(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Option<br />Exercise<br />Price<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Option<br />Expiration<br />Date</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James R. Neal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/28/2013</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,179</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;54.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/28/2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/27/2014</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">178.20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/27/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/26/2015</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">76.60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/26/2025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">218,056</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">102,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">93,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">31,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">31,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/14/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">30,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">27.41</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/14/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/13/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">60,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">14.33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/13/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3/13/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">66,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">18.84</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3/13/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/17/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">60,268</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">38.93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/17/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">12/21/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">60,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">22.56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">12/21/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas M. Burns</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/28/2013</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">435</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">54.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/28/2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/27/2014</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">652</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">178.20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/27/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">6/16/2014</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">4,350</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">93.20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">6/16/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/26/2015</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,537</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">76.60</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/26/2025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">4/3/2015</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">70.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">4/3/2025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">12/22/2016</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">24,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">5.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">12/22/2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">75,778</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">15,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">7,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">4.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/10/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/14/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">27.41</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/14/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/13/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">23,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">14.33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/13/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3/13/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">20,167</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">1,833</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">18.84</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">3/13/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/17/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">12,256</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">7,799</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">38.93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/17/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/22/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">7,778</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">20,222</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">20.22</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2/22/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">11/8/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">11,000</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">18.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">11/8/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Unless otherwise noted, option awards vest in equal monthly installments over 36 months measured from the date of grant. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">One-third</span> of the shares subject to the award vest one year following the grant date and the remaining <span style="white-space:nowrap">two-thirds</span> of the shares subject to the award vest monthly over two years. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Base Salary </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee recognizes the importance of base salary as an element of compensation that helps to attract and retain our named executive officers. We provide base salary as a fixed source of cash compensation to recognize each named executive officer&#8217;s <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> responsibilities, which is designed to provide an appropriate and competitive base level of current cash income for the named executive officers. The 2022 annual base salary of Mr.&#160;Burns was determined and approved by the Compensation Committee as $417,641 in February 2022 and was subsequently increased to $432,258 effective July&#160;1, 2022. The 2022 annual base salary of Mr.&#160;Neal was negotiated as an element of his Amended Employment Agreement dated December&#160;15, 2021. The 2022 base salaries were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"></td>

<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; text-indent:0.50em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Name and Principal Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022&#160;Base&#160;Salary<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Neal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;725,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Burns</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">424,950</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Effective January&#160;1, 2022, Mr.&#160;Burns&#8217; base salary was $417,641. Effective July&#160;1, 2022, his salary was increased to $432,258 as part of a company-wide retention effort. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2022 Bonuses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2022, the Board approved a target bonus opportunity for Mr.&#160;Burns equal to 40% of his 2022 annual base salary, which was based 100% upon the Company&#8217;s achievement of corporate objectives including royalty asset acquisitions, investment in deal team capabilities, new CEO hire, raising investor awareness, IP and license enforcement, and expense control. The amount of cash actually paid to Mr.&#160;Burns was based on the Compensation Committee&#8217;s assessment of the company achieving 60% of the 2022 corporate objectives. Pursuant to Mr.&#160;Neal&#8217;s amended and restated employment agreement dated December&#160;15, 2021, Mr.&#160;Neal received a bonus equal to 60% of his 2022 annual salary. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Equity Compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our ability to grant equity-based awards is a valuable and necessary compensation tool that aligns the long-term financial interests of our executive officers with the financial interests of our stockholders. In addition, we believe that our ability to grant equity-based awards helps us to attract, retain and motivate executive officers, and encourages them to devote their best efforts to our business and financial success. Vesting of equity awards is generally tied to continuous service with us and serves as an additional retention measure. Our executive officers generally are awarded an initial new hire grant upon commencement of employment, as well as annual grants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our named executive officers currently holds stock options under our Long Term Incentive Plan, that were granted subject to the general terms thereof and the applicable forms of stock option agreement thereunder. The specific vesting terms of each named executive officer&#8217;s stock options are described above under &#8220;Outstanding Equity Awards as of December&#160;31, 2022.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently grant all equity awards pursuant to the Long Term Incentive Plan. All options are granted with a per share exercise price equal to no less than the fair market value of a share of our Common Stock on the date of grant, and generally vest on a monthly basis over 36 months, subject to the continued service with us through each vesting date. All options have a maximum term of up to 10 years from the date of grant, subject to earlier expiration following the cessation of an executive officer&#8217;s continuous service with us. Option vesting is subject to acceleration as described below under &#8220;Certain Other Payments upon a Change of Control.&#8221; Options generally remain exercisable for three months following an executive officer&#8217;s termination, except in the event of a termination for cause or due to disability or death. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2022, Mr.&#160;Burns was granted a stock option to purchase 28,000 shares of Common Stock under our Long Term Incentive Plan which vests monthly over three years. In November 2022, Mr.&#160;Burns was granted a stock option to purchase 11,000 shares of Common Stock under our Long Term Incentive Plan, <span style="white-space:nowrap">one-third</span> of which will vest one year following the date of grant and the remaining <span style="white-space:nowrap">two-thirds</span> of which will vest monthly over the following two years. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Employment Terms </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into employment agreements or offer letters with each of our named executive officers. Descriptions of such arrangements with our named executive officers are included under the caption &#8220;Employment Contracts and Termination of Employment and Change of Control Arrangements&#8221; below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Pension Benefits </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our named executive officers is covered by a pension plan or other similar benefit plan that provides for payments or other benefits at, following, or in connection with retirement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-Qualified</span> Deferred Compensation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our named executive officers is covered by a defined contribution or other plan that provides for the deferral of compensation on a basis that is not <span style="white-space:nowrap">tax-qualified.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Employment Contracts and Termination of Employment and Change of Control Arrangements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;15, 2021, Mr.&#160;Neal notified the Company of his decision to retire as the Company&#8217;s Chief Executive Officer, effective at the earlier of (i)&#160;December&#160;31, 2022 or (ii)&#160;the date that the Company hired a new Chief Executive Officer, and we entered into an amended and restated employment agreement with Mr.&#160;Neal. Pursuant to his employment agreement, Mr.&#160;Neal was entitled to receive an annual base salary of $725,000, effective as of December&#160;15, 2021, and an annual bonus equal to 60% of his annual base salary for the fiscal year 2022. The employment agreement also provided for the grant of a stock option to purchase 60,000 shares of Common Stock pursuant to the Long Term Incentive Plan. The stock option provided that if Mr.&#160;Neal retires at or after age fifty-five (55)&#160;and the sum of his age on the date of retirement plus years of full-time employment or consultancy with the Company exceeds seventy (70), and if by reason thereof his termination of service occurred at any time during the option term, then this option would become fully exercisable as of the date of such retirement and would remain exercisable for the full option term until the expiration date of the option as if he had not incurred a termination of service. In connection with the appointment of our new Interim Chief Executive Officer, Mr.&#160;Neal retired as our Chief Executive Officer effective as of December&#160;31, 2022 and resigned as a member of our Board and Chairman of our Board, effective as of January&#160;1, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;7, 2017, the Company entered into an amended and restated employment agreement with Mr.&#160;Burns. Among other things, his employment agreement provides for Mr.&#160;Burns&#8217; continued employment as Chief Financial Officer of the Company. Under his employment agreement, Mr.&#160;Burns continues to be entitled to participate in any benefit plan for which key executives of the Company are eligible. Upon Mr.&#160;Burns&#8217; involuntary termination of employment by the Company without cause and executing a release of claims in favor of the Company, his termination of employment due to his death or permanent disability, or upon his resignation for good reason, his employment agreement provides that Mr.&#160;Burns will be entitled to (i)&#160;a severance payment equal to 75% of his then-current annual base salary; (ii)&#160;a severance payment equal to the <span style="white-space:nowrap">pro-rated</span> portion of his then-current target bonus; (iii)&#160;payment of any earned but unpaid bonus for the prior performance period; (iv)&#160;if elected, the full cost of continuation coverage under the Company&#8217;s group health plans for a period of nine months or a cash payment in lieu of such continuation coverage; and (iv)&#160;outplacement services for nine months not to exceed $15,000 in value. Pursuant to his employment agreement, all payments and benefits to Mr.&#160;Burns thereunder are subject to his compliance with the confidentiality and <span style="white-space:nowrap">non-competition</span> provisions thereof. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;4, 2022, the Company entered into a letter agreement with Mr.&#160;Burns that amends and supplements his amended and restated employment agreement. Pursuant to such amendment, in the event Mr.&#160;Burns remains employed by the Company for a twelve (12)-month period beginning on November 1, 2022 (the &#8220;Eligibility Date&#8221;), he will be deemed &#8220;retirement eligible&#8221; for purposes of his equity awards under the terms of his equity award agreements. Conditioned on his execution of a release in favor of the Company, Mr.&#160;Burns will also receive this benefit if his employment is terminated by the Company without Cause (as defined in his employment agreement), or if he resigns for Good Reason (as defined in his employment agreement), before the Eligibility Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in accordance with a Retention and Severance Plan established by the Company in March 2022 and amended in October 2022 (such plan being applicable to all of the Company&#8217;s current employees), Mr.&#160;Burns is eligible to receive a cash retention bonus if employed through each of two periods: (1)&#160;the three-month anniversary of November&#160;1, 2022 (the &#8220;Initial Period&#8221;) and (2)&#160;the nine-month period immediately following the Initial Period (the &#8220;Extended Period&#8221;). The cash bonus tied to each of the Initial Period and Extended Period will be equal to 25% of Mr.&#160;Burns&#8217; base salary earned during such Initial Period or Extended Period, respectively. In the event Mr.&#160;Burns is terminated by the Company without Cause (as defined in such plan) or resigns for Good Reason (as defined in such plan) during the Initial Period or during the Extended Period, Mr.&#160;Burns will remain eligible to receive the retention bonus for such Initial Period or Extended Period, respectively. On January&#160;31, 2023, Mr.&#160;Burns was paid $27,016 representing the retention bonus for the Initial Period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Other Payments upon a Change of Control </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Named Executive Officers.</span> Each of our named executive officers has entered into a change of control severance agreement. Under each change of control agreement, if the executive officer&#8217;s employment is involuntarily terminated by the Company without cause or if the executive officer resigns with good reason, in either case, within two months prior to signing an agreement for a change of control or within 24 months after a change of control, then the Company may be required to make certain payments and/or provide certain benefits to certain executive officers, as described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change of Control.</span> Under each change of control agreement, a &#8220;change of control&#8221; is defined as the occurrence of any of the following events: (i)&#160;a merger, amalgamation or acquisition in which the Company is not the surviving or continuing entity, except for a transaction the principal purpose of which is to change the jurisdiction of the Company&#8217;s organization; (ii)&#160;the sale, transfer or other disposition of all or substantially all of the assets of the Company; (iii)&#160;any other reorganization or business combination in which 50% or more of the Company&#8217;s outstanding voting securities are transferred to different holders in a single transaction or series of related transactions; (iv)&#160;any approval by the stockholders of the Company of a plan of complete liquidation of the Company; (v)&#160;any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act becoming the &#8220;beneficial owner&#8221; (as defined in Rule <span style="white-space:nowrap">13d-3</span> under said Act), directly or indirectly, of securities of the Company representing more than 50% of the total voting power represented by the Company&#8217;s then-outstanding voting securities; or (vi)&#160;a change in the composition of the Board, as a result of which fewer than a majority of the directors are incumbent directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Vesting of Options</span>. If a named executive officer&#8217;s employment is involuntarily terminated within two months prior to signing an agreement for a change of control or within 12 months after a change of control, the exercisability of all time-based equity awards granted to such executive officer by the Company shall automatically be accelerated so that all such options may be exercised immediately upon such involuntary termination for any or all of the shares subject thereto and the post-termination exercise period shall be extended to 60 months or the remainder of the maximum term of the options (or such shorter period of time to avoid the application of Section&#160;409A of the Code). Additionally, if a named executive officer&#8217;s employment is involuntarily terminated within two months prior to signing an agreement for a change of control or within 12 months after a change of control, the exercisability of a <span style="white-space:nowrap">pro-rated</span> number of performance awards held by such executive officer shall be accelerated, based on the number of days that have elapsed during the performance </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period and the deemed level of achievement of the performance goals as determined by the Board. The awards shall continue to be subject to all other terms and conditions of the Company&#8217;s option plans and the applicable option agreements between the employee and the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Outplacement Program</span>. If a named executive officer&#8217;s employment is involuntarily terminated within two months prior to signing an agreement for a change of control or within 24 months after a change of control, the named executive officer will immediately become entitled to participate in a twelve-month executive outplacement program provided by an executive outplacement service, at the Company&#8217;s expense not to exceed $15,000. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cash Severance.</span> If a named executive officer&#8217;s employment is involuntarily terminated within two months prior to signing an agreement for a change of control or within 12 months after a change of control, then the executive officer shall be entitled to receive a cash severance payment equal to the sum of (A)&#160;an amount equal to 1.5 times (or, in the case of the Chief Executive Officer, two times) the executive officer&#8217;s annual base salary as in effect immediately prior to the involuntary termination plus (B)&#160;an amount equal to 1.5 times (or, in the case of the Chief Executive Officer, two times) the named executive officer&#8217;s target bonus as in effect for the fiscal year in which the involuntary termination occurs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Health and Other Benefits</span>. If a named executive officer&#8217;s employment is involuntarily terminated within two months prior to signing an agreement for a change of control or 12 months after a change of control, then for a period of 18 months (or, in the case of the chief executive officer, 24 months) following such termination, the Company shall make available and pay for the full cost of the coverage (plus an additional amount to pay for the taxes on such payments, if any, plus any taxes on such additional amount) of the executive officer and his or her spouse and eligible dependents under any group health plans of the Company on the date of such termination of employment at the same level of health (i.e., medical, vision and dental) coverage and benefits as in effect for the executive officer or such covered dependents on the date immediately preceding the date of his or her termination, provided that, in each case, the executive officer elects such continuation coverage, or, if necessary for the Company to avoid a tax penalty, a cash payment in lieu of such continuation coverage </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The change of control agreements provide that the legacy &#8220;golden parachute&#8221; excise tax <span style="white-space:nowrap">gross-up</span> provision, pursuant to which the Company will make a <span style="white-space:nowrap">gross-up</span> payment necessary to fully satisfy any excise taxes on the executive officer as a result of payments under the change of control agreement or otherwise, expired on February&#160;10, 2019, and have been replaced with a &#8220;better <span style="white-space:nowrap">after-tax&#8221;</span> provision, pursuant to which payments to the executive officer are either reduced or paid in full, whichever results in a greater economic benefit to the executive officer (after calculation of all taxes on such payments). </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <div style='display: none'><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="xoma-20221231.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references></ix:header></div><div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">PAY VERSUS PERFORMANCE </div></div> <ix:nonNumeric name="ecd:PvpTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73597820"><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Pay Versus Performance Table </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Section&#160;953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company. This disclosure is intended to comply with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K</div> applicable to &#8220;smaller reporting companies.&#8221; For further information concerning the Company&#8217;s compensation philosophy and how the Company seeks to align executive compensation with the Company&#8217;s performance, refer to &#8220;Executive Compensation&#8212;Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table.&#8221; </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:81%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92pt"></td>
<td></td>
<td></td>
<td style="width:92pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:68pt"></td>
<td></td>
<td></td>
<td style="width:68pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:130pt"></td>
<td></td>
<td></td>
<td style="width:130pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:125pt"></td>
<td></td>
<td></td>
<td style="width:125pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:149pt"></td>
<td></td>
<td></td>
<td style="width:149pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:58pt"></td>
<td></td>
<td></td>
<td style="width:58pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table&#160;Total&#160;for<br/>PEO<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually&#160;Paid&#160;to<br/>PEO<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Summary<br/>Compensation<br/>Table Total for<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Compensation<br/>Actually&#160;Paid&#160;to<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div><div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(4)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Initial Fixed<br/>$100 Investment<br/>Based on Total<br/>Stockholder&#160;Return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(5)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net (Loss)<br/>Income<br/>(millions)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(6)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="padding-bottom:2pt ;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(d)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(e)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(f)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(h)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,344,168</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,344,168</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,009,298</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">956,887</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal">41.69</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">17.1</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,510,795</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,510,795</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,135,708</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">349,707</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal">47.25</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">15.8</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (b)&#160;are the amounts of total compensation reported for <ix:nonNumeric name="ecd:PeoName" contextRef="P01_01_2022To12_31_2022">Mr. Neal</ix:nonNumeric> (our Chief Executive Officer and PEO) for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to &#8220;Executive Compensation&#8212;Summary Compensation Table.&#8221; </div> </td> </tr> </table> <ix:nonNumeric name="ecd:AdjToPeoCompFnTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73597880">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (c)&#160;represent the amount of &#8220;compensation actually paid&#8221; to Mr.&#160;Neal, as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div> The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&#160;Neal during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments w<div style="letter-spacing: 0px; top: 0px;;display:inline;">ere </div>made to Mr.&#160;Neal&#8217;s total compensation for each year to determine the compensation actually paid: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:96%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:108pt"></td>
<td></td>
<td></td>
<td style="width:108pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44pt"></td>
<td></td>
<td></td>
<td style="width:44pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:50pt"></td>
<td></td>
<td></td>
<td style="width:50pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:63pt"></td>
<td></td>
<td></td>
<td style="width:63pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation<br/>Table&#160;Total&#160;for&#160;PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity&#160;Award<br/>Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(b)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,344,168</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,344,168</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,510,795</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,633,242</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,633,242</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,510,795</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr> </table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:4%;border-bottom:1px solid #000000; width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns in the Summary Compensation Table for the applicable year. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(b)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The stock option agreement granted in 2021 to Mr.&#160;Neal provided that if Mr.&#160;Neal met certain age and service criteria, he would be eligible to </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric></ix:nonNumeric> <ix:continuation id="TextSelection_73597880" continuedAt="TextSelectionAppend_73597880_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>37</ix:exclude></div></ix:continuation> </div> </div> <ix:continuation id="TextSelectionAppend_73597880_1" continuedAt="TextSelectionAppend_73597880_2"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73597880_2" continuedAt="TextSelectionAppend_73597880_3"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73597880_3" continuedAt="TextSelectionAppend_73597880_4"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_73597820" continuedAt="TextSelectionAppend_73597820_1"> <ix:continuation id="TextSelectionAppend_73597880_4" continuedAt="TextSelectionAppend_73597880_5">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">&#8220;retire&#8221; and his option would become fully exercisable. At the time of grant, Mr.&#160;Neal had satisfied such retirement eligibility and the service-based vesting requirements were deemed to have been met. Therefore, the same fair value is being used for the equity award adjustment as was used for the Summary Compensation Table. The amounts deducted or added in calculating the equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> </ix:continuation><div><ix:continuation id="TextSelectionAppend_73597880_5">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:86%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:213pt"></td>
<td></td>
<td></td>
<td style="width:213pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:256pt"></td>
<td></td>
<td></td>
<td style="width:256pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:170pt"></td>
<td></td>
<td></td>
<td style="width:170pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:208pt"></td>
<td></td>
<td></td>
<td style="width:208pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:218pt"></td>
<td></td>
<td></td>
<td style="width:218pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:21pt"></td>
<td></td>
<td></td>
<td style="width:21pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year End<br/>Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year Change<br/>in<br/>Fair&#160;Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>as of Vesting<br/>Date of<br/>Equity<br/>Awards<br/>Granted and<br/>Vested in the<br/>Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;over<br/>Year<br/>Change in<br/>Fair&#160;Value<br/>of Equity<br/>Awards<br/>Granted<br/>in Prior<br/>Years&#160;that<br/>Vested in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>at the End<br/>of the<br/>Prior Year<br/>of Equity<br/>Awards<br/>that Failed<br/>to Meet<br/>Vesting<br/>Conditions<br/>in&#160;the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,633,242</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,633,242</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"></td> </tr> </table> </ix:continuation> </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (d)&#160;represent the average of the amounts reported for the Company&#8217;s named executive officers (NEOs) as a group (excluding Mr.&#160;Neal, who has served as our CEO since 2016) in the &#8220; Total&#8221; column of the Summary Compensation Table in each applicable year. <ix:nonNumeric name="ecd:NamedExecutiveOfficersFnTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true">Mr. Burns was the sole NEO (excluding Mr. Neal) included for purposes of calculating the average amounts in each applicable year.</ix:nonNumeric> </div> </td> </tr> </table> <ix:nonNumeric name="ecd:AdjToNonPeoNeoCompFnTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73599585">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(4)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (e)&#160;represent the average amount of &#8220;compensation actually paid&#8221; to the NEOs as a group (excluding Mr.&#160;Neal), as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div> The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr.&#160;Neal) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr.&#160;Neal) for each year to determine the compensation actually paid, using the same methodology described above in Note (2): </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:88%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:133pt"></td>
<td></td>
<td></td>
<td style="width:133pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:41pt"></td>
<td></td>
<td></td>
<td style="width:41pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:37pt"></td>
<td></td>
<td></td>
<td style="width:37pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:110pt"></td>
<td></td>
<td></td>
<td style="width:110pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation&#160;Table<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Total&#160;for&#160;Non-PEO&#160;NEOs</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award&#160;Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Compensation<br/>Actually Paid to<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,009,298</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">470,850</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">$<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">418,439</ix:nonFraction>&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">956,887</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,135,708</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">599,719</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">($<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">186,282</ix:nonFraction>)</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">349,707</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amounts deducted or added in calculating the total average equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> </ix:nonNumeric><div><ix:continuation id="TextSelection_73599585">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:77%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:172pt"></td>
<td></td>
<td></td>
<td style="width:172pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:241pt"></td>
<td></td>
<td></td>
<td style="width:241pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:175pt"></td>
<td></td>
<td></td>
<td style="width:175pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:256pt"></td>
<td></td>
<td></td>
<td style="width:256pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:228pt"></td>
<td></td>
<td></td>
<td style="width:228pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:332pt"></td>
<td></td>
<td></td>
<td style="width:332pt"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:21pt"></td>
<td></td>
<td></td>
<td style="width:21pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;End</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year&#160;Average<br/>Change in<br/>Fair Value of<br/>Outstanding<br/>and Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Fair<br/>Value&#160;as&#160;of<br/>Vesting&#160;Date<br/>of Equity<br/>Awards<br/>Granted and<br/>Vested&#160;in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year<br/>Average<br/>Change in<br/>Fair&#160;Value&#160;of<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years<br/>that Vested<br/>in the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value at the<br/>End of the<br/>Prior Year of<br/>Equity&#160;Awards<br/>that&#160;Failed to<br/>Meet Vesting<br/>Conditions&#160;in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Value of<br/>Dividends or<br/>other<br/>Earnings Paid<br/>on Stock or<br/>Option<br/>Awards not<br/>Otherwise<br/>Reflected in<br/>Fair Value or<br/>Total<br/>Compensation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">345,047</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">20,942</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">97,611</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">3,277</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">418,439</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">133,929</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">224,276</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">90,689</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">186,624</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">186,282</ix:nonFraction></td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td> </tr> </table> </ix:continuation> </div> </ix:continuation> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38</div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73597820_1">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(5)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(6)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year. Due to the fact that the Company is a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented. </div> </td> </tr> </table> </ix:continuation> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Narrative to Pay Versus Performance Table </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Analysis of the Information Presented in the Pay Versus Performance Table </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described in more detail above in &#8220;Executive Compensation&#8212;Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table,&#8221; the Company&#8217;s executive compensation program reflects a performance-driven compensation philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance, those Company measures are not financial performance measures and are therefore not presented in the Pay Versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company&#8217;s performance measures with &#8220;compensation actually paid&#8221; (as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K)</div> for a particular year. In accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the Company is providing the following descriptions of the relationships between information presented in the Pay Versus Performance table. </div> <ix:nonNumeric name="ecd:CompActuallyPaidVsNetIncomeTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Compensation Actually Paid and Net Income (Loss) </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39</div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Compensation Actually Paid and Cumulative TSR </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chart below shows the relationship between the compensation actually paid to our PEO and the average compensation actually paid to our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-PEO</div> NEOs, on the one hand, to the Company&#8217;s cumulative TSR over the two years presented in the table, on the other. </div> <ix:nonNumeric name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="margin-top:0pt;margin-bottom:0pt;text-align:center"></div> <div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g344283g45g00.jpg"/> </div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">All information provided above under the &#8220;Pay Versus Performance&#8221; heading will not be deemed to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </div> </div> </div> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">COMPENSATION OF DIRECTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of the Company&#8217;s director compensation program are to enable the Company to attract, motivate and retain outstanding individuals and align their success with that of the Company&#8217;s stockholders through the creation of stockholder value. We attract and retain directors by benchmarking against companies in our industry of similar size to ensure that our director compensation packages remain competitive. The different elements of director compensation are considered in light of the compensation packages provided to similarly-situated directors at peer companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating&#160;&amp; Governance Committee has retained the services of Compensia to assist in evaluating the Company&#8217;s director compensation program against the relevant market. At the direction of the Nominating&#160;&amp; Governance Committee, management created a survey (the &#8220;Director Compensation Survey&#8221;) which compared the Company&#8217;s director pay levels to those of a peer group of 21 companies as reported in its Comparator Group Executive Compensation Data report. The benchmarking process for director compensation used by the Nominating&#160;&amp; Governance Committee based on the Director Compensation Survey is substantially similar to the process used by the Compensation Committee for evaluating executive compensation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2022, each <span style="white-space:nowrap">non-employee</span> director was entitled to receive an annual retainer of $40,000, plus an additional (1) $20,000, in the case of the Chair of the Audit Committee, (2) $9,000, in the case of any other member of the Audit Committee, (3) $15,000, in the case of the Chair of the Compensation Committee, (4) $7,500, in the case of any other member of the Compensation Committee, (5) $12,000, in the case of the Chair of the Nominating&#160;&amp; Governance Committee, (6) $6,000, in the case of any other member of the Nominating&#160;&amp; Governance Committee. In addition, effective May 2022 and retroactive to January&#160;1, 2022, the Director Compensation Policy was amended to include an annual retainer of $40,000 for the Lead Independent Director. In addition, members of the ad-hoc CEO search committee were entitled to a one-time payment of $5,000 each for Mr. Van Ness, Ms. Kosacz and Mr. Perry and $7,500 for Ms. Franklin. Mr. Van Ness declined this payment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each <span style="white-space:nowrap">non-employee</span> director whose service continues is entitled to receive an annual option grant valued at $100,000 that vests monthly over one year. Each new <span style="white-space:nowrap">non-employee</span> director is entitled to receive an initial option grant valued at $250,000 that vests monthly over three years and a <span style="white-space:nowrap">pro-rata</span> portion of the annual option grant that vests monthly from grant date until the next annual grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors who are employees of the Company are neither paid any fees or other remuneration nor awarded stock options, restricted stock awards or shares of Common Stock of the Company for services as members of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum number of shares subject to stock awards that may be granted during any calendar year to any of our <span style="white-space:nowrap">non-employee</span> directors, taken together with any cash fees paid by the Company to such <span style="white-space:nowrap">non-employee</span> director during such calendar year, may not exceed $750,000 in total value (calculating the value of any such stock awards based on the grant date fair value of the stock awards for financial reporting purposes). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the 2022 compensation for members of the Board at any time during 2022. Mr.&#160;Neal, the Company&#8217;s former Chief Executive Officer, is not listed in this table because he received no additional compensation for his services as a member of the Board. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:90%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; text-indent:0.50em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Fees&#160;Earned&#160;or<br />Paid in Cash<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Option&#160;Awards<br />($)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Total<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">W. Denman Van Ness</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;102,500</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;202,299</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Franklin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">55,000</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">154,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Natasha Hernday</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">52,443</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">152,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Kosacz</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">51,885</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">151,684</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph M. Limber</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">60,000</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">159,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Perry</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">52,500</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">152,299</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jack L. Wyszomierski</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">64,885</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">99,799</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom" align="right">164,684</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The option amounts represent the aggregate grant date fair value for option awards computed in accordance with FASB ASC Topic 718. See Note 10 of the consolidated financial statements in the 2022 Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022 filed on March&#160;9, 2023 regarding assumptions underlying valuation of equity awards. As of December&#160;31, 2022, the aggregate number of options outstanding for each <span style="white-space:nowrap">non-employee</span> director were as follows: Mr.&#160;Van Ness: 36,965, Ms.&#160;Franklin: 26,278, Ms.&#160;Hernday: 27,348, Ms.&#160;Kosacz: 48,395, Mr.&#160;Limber: 50,213, Mr.&#160;Perry: 48,690, and Mr.&#160;Wyszomierski: 50,213. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TRANSACTIONS WITH RELATED PERSONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of transactions since January&#160;1, 2021 in which (i)&#160;we have been a participant, (ii)&#160;the amount involved exceeded or will exceed $120,000, and (iii)&#160;any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of their immediate family or person sharing their household, had or will have a direct or indirect material interest. Each such transaction is subject to review and <span style="white-space:nowrap">pre-approval</span> by the Audit Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2021, the Company issued and sold an aggregate of 1,600,000 depositary shares, each representing a 1/1000th fractional interest in a share of the Company&#8217;s 8.375% Series B Cumulative Perpetual Preferred Stock (the &#8220;Series B Depositary Shares&#8221;) in a public offering at a price to the public of $25.00 per depositary share. The spouse of James Neal, our former Chief Executive Officer and Board Chair, purchased 8,000 shares of the Series B Depositary Shares in the public offering at the public offering price of $25.00 per depositary share for an aggregate amount of $200,000. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Procedures for Approval of Related Party Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board reviews the relationships that each director has with the Company and shall endeavor to have a majority of directors that are &#8220;independent directors&#8221; as defined by the SEC and Nasdaq rules. As part of the review process, the Company distributes and collects questionnaires that solicit information about any direct or indirect transactions with the Company from each of our directors and officers and legal counsel reviews the responses to these questionnaires and reports any related party transactions to the Audit Committee. We may enter into arrangements in the ordinary course of our business that involve the Company&#8217;s receiving or providing goods or services on a <span style="white-space:nowrap">non-exclusive</span> basis and at arm&#8217;s length negotiated rates or in accordance with regulated price schedules with corporations and other organizations in which a Company director, executive officer or nominee for director may also be a director, trustee or investor, or have some other direct or indirect relationship. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Code of Ethics requires all directors, officers and employees to avoid any situation that involves an actual or potential conflict of interest with the Company&#8217;s objectives and best interests. Employees are encouraged to direct any questions regarding conflicts of interest to the Company&#8217;s Chief Financial Officer or legal department. All related party transactions involving the Company&#8217;s directors or executive officers or members of their immediate families must be reviewed and approved in writing in advance by the Audit Committee. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">HOUSEHOLDING OF PROXY MATERIALS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other annual meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other annual meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are XOMA stockholders will be &#8220;householding&#8221; the Company&#8217;s proxy materials. A single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or XOMA. Direct your written request to the Company&#8217;s principal office, at 2200 Powell Street, Suite 310, Emeryville, California 94608, Attention: Secretary or your telephonic request to (510) <span style="white-space:nowrap">204-7276.</span> Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OTHER MATTERS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board does not know of any matters to be presented at this annual meeting other than those set forth in this proxy statement and in the notice accompanying this proxy statement. If other matters should properly come before the meeting, it is intended that the proxy holders will vote on such matters in accordance with their best judgment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important that your shares of Common Stock be represented at the meeting, regardless of the number of shares of Common Stock you hold. You are, therefore, urged to promptly vote your proxy by accessing the internet, by calling the toll-free telephone number as instructed in the Notice, or if you have elected to receive a paper copy of the proxy materials, by completing, signing and returning the proxy card that is provided. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">A copy of the Company&#8217;s Annual Report to the Securities and Exchange Commission on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2022 is available without charge upon written request to: Secretary, XOMA Corporation, 2200 Powell Street, Suite 310, Emeryville, California 94608. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">STOCKHOLDER PROPOSALS AND OTHER COMMUNICATIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A stockholder who intends to present a proposal at the 2024 meeting of stockholders must submit such proposal to the Company by December&#160;6, 2023 for inclusion in the Company&#8217;s 2024 proxy statement and proxy card relating to such meeting. The proposal must be mailed to the Company&#8217;s principal office at 2200 Powell Street, Suite 310, Emeryville, California 94608, Attention: Secretary and must comply with all applicable requirements of Rule <span style="white-space:nowrap">14a-8</span> promulgated under the Exchange Act. A stockholder who intends to submit a proposal that is not to be included in next year&#8217;s proxy materials, but that may be considered at the annual meeting of stockholders to be held in 2024, must do so in writing following the above instructions not earlier than the close of business on January&#160;20, 2024 and not later than the close of business on February&#160;19, 2024. In addition, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also comply with the additional requirements of Rule <span style="white-space:nowrap">14a-19(b).</span> We advise you to review our <span style="white-space:nowrap">By-laws,</span> which contain additional requirements about advance notice of stockholder proposals and director nominations, including the different notice submission date requirements in the event our annual meeting for 2024 is held more than 30 days before or 60 days after May&#160;17, 2024. The section titled &#8220;Nominating&#160;&amp; Governance Committee&#8221; in this proxy statement provides additional information on the director nomination process. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all other stockholder communications with the Board or a particular director, a stockholder may send a letter to the Company&#8217;s principal office at 2200 Powell Street, Suite 310, Emeryville, California 94608, Attention: Secretary. The mailing envelope must contain a clear notation indicating that the enclosed letter is a &#8220;Stockholder-Board Communication&#8221; or &#8220;Stockholder-Director Communication.&#8221; The letter must identify the author as a stockholder and clearly state whether the intended recipients are all members of the Board or just certain specified individual director or directors. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap">By Order of the Board,</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap">


<img src="g344283g04g51.jpg" alt="LOGO" />
</td></tr>


<tr style="font-size:1pt">
<td style="height:3.75pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Thomas Burns</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Senior Vice President, Finance and Chief Financial Officer</td></tr>
</table></div> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">April&#160;4, 2023 </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Emeryville, California </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">APPENDIX A </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">XOMA CORPORATION </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2010 LONG TERM INCENTIVE AND STOCK AWARD PLAN </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(as amended through March&#160;29, 2023) </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">1.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Purposes</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purposes of the XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan are to advance the interests of XOMA Corporation and its stockholders by providing a means to attract, retain, and motivate employees, consultants and directors of the Company, its Subsidiaries and Affiliates, to provide for competitive compensation opportunities, to encourage long term service, to recognize individual contributions and reward achievement of performance goals, and to promote the creation of long term value for stockholders by aligning the interests of such persons with those of stockholders. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">2.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Definitions</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Plan, the following terms shall be defined as set forth below: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) &#8220;Affiliate&#8221; means any entity other than the Company and its Subsidiaries that is designated by the Board or the Committee as a participating employer under this Plan; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the Company directly or indirectly owns at least 20% of the combined voting power of all classes of stock of such entity or at least 20% of the ownership interests in such entity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) &#8220;Award&#8221; means any Option, SAR, Restricted Share, Restricted Stock Unit, Performance Share, Performance Unit, Dividend Equivalent, or Other Stock-Based Award granted to an Eligible Person under this Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) &#8220;Award Agreement&#8221; means any written agreement, contract, or other instrument or document evidencing an Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) &#8220;Beneficiary&#8221; means the person, persons, trust or trusts which have been designated by an Eligible Person in his or her most recent written beneficiary designation filed with the Company to receive the benefits specified under this Plan upon the death of the Eligible Person, or, if there is no designated Beneficiary or surviving designated Beneficiary, then the person, persons, trust or trusts entitled by will or the laws of descent and distribution to receive such benefits. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) &#8220;Board&#8221; means the Board of Directors of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) &#8220;Change in Control&#8221; means the occurrence of any of the following events: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) a merger, consolidation or acquisition in which the Company is not the surviving or continuing entity, except for a transaction the principal purpose of which is to change the jurisdiction of the Company&#8217;s organization; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) the sale, transfer or other disposition of all or substantially all of the assets of the Company; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) any other reorganization or business combination in which fifty percent (50%) or more of the Company&#8217;s outstanding voting securities are transferred to different holders in a single transaction or series of related transactions; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) any approval by the stockholders of the Company of a plan of complete liquidation of the Company; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the &#8220;beneficial owner&#8221; (as defined in Rule <span style="white-space:nowrap">13d-3</span> under the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities; or </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vi) a change in the composition of the Board, as a result of which fewer than a majority of the directors are Incumbent Directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) &#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended from time to time. References to any provision of the Code shall be deemed to include successor provisions thereto and regulations thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) &#8220;Committee&#8221; means the Compensation Committee of the Board, or such other Board committee or committees (which may include the entire Board) as may be designated by the Board to administer all or any portion of this Plan; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that, unless otherwise determined by the Board, a Committee shall consist of two or more directors of the Company, each of whom is a <span style="white-space:nowrap">&#8220;non-employee</span> director&#8221; within the meaning of Rule <span style="white-space:nowrap">16b-3</span> under the Exchange Act, to the extent applicable; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">further</span>, that the mere fact that a Committee shall fail to qualify under the foregoing requirement shall not invalidate any Award made by such Committee which Award is otherwise validly made under this Plan. Different Committees may administer this Plan with respect to different groups of Eligible Persons. As used herein, the singular &#8220;Committee&#8221; shall include the plural &#8220;Committees&#8221; if applicable, except where the context requires otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) &#8220;Company&#8221; means XOMA Corporation, a Delaware corporation, or any successor company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) &#8220;Director&#8221; means a member of the Board who is not an employee of the Company, a Subsidiary or an Affiliate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) &#8220;Dividend Equivalent&#8221; means a right, granted under Section&#160;5(g), to receive cash, Shares, or other property equal in value to dividends paid with respect to a specified number of Shares. Dividend Equivalents may be awarded on a free-standing basis or in connection with another Award, and may be paid currently or on a deferred basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) &#8220;Effective Date&#8221; means July&#160;21, 2010. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(m) &#8220;Eligible Person&#8221; means (i)&#160;an employee or consultant of the Company, a Subsidiary or an Affiliate, including any director who is an employee, or (ii)&#160;a Director. Notwithstanding any provisions of this Plan to the contrary, an Award may be granted to an employee or consultant in connection with his or her hiring or retention prior to the date the employee or consultant first performs services for the Company, a Subsidiary or an Affiliate; provided, however, that any such Award shall not become vested or exercisable prior to the date the employee or consultant first performs such services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(n) &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended from time to time. References to any provision of the Exchange Act shall be deemed to include successor provisions thereto and regulations thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(o) &#8220;Fair Market Value&#8221; means: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) if the Shares are not at the time listed or admitted to trading on any stock exchange but are traded in the <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> market, the fair market value shall be the closing selling price per Share on the date in question, as such price is reported on The NASDAQ Global Market or any successor system; <span style="text-decoration:underline">provided</span> that if there is no reported closing selling price for Shares on the date in question, then the closing selling price on the last preceding date for which such quotation exists shall be determinative of fair market value; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) if the Shares are at the time listed or admitted to trading on any stock exchange, then the fair market value shall be the closing selling price per Share on the date in question on the stock exchange determined by the Committee to be the primary market for the Shares, as such price is officially quoted on such exchange; <span style="text-decoration:underline">provided</span> that if there is no reported sale of Shares on such exchange on the date in question, then the fair market value shall be the closing selling price on the exchange on the last preceding date for which such quotation exists; or </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) if the Shares are at the time neither listed nor admitted to trading on any stock exchange nor traded in the <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> market (or if the Committee determines that the value as determined pursuant to subsection (i)&#160;or (ii)&#160;above does not reflect fair market value), then the Committee shall determine fair market value after taking into account such factors as it deems appropriate, including one or more independent professional appraisals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(p) &#8220;Incumbent Directors&#8221; means directors who (i)&#160;are directors of the Company as of the date hereof, (ii)&#160;are elected, or nominated for election, to the Board with the affirmative votes of the directors of the Company as of the date hereof, or (iii)&#160;are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of those directors whose election or nomination was not in connection with any transaction described in subsections (i)&#160;through (v) of the definition of Change in Control or in connection with an actual or threatened proxy contest relating to the election of directors of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(q) &#8220;ISO&#8221; means any Option intended to be and designated as an incentive stock option within the meaning of Section&#160;422 of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(r) &#8220;NQSO&#8221; means any Option that is not an ISO. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(s) &#8220;Option&#8221; means a right, granted under Section&#160;5(b), to purchase Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(t) &#8220;Other Stock-Based Award&#8221; means a right, granted under Section&#160;5(h) that relates to or is valued by reference to Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(u) &#8220;Participant&#8221; means an Eligible Person who has been granted an Award under this Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) &#8220;Performance Period&#8221; shall have the meaning set forth in Section&#160;5(f)(i). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(w) &#8220;Performance Share&#8221; means a performance share granted under Section&#160;5(f). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(x) &#8220;Performance Unit&#8221; means a performance unit granted under Section&#160;5(f). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(y) &#8220;Plan&#8221; means this XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(z) &#8220;Restricted Shares&#8221; means an Award of Shares under Section&#160;5(d) that may be subject to certain restrictions and to a risk of forfeiture. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(aa) &#8220;Restricted Stock Unit&#8221; means a right, granted under Section&#160;5(e), to receive Shares or cash at the end of a specified deferral period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(bb) &#8220;Rule <span style="white-space:nowrap">16b-3&#8221;</span> means Rule <span style="white-space:nowrap">16b-3,</span> as from time to time in effect and applicable to this Plan and Participants, promulgated by the Securities and Exchange Commission under Section&#160;16 of the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(cc) &#8220;SAR&#8221; or &#8220;Stock Appreciation Right&#8221; means the right, granted under Section&#160;5(c), to be paid an amount measured by the difference between the exercise price of the right and the Fair Market Value of Shares on the date of exercise of the right, with payment to be made in cash, Shares, or property as specified in the Award or determined by the Committee. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(dd) &#8220;Shares&#8221; means shares of common stock of the Company, and such other securities as may be substituted for Shares pursuant to Section&#160;4(c) hereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ee) &#8220;Subsidiary&#8221; means any company (other than the Company) in an unbroken chain of companies beginning with the Company if each of the companies (other than the last company in the unbroken chain) owns shares possessing 50% or more of the total combined voting power of all classes of stock in one of the other companies in the chain. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ff) &#8220;Termination of Service&#8221; means the termination of the Participant&#8217;s employment, consulting services or directorship with the Company, its Subsidiaries and its Affiliates, as the case may be. A Participant employed by a Subsidiary of the Company or one of its Affiliates shall also be deemed to incur a Termination of Service if the Subsidiary of the Company or Affiliate ceases to be such a Subsidiary or an Affiliate, as the case may be, and the Participant does not immediately thereafter become an employee or director of, or a consultant to, the Company, another Subsidiary of the Company or an Affiliate. In the event that a Participant who is an employee of the Company, a Subsidiary or an Affiliate becomes a Director or a consultant to the Company, a Subsidiary or an Affiliate upon the Participant&#8217;s termination of employment, unless otherwise determined by the Committee in its sole discretion, no Termination of Service shall be deemed to occur until such time as such Participant is no longer an employee of, or consultant to, the Company, a Subsidiary or an Affiliate or a Director, as the case may be. If a Participant who is a Director becomes an employee of, or a consultant to, the Company, a Subsidiary or an Affiliate upon such Participant ceasing to be a Director, unless otherwise determined by the Committee in its sole discretion, such termination of the Participant&#8217;s directorship shall not be treated as a Termination of Service unless and until the Participant&#8217;s employment or consultancy, as the case may be, terminates. Temporary absences from employment because of illness, vacation or leave of absence and transfers among the Company and its Subsidiaries and Affiliates shall not be considered a Termination of Service. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">3.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Administration</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Authority of the Committee.</span> This Plan shall be administered by the Committee, and the Committee shall have full and final authority to take the following actions, in each case subject to and consistent with the provisions of this Plan: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) to select Eligible Persons to whom Awards may be granted; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) to designate Affiliates; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) to determine the type or types of Awards to be granted to each Eligible Person; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) to determine the type and number of Awards to be granted, the number of Shares to which an Award may relate, the terms and conditions of any Award granted under this Plan (including, but not limited to, any exercise price, grant price, or purchase price, any restriction or condition, any schedule for lapse of restrictions or conditions relating to transferability or forfeiture, exercisability, or settlement of an Award, and waiver or accelerations thereof, and waivers of performance conditions relating to an Award, based in each case on such considerations as the Committee shall determine), and all other matters to be determined in connection with an Award; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) to determine whether, to what extent, and under what circumstances an Award may be settled, or the exercise price of an Award may be paid, in cash, Shares, other Awards, or other property, or an Award may be canceled, forfeited, exchanged, or surrendered; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vi) to determine whether, to what extent, and under what circumstances cash, Shares, other Awards, or other property payable with respect to an Award will be deferred either automatically, at the election of the Committee, or at the election of the Eligible Person, <span style="text-decoration:underline">provided</span> that such deferral shall be intended to be in compliance with Section&#160;409A of the Code; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vii) to prescribe the form of each Award Agreement, which need not be identical for each Eligible Person; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(viii) to adopt, amend, suspend, waive, and rescind such rules and regulations and appoint such agents as the Committee may deem necessary or advisable to administer this Plan; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ix) to correct any defect or supply any omission or reconcile any inconsistency in this Plan and to construe and interpret this Plan and any Award, rules and regulations, Award Agreement, or other instrument hereunder; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(x) to accelerate the exercisability or vesting of all or any portion of any Award or to extend the period during which an Award is exercisable; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(xi) to determine whether uncertificated Shares may be used in satisfying Awards and otherwise in connection with this Plan; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(xii) to make all other decisions and determinations as may be required under the terms of this Plan or as the Committee may deem necessary or advisable for the administration of this Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Manner of Exercise of Committee Authority.</span> The Committee shall have sole discretion in exercising its authority under this Plan. Any action of the Committee with respect to this Plan shall be final, conclusive, and binding on all persons, including the Company, Subsidiaries, Affiliates, Eligible Persons, any person claiming any rights under this Plan from or through any Eligible Person, and stockholders. The express grant of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed as limiting any power or authority of the Committee. The Committee may delegate to other members of the Board or officers or managers of the Company or any Subsidiary or Affiliate the authority, subject to such terms as the Committee shall determine, to perform administrative functions and, with respect to Awards granted to persons not subject to Section&#160;16 of the Exchange Act, to perform such other functions as the Committee may determine, to the extent permitted under Rule <span style="white-space:nowrap">16b-3</span> (if applicable) and applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">Limitation of Liability.</span> Each member of the Committee shall be entitled to, in good faith, rely or act upon any report or other information furnished to him or her by any officer or other employee of the Company or any Subsidiary or Affiliate, the Company&#8217;s independent certified public accountants, or other professional retained by the Company to assist in the administration of this Plan. No member of the Committee, and no officer or employee of the Company acting on behalf of the Committee, shall be personally liable for any action, determination, or interpretation taken or made in good faith with respect to this Plan, and all members of the Committee and any officer or employee of the Company acting on their behalf shall, to the extent permitted by law, be fully indemnified and protected by the Company with respect to any such action, determination, or interpretation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">No Option or SAR Repricing Without Stockholder Approval.</span> Except as provided in the first sentence of Section&#160;4(c) hereof relating to certain anti-dilution adjustments, unless the approval of stockholders of the Company is obtained, (i)&#160;Options and SARs shall not be amended to lower their exercise price, (ii)&#160;Options and SARs will not be exchanged for other Options or SARs with lower exercise prices, (iii)&#160;Options and SARs with an exercise price in excess of the Fair Market Value of the underlying Shares will not be exchanged for cash or other property and (iii)&#160;no other action shall be taken with respect to Options or SARs that would be treated as a repricing under the rules of the principal stock exchange on which the Shares are listed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <span style="text-decoration:underline">Limitation on Committee&#8217;s Authority under 409A.</span> Anything in this Plan to the contrary notwithstanding, the Committee&#8217;s authority to modify outstanding Awards shall be limited to the extent necessary so that the existence of such authority does not (i)&#160;cause an Award that is not otherwise deferred compensation subject to Section&#160;409A of the Code to become deferred compensation subject to Section&#160;409A of the Code or (ii)&#160;cause an Award that is otherwise deferred compensation subject to Section&#160;409A of the Code to fail to meet the requirements prescribed by Section&#160;409A of the Code. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">4.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Shares Subject to this Plan</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Subject to adjustment as provided in Section&#160;4(c) hereof, the total number of Shares reserved for issuance in connection with Awards under this Plan shall be (i) 4,013,062 plus (ii)&#160;the number of Shares subject to awards granted prior to the Effective Date of this Plan under the Company&#8217;s 1981 Share Option Plan, its Restricted Share Plan or its 1992 Directors Share Option Plan (the &#8220;Prior Plans&#8221;) which awards are, after the Effective Date, forfeited, canceled, surrendered or otherwise terminated without a distribution of Shares to the holder of the award; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that, subject to adjustment as provided in Section&#160;4(c) hereof, no more than 4,013,062 Shares may be issued as ISOs under this Plan; and, <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">further</span>, that for each Restricted Share, Restricted Stock Unit, Performance Share, Performance Unit, Dividend Equivalent or Other Stock-Based Award issued, such total number of available Shares shall be reduced by 1.08 Shares. No Award may be granted if the number of Shares to which such Award relates, when added to the number of Shares previously issued under this Plan, exceeds the number of Shares reserved under the applicable provisions of the preceding sentence. If any Awards are forfeited, canceled, terminated, exchanged or surrendered or such Award is settled in cash or otherwise terminates without a distribution of Shares to the Participant, any Shares counted against the number of Shares reserved and available under this Plan with respect to such Award shall, to the extent of any such forfeiture, repurchase, settlement, termination, cancellation, exchange or surrender, again be available for Awards under this Plan. Further, for each share underlying an Award that was granted under this Plan and is a Restricted Share, Restricted Stock Unit, Performance Share, Performance Unit, Dividend Equivalent or Other Stock-Based Award and for each share underlying an award other than an option or stock appreciation right that was granted under a Prior Plan, in each case, that is forfeited, cancelled, terminated, exchanged or surrendered, such forfeiture, cancellation, termination, exchange or surrender will result in the addition of 1.08 shares to the share reserve of this Plan. Upon the exercise of any Award granted in tandem with any other Awards, such related Awards shall be canceled to the extent of the number of Shares as to which the Award is exercised. If any shares subject to an Award are not delivered to a participant because the Award is exercised through a reduction of shares subject to the Award (i.e., &#8220;net exercised&#8221;), the number of shares that are not delivered to the participant shall not remain available for issuance under the Plan. Also, any shares withheld or reacquired by the Company pursuant to the exercise of an option or SAR or as consideration for the exercise of an option or SAR, and any shares withheld or reacquired by the Company in satisfaction of the Company&#8217;s tax withholding obligation on an Award shall not again become available for issuance under the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) In the event that the Committee shall determine that any dividend in Shares, recapitalization, Share split, reverse split, reorganization, merger, consolidation, <span style="white-space:nowrap">spin-off,</span> combination, repurchase, share exchange, extraordinary distribution or other similar corporate transaction or event, affects the Shares such that an adjustment is appropriate in order to prevent dilution or enlargement of the rights of Eligible Persons under this Plan, then the Committee shall make such equitable changes or adjustments as it deems appropriate and, in such manner as it may deem equitable, (i)&#160;adjust any or all of (w)&#160;the number and kind of shares which may thereafter be issued under this Plan, (x)&#160;the number and kind of shares, other securities or other consideration issued or issuable in respect of outstanding Awards, and (y)&#160;the exercise price, grant price, or purchase price relating to any Award, or (ii)&#160;provide for a distribution of cash or property in respect of any Award; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, in each case that, with respect to ISOs, such adjustment shall be made in accordance with Section&#160;424(a) of the Code, unless the Committee determines otherwise; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">further</span>, that no adjustment shall be made pursuant to this Section&#160;4(c) that causes any Award that is not otherwise deferred compensation subject to Section&#160;409A of the Code to be treated as deferred compensation pursuant to Section&#160;409A of the Code. In addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria and performance objectives, if any, included in, Awards in recognition of unusual or <span style="white-space:nowrap">non-recurring</span> events (including, without limitation, events described in the preceding sentence) affecting the Company or any Subsidiary or Affiliate or the financial statements of the Company or any Subsidiary or Affiliate, or in response to changes in applicable laws, regulations, or accounting principles. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Any Shares distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares or treasury Shares including Shares acquired by purchase in the open market or in private transactions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline"><span style="white-space:nowrap">Non-Employee</span> Director Aggregate Compensation Limit</span>. The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a <span style="white-space:nowrap">non-employee</span> director with respect to any period commencing on the date of the Company&#8217;s annual meeting of stockholders for a particular year and ending on the day immediately prior to the date of the Company&#8217;s annual meeting of stockholders for the next subsequent year, including Awards granted and cash fees paid by the Company to such <span style="white-space:nowrap">non-employee</span> director, will not exceed $750,000 in total value, calculating the value of any Awards based on the grant date fair value of such Awards for financial reporting purposes. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">5.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Specific Terms of Awards</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">General</span>. Awards may be granted on the terms and conditions set forth in this Section&#160;5. In addition, the Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter (subject to Section&#160;8(d)), such additional terms and conditions, not inconsistent with the provisions of this Plan, as the Committee shall determine, including terms regarding forfeiture of Awards or continued exercisability of Awards in the event of Termination of Service by the Eligible Person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Options</span>. The Committee is authorized to grant Options, which may be NQSOs or ISOs, to Eligible Persons on the following terms and conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Exercise Price</span>. The exercise price per Share purchasable under an Option shall be determined by the Committee; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the exercise price per Share of an Option shall not be less than the Fair Market Value of a Share on the date of grant of the Option. The Committee may, without limitation, set an exercise price that is based upon achievement of performance criteria if deemed appropriate by the Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <span style="text-decoration:underline">Option Term</span>. The term of each Option shall be determined by the Committee; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that such term shall not be longer than ten years from the date of grant of the Option. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) <span style="text-decoration:underline">Time and Method of Exercise</span>. The Committee shall determine at the date of grant or thereafter the time or times at which an Option may be exercised in whole or in part (including, without limitation, upon achievement of performance criteria if deemed appropriate by the Committee), the methods by which such exercise price may be paid or deemed to be paid (including, without limitation, broker-assisted exercise arrangements), the form of such payment (including, without limitation, cash, Shares or other property), and the methods by which Shares will be delivered or deemed to be delivered to Eligible Persons. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) <span style="text-decoration:underline">ISOs</span>. The terms of any ISO granted under this Plan shall comply in all respects with the provisions of Section&#160;422 of the Code, including but not limited to the requirement that the ISO shall be granted within ten years from the earlier of the date of adoption or stockholder approval of this Plan. ISOs may only be granted to employees of the Company or a Subsidiary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">SARs</span>. The Committee is authorized to grant SARs (Stock Appreciation Rights) to Eligible Persons on the following terms and conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Right to Payment</span>. A SAR shall confer on the Eligible Person to whom it is granted a right to receive with respect to each Share subject thereto, upon exercise thereof, the excess of (1)&#160;the Fair Market Value of one Share on the date of exercise over (2)&#160;the exercise price per Share of the SAR, as determined by the Committee as of the date of grant of the SAR (which shall not be less than the Fair Market Value per Share on the date of grant of the SAR and, in the case of a SAR granted in tandem with an Option, shall be equal to the exercise price of the underlying Option). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <span style="text-decoration:underline">Other Terms</span>. The Committee shall determine, at the time of grant or thereafter, the time or times at which a SAR may be exercised in whole or in part (which shall not be more than ten years after the date of grant of the SAR), the method of exercise, method of settlement, form of consideration payable in settlement, method by which Shares will be delivered or deemed to be delivered to Eligible Persons, whether or not a SAR shall be in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
tandem with any other Award, and any other terms and conditions of any SAR. Unless the Committee determines otherwise, a SAR (1)&#160;granted in tandem with an NQSO may be granted at the time of grant of the related NQSO or at any time thereafter and (2)&#160;granted in tandem with an ISO may only be granted at the time of grant of the related ISO. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Restricted Shares</span>. The Committee is authorized to grant Restricted Shares to Eligible Persons on the following terms and conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Issuance and Restrictions</span>. Restricted Shares shall be subject to such restrictions on transferability and other restrictions, if any, as the Committee may impose at the date of grant or thereafter, which restrictions may lapse separately or in combination at such times, under such circumstances (including, without limitation, upon achievement of performance criteria if deemed appropriate by the Committee), in such installments, or otherwise, as the Committee may determine. Except to the extent restricted under the Award Agreement relating to the Restricted Shares, an Eligible Person granted Restricted Shares shall have all of the rights of a stockholder including, without limitation, the right to vote Restricted Shares and the right to receive dividends thereon. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <span style="text-decoration:underline">Forfeiture</span>. Except as otherwise determined by the Committee, at the date of grant or thereafter, upon Termination of Service during the applicable restriction period, Restricted Shares shall be repurchased by the Company for a nominal amount equal to their par value and any accrued but unpaid dividends or Dividend Equivalents that are at that time subject to restrictions shall be forfeited; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that restrictions or forfeiture conditions relating to Restricted Shares will be waived in whole or in part in the event of Termination of Service resulting from specified causes, and the Committee may in other cases waive in whole or in part the forfeiture of Restricted Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) <span style="text-decoration:underline">Certificates for Shares</span>. Restricted Shares granted under this Plan may be evidenced in such manner as the Committee shall determine. If certificates representing Restricted Shares are registered in the name of the Eligible Person, such certificates shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Shares, and, unless otherwise determined by the Committee, the Company shall retain physical possession of the certificate and the Participant shall deliver a stock power to the Company, endorsed in blank, relating to the Restricted Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) <span style="text-decoration:underline">Dividends</span>. Dividends paid on Restricted Shares shall be either paid at the dividend payment date, or deferred for payment to such date, and subject to such conditions, as determined by the Committee, in cash or in restricted or unrestricted Shares having a Fair Market Value equal to the amount of such dividends. Unless otherwise determined by the Committee, Shares distributed in connection with a Share split or dividend in Shares, and other property distributed as a dividend, shall be subject to restrictions and a risk of forfeiture to the same extent as the Restricted Shares with respect to which such Shares or other property has been distributed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <span style="text-decoration:underline">Restricted Stock Units</span>. The Committee is authorized to grant Restricted Stock Units to Eligible Persons, subject to the following terms and conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Award and Restrictions</span>. Delivery of Shares or cash, as the case may be, will occur upon expiration of the deferral period specified for Restricted Stock Units by the Committee (or, if permitted by the Committee, as elected by the Eligible Person). In addition, Restricted Stock Units shall be subject to such restrictions as the Committee may impose, if any (including, without limitation, the achievement of performance criteria if deemed appropriate by the Committee), at the date of grant or thereafter, which restrictions may lapse at the expiration of the deferral period or at earlier or later specified times, separately or in combination, in installments or otherwise, as the Committee may determine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <span style="text-decoration:underline">Forfeiture</span>. Except as otherwise determined by the Committee at the date of grant or thereafter, upon Termination of Service during the applicable deferral period or portion thereof to which forfeiture conditions </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
apply (as provided in the Award Agreement evidencing the Restricted Stock Units), or upon failure to satisfy any other conditions precedent to the delivery of Shares or cash to which such Restricted Stock Units relate, all Restricted Stock Units that are at that time subject to deferral or restriction shall be forfeited; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that restrictions or forfeiture conditions relating to Restricted Stock Units will be waived in whole or in part in the event of Termination of Service resulting from specified causes, and the Committee may in other cases waive in whole or in part the forfeiture of Restricted Stock Units. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) <span style="text-decoration:underline">Dividend Equivalents</span>. Unless otherwise determined by the Committee at the date of grant, Dividend Equivalents on the specified number of Shares covered by a Restricted Stock Unit shall be either (A)&#160;paid with respect to such Restricted Stock Unit at the dividend payment date in cash or in restricted or unrestricted Shares having a Fair Market Value equal to the amount of such dividends, or (B)&#160;deferred with respect to such Restricted Stock Unit and the amount or value thereof automatically deemed reinvested in additional Restricted Stock Units or other Awards, as the Committee shall determine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <span style="text-decoration:underline">Performance Shares and Performance Units</span>. The Committee is authorized to grant Performance Shares or Performance Units or both to Eligible Persons on the following terms and conditions: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Performance Period</span>. The Committee shall determine a performance period (the &#8220;Performance Period&#8221;) of one or more years or other periods and shall determine the performance objectives for grants of Performance Shares and Performance Units. Performance objectives may vary from Eligible Person to Eligible Person and shall be based upon the performance criteria as the Committee may deem appropriate. The performance objectives may be determined by reference to the performance of the Company, or of a Subsidiary or Affiliate, or of a division or unit of any of the foregoing. Performance Periods may overlap and Eligible Persons may participate simultaneously with respect to Performance Shares and Performance Units for which different Performance Periods are prescribed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) <span style="text-decoration:underline">Award Value</span>. At the beginning of a Performance Period, the Committee shall determine for each Eligible Person or group of Eligible Persons with respect to that Performance Period the range of number of Shares, if any, in the case of Performance Shares, and either the range of number of Shares or the range of dollar values, if any, in the case of Performance Units, which may be fixed or may vary in accordance with such performance or other criteria specified by the Committee, which shall be paid to an Eligible Person as an Award if the relevant measure of Company performance for the Performance Period is met. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) <span style="text-decoration:underline">Significant Events</span>. If during the course of a Performance Period there shall occur significant events as determined by the Committee which the Committee expects to have a substantial effect on a performance objective during such period, the Committee may revise such objective. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) <span style="text-decoration:underline">Forfeiture</span>. Except as otherwise determined by the Committee at the date of grant or thereafter, upon Termination of Service during the applicable Performance Period, Performance Shares and Performance Units for which the Performance Period was prescribed shall be forfeited; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in an individual case, that restrictions or forfeiture conditions relating to Performance Shares and Performance Units will be waived in whole or in part in the event of Terminations of Service resulting from specified causes, and the Committee may in other cases waive in whole or in part the forfeiture of Performance Shares and Performance Units. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) <span style="text-decoration:underline">Payment</span>. Each Performance Share or Performance Unit may be paid in whole Shares, or cash, or a combination of Shares and cash either as a lump sum payment or in installments, all as the Committee shall determine, at the time of grant of the Performance Share or Performance Unit or otherwise, commencing at the time determined by the Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vi) <span style="text-decoration:underline">Restriction on Dividends</span>. No dividends or Dividend Equivalents shall be paid on any Performance Share or Performance Unit until such time (if ever) as the performance criteria associated therewith have been met. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <span style="text-decoration:underline">Dividend Equivalents</span>. The Committee is authorized to grant Dividend Equivalents to Eligible Persons. The Committee may provide, at the date of grant or thereafter, that Dividend Equivalents shall be paid or distributed when accrued or shall be deemed to have been reinvested in additional Shares, or other investment vehicles as the Committee may specify; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that, unless otherwise determined by the Committee, Dividend Equivalents (other than freestanding Dividend Equivalents) shall be subject to all conditions and restrictions of any underlying Awards to which they relate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <span style="text-decoration:underline">Other Stock-Based Awards</span>. The Committee is authorized, subject to limitations under applicable law, to grant to Eligible Persons such other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares, as deemed by the Committee to be consistent with the purposes of this Plan, including, without limitation, unrestricted shares awarded purely as a &#8220;bonus&#8221; and not subject to any restrictions or conditions, other rights convertible or exchangeable into Shares, purchase rights for Shares, Awards with value and payment contingent upon performance of the Company or any other factors designated by the Committee, and Awards valued by reference to the performance of specified Subsidiaries or Affiliates. The Committee shall determine the terms and conditions of such Awards at date of grant or thereafter. Shares delivered pursuant to an Award in the nature of a purchase right granted under this Section&#160;5(h) shall be purchased for such consideration, paid for at such times, by such methods, and in such forms, including, without limitation, cash, Shares, notes or other property, as the Committee shall determine. Cash awards, as an element of or supplement to any other Award under this Plan, shall also be authorized pursuant to this Section&#160;5(h). </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">6.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Certain Provisions Applicable to Awards</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Stand-Alone, Additional, Tandem and Substitute Awards</span>. Awards granted under this Plan may, in the discretion of the Committee, be granted to Eligible Persons either alone or in addition to, in tandem with, or in exchange or substitution for, any other Award granted under this Plan or any award granted under any other plan or agreement of the Company, any Subsidiary or Affiliate, or any business entity to be acquired by the Company or a Subsidiary or Affiliate, or any other right of an Eligible Person to receive payment from the Company or any Subsidiary or Affiliate. Awards may be granted in addition to or in tandem with such other Awards or awards, and may be granted either as of the same time as, or a different time from, the grant of such other Awards or awards. Subject to the provisions of Section&#160;3(d) hereof prohibiting Option and SAR repricing without stockholder approval, the per Share exercise price of any Option, or grant price of any SAR, which is granted in connection with the substitution of awards granted under any other plan or agreement of the Company or any Subsidiary or Affiliate, or any business entity to be acquired by the Company or any Subsidiary or Affiliate, shall be determined by the Committee, in its discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Term of Awards</span>. The term of each Award granted to an Eligible Person shall be for such period as may be determined by the Committee; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that in no event shall the term of any Option or SAR exceed a period of ten years from the date of its grant (or, in the case of ISOs, such shorter period as may be applicable under Section&#160;422 of the Code). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">Form of Payment Under Awards</span>. Subject to the terms of this Plan and any applicable Award Agreement, payments to be made by the Company or a Subsidiary or Affiliate upon the grant, maturation, or exercise of an Award may be made in such forms as the Committee shall determine at the date of grant or thereafter, including, without limitation, cash, Shares, notes or other property, and may be made in a single payment or transfer, in installments, or on a deferred basis, <span style="text-decoration:underline">provided</span> that any such deferral shall be intended to be in compliance with Section&#160;409A of the Code. The Committee may make rules relating to installment or deferred payments with respect to Awards, including the rate of interest to be credited with respect to such payments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Nontransferability</span>. Awards shall not be transferable by an Eligible Person except by will or the laws of descent and distribution (except pursuant to a Beneficiary designation) and shall be exercisable during the lifetime of an Eligible Person only by such Eligible Person or his or her guardian or legal representative, <span style="text-decoration:underline">provided</span> that Awards that are NQSOs may be transferred or assigned by the optionee to the optionee&#8217;s spouse or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
descendent (any such spouse or descendent, an &#8220;Immediate Family Member&#8221;) or a corporation, partnership, limited liability company or trust so long as all of the stockholders, partners, members or beneficiaries thereof, as the case may be, are either the optionee or the optionee&#8217;s Immediate Family Member, <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">further</span>, that (i)&#160;there may be no consideration for any such transfer and (ii)&#160;subsequent transfers of the transferred NQSO will be prohibited other than by will or the laws of descent and distribution. An Eligible Person&#8217;s rights under this Plan may not be pledged, mortgaged, hypothecated, or otherwise encumbered, and shall not be subject to claims of the Eligible Person&#8217;s creditors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <span style="text-decoration:underline">Noncompetition</span>. The Committee may, by way of the Award Agreements or otherwise, establish such other terms, conditions, restrictions and/or limitations, if any, of any Award, provided they are not inconsistent with this Plan, including, without limitation, the requirement that the Participant not engage in competition with, solicit customers or employees of, or disclose or use confidential information of the Company or its Affiliates. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">7.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Change in Control Provisions</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by the Committee at the time of the Award grant, in the event of a Change in Control, each outstanding Award shall either be assumed by the successor company or parent thereof or to be replaced with comparable awards with respect to capital stock of the successor company or parent thereof, such comparability to be determined by the Committee; provided, however<span style="font-style:italic">,</span> that notwithstanding the foregoing, if an outstanding Award is not so assumed or replaced, then (i)&#160;such outstanding Award pursuant to which the Participant may have rights the exercise of which is restricted or limited, shall become fully exercisable at the time of the Change in Control, and (ii)&#160;unless the right to lapse of restrictions or limitations is waived or deferred by a Participant prior to such lapse, all restrictions or limitations (including risks of forfeiture and deferrals) on such outstanding Award subject to restrictions or limitations under this Plan shall lapse, and all performance criteria and other conditions to payment of Awards under which payments of cash, Shares or other property are subject to conditions shall be deemed to be achieved or fulfilled at target (if applicable) and shall be waived by the Company at the time of the Change in Control. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">8.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">General Provisions</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Compliance with Legal and Trading Requirements</span>. This Plan, the granting and exercising of Awards thereunder, and the other obligations of the Company under this Plan and any Award Agreement, shall be subject to all applicable federal, state and foreign laws, rules and regulations, and to such approvals by any stock exchange, regulatory or governmental agency as may be required. The Company, in its discretion, may postpone the issuance or delivery of Shares under any Award until completion of such stock exchange or market system listing or registration or qualification of such Shares or any required action under any state, federal or foreign law, rule or regulation as the Company may consider appropriate, and may require any Participant to make such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of Shares in compliance with applicable laws, rules and regulations. No provisions of this Plan shall be interpreted or construed to obligate the Company to register any Shares under federal, state or foreign law. The Shares issued under this Plan may be subject to such other restrictions on transfer as determined by the Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">No Right to Continued Employment or Service</span>. Neither this Plan nor any action taken thereunder shall be construed as giving any employee, consultant or director the right to be retained in the employ or service of the Company or any of its Subsidiaries or Affiliates, nor shall it interfere in any way with the right of the Company or any of its Subsidiaries or Affiliates to terminate any employee&#8217;s, consultant&#8217;s or director&#8217;s employment or service at any time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">Taxes</span>. The Company or any Subsidiary or Affiliate is authorized to withhold from any Award granted, any payment relating to an Award under this Plan, including from a distribution of Shares, or any payroll or other payment to an Eligible Person, amounts of withholding and other taxes due in connection with any transaction </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
involving an Award, and to take such other action as the Committee may deem advisable to enable the Company and Eligible Persons to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award. This authority shall include authority to withhold or receive Shares or other property and to make cash payments in respect thereof in satisfaction of an Eligible Person&#8217;s tax obligations; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the amount of tax withholding to be satisfied by withholding Shares shall be limited to the minimum amount of taxes, including employment taxes, required to be withheld under applicable Federal, state and local law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Changes to this Plan and Awards</span>. The Board may amend, alter, suspend, discontinue, or terminate this Plan or the Committee&#8217;s authority to grant Awards under this Plan without the consent of stockholders of the Company or Participants, except that any such amendment or alteration shall be subject to the approval of the Company&#8217;s stockholders (i)&#160;to the extent such stockholder approval is required under the rules of any stock exchange or automated quotation system on which the Shares may then be listed or quoted, or (ii)&#160;as it applies to ISOs, to the extent such stockholder approval is required under Section&#160;422 of the Code; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that, without the consent of an affected Participant, no amendment, alteration, suspension, discontinuation, or termination of this Plan may materially and adversely affect the rights of such Participant under any Award theretofore granted to him or her. The Committee may waive any conditions or rights under, amend any terms of, or amend, alter, suspend, discontinue or terminate, any Award theretofore granted, prospectively or retrospectively; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that, without the consent of a Participant, no amendment, alteration, suspension, discontinuation or termination of any Award may materially and adversely affect the rights of such Participant under any Award theretofore granted to him or her. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) <span style="text-decoration:underline">No Rights to Awards; No Stockholder Rights</span>. No Eligible Person or employee shall have any claim to be granted any Award under this Plan, and there is no obligation for uniformity of treatment of Eligible Persons and employees. No Award shall confer on any Eligible Person any of the rights of a stockholder of the Company unless and until Shares are duly issued or transferred to the Eligible Person in accordance with the terms of the Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) <span style="text-decoration:underline">Unfunded Status of Awards</span>. This Plan is intended to constitute an &#8220;unfunded&#8221; plan for incentive compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in this Plan or any Award shall give any such Participant any rights that are greater than those of a general creditor of the Company; <span style="text-decoration:underline">provided</span>, <span style="text-decoration:underline">however</span>, that the Committee may authorize the creation of trusts or make other arrangements to meet the Company&#8217;s obligations under this Plan to deliver cash, Shares, other Awards, or other property pursuant to any Award, which trusts or other arrangements shall be consistent with the &#8220;unfunded&#8221; status of this Plan unless the Committee otherwise determines with the consent of each affected Participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) <span style="text-decoration:underline">Nonexclusivity of this Plan</span>. Neither the adoption of this Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of options and other awards otherwise than under this Plan, and such arrangements may be either applicable generally or only in specific cases. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) <span style="text-decoration:underline">Not Compensation for Benefit Plans</span>. No Award payable under this Plan shall be deemed salary or compensation for the purpose of computing benefits under any benefit plan or other arrangement of the Company for the benefit of its employees, consultants or directors unless the Company shall determine otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">No Fractional Shares</span>. No fractional Shares shall be issued or delivered pursuant to this Plan or any Award. The Committee shall determine whether cash, other Awards, or other property shall be issued or paid in lieu of such fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or otherwise eliminated. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) <span style="text-decoration:underline">Governing Law</span>. The validity, construction, and effect of this Plan, any rules and regulations relating to this Plan, and any Award Agreement shall be determined in accordance with the laws of the State of Delaware without giving effect to principles of conflict of laws thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) <span style="text-decoration:underline">Effective Date; Plan Termination</span>. This Plan became effective as of the Effective Date. This Plan shall terminate as to future awards on April&#160;1, 2029 unless earlier terminated or extended by amendment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) <span style="text-decoration:underline">Section 409A</span>. Awards under this Plan are intended to comply with, or be exempt from, the applicable requirements of Section&#160;409A of the Code and shall be limited, construed and interpreted in accordance with such intent. Although the Company does not guarantee any particular tax treatment, to the extent that any Award is subject to Section&#160;409A of the Code, it shall be paid in a manner that is intended to comply with Section&#160;409A of the Code, including regulations and any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect thereto. In no event whatsoever shall the Company be liable for any additional tax, interest or penalties that may be imposed on a Participant by Section&#160;409A of the Code or any damages for failing to comply with Section&#160;409A of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(o) <span style="text-decoration:underline">Change of Domicile</span>. This Plan has been amended and restated to give effect to the Company&#8217;s change of its jurisdiction of incorporation from Bermuda to Delaware (the &#8220;Domestication&#8221;), effective December&#160;31, 2011 (the &#8220;Domestication Effective Date&#8221;). To the extent that Shares are required to, or may, be issued pursuant to an Award, shares of common stock of XOMA Corporation, a Delaware corporation, will be issued upon exercise or payment of any such Award previously or hereafter granted under this Plan, including Awards that were outstanding prior to the Domestication Effective Date. Until surrendered and exchanged, each certificate delivered to a Participant pursuant to this Plan and evidencing outstanding Shares immediately prior to the Domestication Effective Date shall, for all purposes of this Plan and the Shares, continue to evidence the identical amount and number of outstanding Shares at and after the Domestication Effective Date. After the Domestication Effective Date, the Company may make such modifications in the certificates evidencing (and the form of) the Shares as it deems necessary to reflect the substance of the changes to this Plan relating to the Domestication, but no such modifications shall be necessary to reflect the substance thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(p) <span style="text-decoration:underline">Titles and Headings</span>. The titles and headings of the sections in this Plan are for convenience of reference only. In the event of any conflict, the text of this Plan, rather than such titles or headings, shall control. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:46%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:53%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">XOMA CORPORATION</span></p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">ATTN: THOMAS BURNS</span></p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">2200 POWELL STREET, SUITE 310</span></p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">EMERYVILLE, CA 94608</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt;margin-bottom:0pt">&#160;&#160;&#160;&#160;


<img src="g344283gra0064.jpg" alt="LOGO" />
</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">VOTE BY INTERNET</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">Before The Meeting </span>- Go to <span style="font-weight:bold"><span style="text-decoration:underline">www.proxyvote.com</span> or scan the QR Barcode above</span></p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 p.m. Eastern Time on May&#160;16, 2023 for shares held directly and by 11:59 p.m. Eastern Time on May&#160;15, 2023 for shares held in a 401(k) plan. Have your proxy card in hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form.</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman"><span style="font-style:italic">During The Meeting</span> - Go to <span style="font-weight:bold"><span style="text-decoration:underline">www.virtualshareholdermeeting.com/XOMA2023</span></span></p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman">You may attend the Meeting via the Internet and vote during the Meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">VOTE BY PHONE - <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903</span></span></span></p> <p style="margin-top:0pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman">Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m. Eastern Time on May&#160;16, 2023 for shares held directly and by 11:59 p.m. Eastern Time on May&#160;15, 2023 for shares held in a 401(k) plan. Have your proxy card in hand when you call and then follow the instructions.</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">VOTE BY MAIL</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and return it in the postage-paid envelope we</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-right:2.00em; font-size:8pt; font-family:Times New Roman">have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Edgewood, NY 11717.</p></td></tr>
</table> <p style="font-size:42pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;V06321-P89225&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; KEEP THIS PORTION FOR YOUR RECORDS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212; </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">DETACH AND RETURN THIS PORTION ONLY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </p> <p style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 2.00pt;border-radius:8pt; background-color:;padding-top:2pt;padding-bottom:3pt">
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:27%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top" colspan="7"><span style="font-size:7pt"><span style="font-weight:bold">&#160;&#160;&#160;&#160;XOMA CORPORATION</span></span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:top" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">All</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:top" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">Withhold</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">All</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:top" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">For&#160;All&#160;&#160;&#160;&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman;text-align:center"><span style="font-weight:bold">Except</span>&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:top" rowspan="2"><span style="font-size:7pt">To withhold authority to vote for any individual nominee(s), mark &#8220;For All Except&#8221; and write the number(s) of the nominee(s) on the line below.</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="5"> <p style="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:3pt; margin-bottom:0pt; margin-left:0.90em; font-size:7pt; font-family:Times New Roman;font-weight:bold">The Board of Directors recommends you vote</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:0.90em; font-size:7pt; font-family:Times New Roman;font-weight:bold">FOR ALL the nominees:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style=" BORDER-TOP:2.00pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000;vertical-align:top"><span style="font-size:x-small">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="5"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman">1.&#8195;&#8201;Election of Directors</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#8201;&#8201;Nominees:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman"><span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="7"> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman"><span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#8201;&#8201;</span>01) &#160;&#160;Heather L. Franklin <span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>05) &#160;&#160;Joseph M. Limber<span style="font-weight:bold"></span></p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman"><span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#8201;&#8201;</span>02) &#160;&#160;Natasha Hernday<span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>06) &#160;&#160;Matthew D. Perry<span style="font-weight:bold"></span></p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman"><span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#8201;&#8201;</span>03) &#160;&#160;Owen Hughes<span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>07) &#160;&#160;Jack L. Wyszomierski<span style="font-weight:bold"></span></p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman"><span style="font-weight:bold">&#160;&#160;&#160;&#160;&#160;&#160;&#8201;&#8201;</span>04) &#160;&#160;Barbara Kosacz<span style="font-weight:bold"></span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"></td>
<td style="height:9.75pt" colspan="14"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="4"></td>
<td style="height:9.75pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.90em; font-size:7pt; font-family:Times New Roman;font-weight:bold">The Board of Directors recommends you vote FOR the following proposals:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:7pt"><span style="font-weight:bold">For</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:7pt"><span style="font-weight:bold">Against</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-size:7pt"><span style="font-weight:bold">Abstain</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"></td>
<td style="height:9.75pt" colspan="14"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="2"></td>
<td style="height:9.75pt" colspan="4"></td>
<td style="height:9.75pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman">2.&#8195;&#8201;To approve an amendment to the XOMA Corporation Amended and Restated 2010 Long Term Incentive and Stock Award Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 709,000 shares;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="14"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman">3.&#8195;&#8201;To ratify the selection by the Audit Committee of the Board of Deloitte &amp; Touche LLP as the independent registered public accounting firm of XOMA for its fiscal year ending December 31, 2023;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="14"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman">4.&#8195;&#8201;To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in the proxy statement; and</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="14"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:0.90em; font-size:7pt; font-family:Times New Roman;font-weight:bold">The Board of Directors recommends you vote 3 Years on the following proposal:</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">1&#160;Year</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">2&#160;Years</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">3&#160;Years</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="14"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-2.00em; font-size:7pt; font-family:Times New Roman">5.&#8195;&#8201;To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman;text-align:center">&#9744;</p> <p style="font-size:3pt;margin-top:0pt;margin-bottom:0pt;text-align:left">&#160;</p> <p style="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="14"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="13"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.90em; font-size:7pt; font-family:Times New Roman"><span style="font-weight:bold">NOTE: </span>To transact such other business as may properly come before the annual meeting or any adjournment.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="15"> <p style="font-size:14pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:14pt; margin-bottom:1pt; margin-left:0.80em; margin-right:25.00em; font-size:7pt; font-family:Times New Roman">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr></table>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:4%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:26%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:23%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="4" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:6pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:6pt">&#160;</td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td colspan="6" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:6pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:6pt">&#160;</td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="font-size:1px; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="3" style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="5" style="BORDER-BOTTOM:1.00pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:-0.50em; font-size:7pt; font-family:Times New Roman">Signature&#160;[PLEASE&#160;SIGN&#160;WITHIN&#160;BOX]</p> <p style="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:7pt; font-family:Times New Roman">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:7pt; font-family:Times New Roman">Signature&#160;(Joint&#160;Owners)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:-0.50em; font-size:7pt; font-family:Times New Roman">Date</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
</table> </div>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:30pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com. </p> <p style="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212;&#160;&#8212; </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:right">V06322-P89225&#160;&#160;&#160;&#160;&#160;&#160; </p> <p style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:SEPARATE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:100%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-radius:5pt; BORDER:2.00pt solid #000000; padding-left:8pt; padding-right:2pt;vertical-align:top"> <p style="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">XOMA CORPORATION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Annual Meeting of Stockholders</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">May&#160;17, 2023 9:00 AM PDT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">This proxy is solicited by the Board of Directors</p> <p style="font-size:24pt; margin-top:0pt; margin-bottom:0pt;text-align:left">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; margin-right:1.00em; font-size:10pt; font-family:Times New Roman">The stockholder(s) hereby appoint(s) Owen Hughes and Thomas M. Burns, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of common stock of XOMA CORPORATION that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held virtually at www.virtualshareholdermeeting.com/XOMA2023 at 9:00 AM PDT on May&#160;17, 2023 and any adjournment or postponement thereof.</p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; margin-right:1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations.</p> <p style="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Continued and to be signed on reverse side</p> <p style="font-size:36pt;margin-top:0pt;margin-bottom:0pt;text-align:left">&#160;</p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>xoma-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 03-April-2023 [11:53:06] {AM}-->
<schema targetNamespace="http://www.xoma.com/20221231" elementFormDefault="qualified" xmlns:xoma="http://www.xoma.com/20221231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="xoma-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd" />
<import namespace="http://xbrl.sec.gov/dei-sub/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
<import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
<import namespace="http://xbrl.sec.gov/ecd-sub/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd" />
<import namespace="http://xbrl.sec.gov/ecd/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd" />
<import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/srt-roles/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" />
<element name="ReportedValueOfEquityAwardsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_ReportedValueOfEquityAwardsMember" substitutionGroup="xbrli:item" />
<element name="EquityAwardAdjustmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_EquityAwardAdjustmentsMember" substitutionGroup="xbrli:item" />
<element name="YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" substitutionGroup="xbrli:item" />
<element name="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" substitutionGroup="xbrli:item" />
<element name="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" substitutionGroup="xbrli:item" />
<element name="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" substitutionGroup="xbrli:item" />
<element name="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" substitutionGroup="xbrli:item" />
<element name="TotalEquityAwardAdjustmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="xoma_TotalEquityAwardAdjustmentsMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>xoma-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 03-April-2023 [11:53:06] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember" xlink:label="AllAdjToCompMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_ReportedValueOfEquityAwardsMember" xlink:label="ReportedValueOfEquityAwardsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="ReportedValueOfEquityAwardsMember" order="100" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_EquityAwardAdjustmentsMember" xlink:label="EquityAwardAdjustmentsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="EquityAwardAdjustmentsMember" order="101" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" order="102" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" order="103" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" order="104" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" xlink:label="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" order="105" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" xlink:label="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" order="106" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_TotalEquityAwardAdjustmentsMember" xlink:label="TotalEquityAwardAdjustmentsMember" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="TotalEquityAwardAdjustmentsMember" order="107" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>xoma-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 03-April-2023 [11:53:06] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_ReportedValueOfEquityAwardsMember" xlink:label="loc_xoma_ReportedValueOfEquityAwardsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_ReportedValueOfEquityAwardsMember" xml:lang="en-US">Reported Value of Equity Awards [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_ReportedValueOfEquityAwardsMember" xlink:to="lab_xoma_ReportedValueOfEquityAwardsMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_EquityAwardAdjustmentsMember" xlink:label="loc_xoma_EquityAwardAdjustmentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_EquityAwardAdjustmentsMember" xml:lang="en-US">Equity Award Adjustments [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_EquityAwardAdjustmentsMember" xlink:to="lab_xoma_EquityAwardAdjustmentsMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="loc_xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xml:lang="en-US">Year End Fair Value of Outstanding and Unvested Equity Awards Granted [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:to="lab_xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="loc_xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xml:lang="en-US">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:to="lab_xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xml:lang="en-US">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="lab_xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" xlink:label="loc_xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" xml:lang="en-US">Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" xlink:to="lab_xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" xlink:label="loc_xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" xml:lang="en-US">Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" xlink:to="lab_xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_TotalEquityAwardAdjustmentsMember" xlink:label="loc_xoma_TotalEquityAwardAdjustmentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_xoma_TotalEquityAwardAdjustmentsMember" xml:lang="en-US">Total Equity Award Adjustments [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_xoma_TotalEquityAwardAdjustmentsMember" xlink:to="lab_xoma_TotalEquityAwardAdjustmentsMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>xoma-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 03-April-2023 [11:53:06] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember" xlink:label="AllAdjToCompMember" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_ReportedValueOfEquityAwardsMember" xlink:label="ReportedValueOfEquityAwardsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="ReportedValueOfEquityAwardsMember" order="100" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_EquityAwardAdjustmentsMember" xlink:label="EquityAwardAdjustmentsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="EquityAwardAdjustmentsMember" order="101" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" order="102" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" xlink:label="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember" order="103" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" order="104" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" xlink:label="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember" order="105" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" xlink:label="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember" order="106" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="xoma-20221231.xsd#xoma_TotalEquityAwardAdjustmentsMember" xlink:label="TotalEquityAwardAdjustmentsMember" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllAdjToCompMember" xlink:to="TotalEquityAwardAdjustmentsMember" order="107" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g344283g02g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g344283g02g01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1FB4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &8:^930X0DE-! 0      #\< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1QP"   "    .$))300E
M       0D&G9X/7JKH'Q$JESH"0H6#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#
MO_XU  (  3A"24T$)@      #@             _@   .$))300-       $
M    6CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M300*       !   X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      -!    !@              2P
M ,@    & &< ,  R &< ,  Q     0                         !
M          #(    2P                     !
M     !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG    2P    !29VAT;&]N9P   ,@    &<VQI8V5S5FQ,<P
M  %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M   '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I
M9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP
M90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   $L
M    4F=H=&QO;F<   #(     W5R;%1%6%0    !        ;G5L;%1%6%0
M   !        37-G951%6%0    !       &86QT5&%G5$585     $
M  YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M  EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U
M;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M        #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N
M9P      .$))300H       ,     C_P        .$))3001       ! 0 X
M0DE-!!0       0    $.$))300,      [0     0   )4    X   !P
M8@    ZT !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L
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M_P#W6_<9_A/YRQ'X?Q\T#8KA-2E^BUY<U&&,RGO=1 \
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !+ ,@# 1$
M A$! Q$!_\0 'P   @,  P # 0            H("0L%!@<! @0#_\0 -1
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MDKH]@I^Q!%'-=LI%)*D+1QM*+Z\7^&[.:F$;DCMH>'HRHCI%?@>*XDFAA/\
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M=Z2S<L$O-'1K22E[,RK+.K+4HP%5B@24<46.*&,DK&3NC-P#.R/(V,XE1?\
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M[=R%F*K)!2JO)5#&-T>S:D,4H:J0?3?Q*O,R2M'UIZ\09"?"JK=5S1I@-/\
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M//9L2G=I)'_H!LJ(BA8XHT"QQ1JD<:JB*H?;&8VCA\?3Q>,K1TZ%"".M4K1
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M:P:D_DUM).T^5O7M'\O;XD6^SK2/^/O[B&U51/C\JV[XU%Y8.^AW.]NO*1[
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M98Q(@#B.1TY<78'S"BZ4]/,O?4FIS?5CKU0Z7-6D2\SM_4</8"ON*.YKR?;
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M5$XN%QUE!<?'TB34L4O)./%5,H)5I^H-9.69(@%,LP09*O4P1/9X?K^<^?\
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7:K! [HI+*KM$B%E5B2H8D DD $GK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g344283g02g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g344283g02g02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[0V^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    #:*^-) X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!I49%@
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]       $@ U     0 M    !@
M 3A"24T#]P      '   _____________________________P/H   X0DE-
M! @      !     !   "0    D      .$))300>       $     #A"24T$
M&@     #00    8              #T   #+    !@!G #  ,@!G #  ,@
M  $                          0              RP   #T
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   #T     4F=H
M=&QO;F<   #+    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<    ]     %)G:'1L;VYG    RP    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M  L( !T 8 $!$0#_Q  =   " 04! 0              !P8! @,$!0@*_\0
M)Q   04  00" P$  P      ! $" P4&!P 1$B$3%!4B,0@60E'_V@ ( 0$
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6HG9$1$](B)Z1$](GI.J]'1T='7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g344283g04g51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g344283g04g51.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[0[J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    #LZ^-Y X0DE-! 0      %,< @   @  ' )0  AR<C8Q,S(Y-1P"!0 Z
M36EC<F]S;V9T(%=O<F0@+2!83TU!("T@(#(P,C,@4')O>'D@4W1A=&5M96YT
M($1%1B Q-$$N9&]C>  X0DE-!"4      !!Y4E(([GOW.4M:63:DD#V;.$))
M300Z      #E    $     $       MP<FEN=$]U='!U=     4     4'-T
M4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I
M>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M     #^    X0DE-! T       0   !:.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         !.$))30/T
M       2 #4    ! "T    &       !.$))30/W       <  #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      -!    !@
M&    (X    & &< ,  S &< ,  P     0                         !
M              ".    &                      !
M         !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG    &     !29VAT;&]N9P   (X    &<VQI8V5S5FQ,
M<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M       '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E
M3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E
M5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M !@     4F=H=&QO;F<   ".     W5R;%1%6%0    !        ;G5L;%1%
M6%0    !        37-G951%6%0    !       &86QT5&%G5$585     $
M      YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M      EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A
M=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E
M9F%U;'0    +8@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! ?_   L( !@ C@$!$0#_Q  =   " @,  P
M        " 0'!08) 0,*_\0 *!   00#  $$ @(# 0      ! (#!08!!P@
M"1$2$Q05%D$7(2(R_]H " $!   _ /M1V==^N5V$>NZ-T3K!V*^HQV1V/NS<
M1-<A&%BS4Q'CAP]+US3M@6:9<E(H*+GARI.0JK0;$RU'F-8D!#61ZQD:+ZD-
MV_7_ )70'+FB&!QWEG#Z]T5>-SR)YRU"?4WF<V)LRB1[$>VW@WVPQ46C/MRP
MM;[K:U-,2B.9.HY\V)*M/J$[? & .4^=%ZMTWSS10I0-3;",A./677^R99A?
MR:6[@G]F]A#C[OUCH;^+:9X?'-R!/5(L]U=N+?5]V<M&6W0T@!C+_P OGE,8
M?SR3&I^/RS]*4BX0/[)^A+>$X]DQWK+;5U%8(#5^E>[>INA>JTQA26^?Z_5N
M3;,Y(.'C#LA6_:YCFC(B#T9K^+<(0279;?,,8*R:$S @S9^&0B>I>A8+<U:U
M)2X7H2^5C9>X@X]_^<72G5;%-K<O(OR!9(Z(N P0_@=F-CG@XM9>$AXE'@G)
M3]9&9,R /;_AX>'AY5NS-SZYU"_0@[W/XC)/9][@];T*&$!/F)NS6R><5A@.
M,AHD8R2?$CA&R):?E,#?KH"&$*E9<D0)E3OF*M'1_/5(M$91[EO;3M4NTV:%
M'0].L6RZ9#6N5/DBV@0!(ZNR$T/,&D%F/-#L-C!N*6ZO"<8]_+G\/#P\/#P\
M5K:78>F=:3[E!C3IW<&X,.99:TIHZ&<V7LQEW#[3&5V6+AGL1&NHU.7%N*GM
MFS=,@%-BF):DW7Q7&<<[;UW)%3;[,YU)UIH7A+4T>;[+TWK+>M'V?U-<"D K
M*S&;"N%3:G8[6<6UEIW!E?U-$66SE$+'%'VE$/N,"&Z+L/U6N.^(]-(M?/G*
MN_[=JZR76&AA=JQ&G+5K#55]OME"&=<F;9M_:L<#>+I9SP1G%2%RD*Q<IBQ%
M1CJ5R\BO#1"V?YN]6OGW>U)+FYJM[0J5PA+!-5JPUF@ZJW-T36LF0;@Z2Y6I
M[$TUJR?B;+6,9,8#7+F1M=)'EVCHTB+;_'8),<K5/6//&ZZ5;-B:^V=$%TZA
M3BJS>9BSQ\]KO-,L"!8XQ4/:X[8L35)6O'I&EHQW(\N"&O'YPR/;YNI3G&H[
M6XW6V\ZCK/FA;0QR8LAQ.]M7*0S)*=99P ZO%IRE!>7B1VOQU9P[]CS:,I^2
MTXRRS+S)++1 [K3X[[3;S#[+B767F74X6TZTZC*D.-.(4E;;B%*2M*L*3G.,
MXSYZ3SPHL$R3DS!8^.CA2#CSSGVA0@0A&EOE%EE/K;9&&&8;6\^^\M#332%N
M.*2A.<XYK3'J15_9TM,T/A75MJ[(OL:X7'FVJLO-TOG2HRK#;>?KN>];&PB"
M=^E;R%KC:.!;Y8I#1#(P^"4H0OB/W]1MC1]XC-O[\ZOAMJ]HO_ATZ(Y-YWM]
MTJ55T;1K<MO!,92/T[CTTQ-RR&F'K9<]HVK78,[&-.B+=- *#84[NB-1^D)R
M-L>O6BV;RH.U>C(J'RZ$/99:I;#E:U/OH%5,%U37VJ( ^%$N"76607Y1L>=L
MZ'1W<C2OV.DNN=$9?U#]>Y2T_KS0/96Z@5J6EZ3UES)?_P!<+\77VD+=)OS-
M#P0T^H=Q0[L>DUMUO*',+^"L9\R\!VU*6)LQT;BON:.;">RPYF?T]3J^XZYC
MV_V&/+;2$)-9S[Y]BA671?\ G./NQGV]]B$ZCV).%L@UGC+IUUYT=YU1%O%U
M'1(T=QM:&T-/GS&U'4^R\KRI7TM//X;0IQD8C&,^T]J_]B60K T-SQK3786<
MO_*8V9NK,\2WAK+/U8Q7-<5&7;>R5C)"49_E#.&?@TXYG/V*;1?]*$V(.*2[
ML2=J$M($8&R,+3:U+P,;&?!+WY3:B9JS6$R74\I;/P)4W$I;PPK. _=_V:6+
M:9_?TMMV5JFDX?F6DZ89B:H;';=VE_/K];3#RRDM7*&8U=4YZBLMG1(V'2H0
MP^W,14AC(S)+[3CQ"0JLG^&MZ[?&DA.A_4%Z-E(LY0R6JIS.#4N4JPR(WES)
M0!DC6!;ELV6%/^Q3):"=D--D"*6*2R^S]:6L!J+T=.%=001E>"H^Q+U'RLP?
M.SHFRMW;;M$)9)&3R]^P=LU*;MT;K^Q)D&WUL2:)BI&?MV,)1+Y/]LYS;FP?
M3GY:ML92(^CT*'YY<U]=!;]72N>ZEK?7PB[,!'E1T9(SM3?HLY0K,7"(+676
M9*?J<C,U*33B3JLE"F.E.D>2?3NYRMI0LAO-O9G41HDD%*LC=);4NFSZ7@N-
M2I,?G_#Q4G'Z12V)EQYU"6]:HRZ^^\02I]YS+GFX[4YKN]Y;K='UMT';>9-$
M0E1Q6R]<<]4F@TZV$/M.&)"<KNS9.(GW=?000+D>*-#4BI0TFPL%UX>S,-F?
MC#UCK'TM^(-9! B9TXG:+H9DG-.D[\M]TWN.?;)Y3;MCO)%;VG/VBF"7BQE(
M65+VB'K47*/N$$M,O#B/*&\E[Q]-+D#;^H]E:O@-':?TS([)"PR=L756G=95
MBZAFXF09Q\K,I'U@4LQB:("S'68=18Y4U!2,O'XD0GC<',.C1J\94J74ZM(2
MZ9\ZN5R%@RYM$3'P+4J1%1PX3IS$'%)1&PXY*V,N#Q87S' 84V*VZ]AK[E[&
M2,.8.0&8.R4(4RZ,4*2TV^.2.^A33XY##J5M/,O-*4VZTXE3;B%*0M.4YSC,
M&%@X6MQ@D+7H>+@88!K#(,3"QXD7&!,I_P#+0@ ++ HS6/Z;9:0G']8\5F]\
M#<6;/V/,;=V)S#IFZ[)L+0S4[;[+2(B6E9C ;8[(SDDHQAT<PAID4=E)3["R
MLLLH94]EO'Q\8:G:WUWKP+$;K^A4NC1V,-IP!3JM!UD+"6L*2TG L*"$QC#:
65J2WCZ_9&%*PGVQG/ONGAX>'AY__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g344283g45g00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g344283g45g00.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1;24&AO=&]S:&]P(#,N,  X0DE-! 0
M    %K:^6!0X0DE-! 0      %L< 5H  QLE1QP"   "   < E  "')R-C$S
M,CDU' (% #I-:6-R;W-O9G0@5V]R9" M(%A/34$@+2 @,C R,R!0<F]X>2!3
M=&%T96UE;G0@1$5&(#$T02YD;V-X #A"24T$)0      $"T6L:^Q_';L):Y1
MGKS1%80X0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T
M!0    !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M
M#W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
M      ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4
M= !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q <L            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ "4S,P  0 ! )3,S  !  $X0DE-!"8
M  X             /X   #A"24T#\@      "@  ________   X0DE-! T
M      0   !:.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!$0
M !     "   "0    D      .$))300>       $     #A"24T$&@     #
M00    8              \0   7F    !@!G #0 -0!G #  ,     $
M                     0             %Y@   \0
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   \0     4F=H=&QO;F<
M  7F    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   /$     %)G:'1L;VYG   %Y@    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ 9@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M!<[O_724FVCP"6T> 2V^9^]+;YG[TE*VM\ J>1U/#QX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M:X+)/;$Z68.F*"1TOQ;UOOICVXXUP(K\&E:)4HDL;ZXZ/>A]K<@SC & , 8
MP!@# & , 8 P!@# & , 8 P!@# *?%^TR_*'WGSC!6'FKT][$=[&Y^<)#SM7
M C\KZS]A4,%BWNK$E.0^FUUDJU.5ZLS[2OOU(B?M;I-A7HI^*?$;O)1^NDX;
M,4$SG#B/7;5VS:+"DX>,W;5-5LK*O?O[]_05FZ1;6KWTKO,2Z[PE;#OW1#G@
MSS/2B2@++^&^HUSK+4Q9]]"U>]R2LB>W53E]/XV,K)Z,5[+6",>##VM*=:RD
M"1K!(<JZ4NKV:ETWZ;KRBFTXIUI>FVL7[?1J==2NAHEJK;KOJ)J#7YN1CY)A
M#)S+A:,9Q[=LXH4E'ZH7^GQ-:?NVYA.[4FZA6X2RIA)<9^JJN[EVJA8"9A6C
M0TJ<]::;U2M??13I<PDW)IM--5^JZTIT4[:F3[A8Z! ,FV7=")@**;<6X'*
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M0$TTDDR !$TR)@!")D*!2D "E "@ 8!^@%* B(  "8=IA   3#LV;1$/".P
M#:/N!LP#G & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?@=JV471=*-T%'+8BR;=
MP=),RZ";CD^<$16,45$B+\DERQ2&*57DD^.!N(78!^A4R$#BD(0A=O&V%*!0
MXWO[   V_I\.!1+!4.P%*7H* % 1$1   -HB.T1Z/=$>D1\(CTC@'. , I\7
M[3+\H?>?.,%8>:O3WL1WL;GYPD/.U<"/ROK/V%0P6& , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P"GQ?M,ORA]Y\XP5AYJ]/>Q'>QN?G"0\[5
MP(_*^L_85#!8X,8I2B8P@4I0$QC&$ *4H!M$1$>@  .D1'H .D< X34(J0BJ
M1R*)J$*HFHF8#D4(< ,0Y#E$2F(8H@8IBB(& 0$!$!P#M@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# *?%^TR_*'WGSC!6'FKT][$=[&Y^<)#SM7
M C\KZS]A4,%BW>K5?&U::7>M@C9UPG*[(1AT::YB6EG52=I"DJ2'5G7;&&.Y
M,F8X&:R;I)D^1Y5DN)DW D,(E>FK_1C[\VG Q%B*GJI'2O!^M;31J5C)'3>O
MV=*RP]5=U*N1<G4RU6^L*K3HY*2U4?*PKY1^O57:NG[Q.2J+2=D6"J]VYK26
MCY.==^.B^_I]W?Z:84I)Q^"_@K'1STO;5<*7>QW@T5I-DJNI6KTFXJCZ'K5K
MDUYXL]9T*<%JF;-)6^X2;MFQ?U&;EE9*D14(_ADZ\-H19SC JQF&U1%([.-/
MIK3#5[W+VWEX)IMYM*WO"M6ZTJF]?NL<EW!71R #59!!3C;3&7;'<D$FP=I0
M(FZ:B!N-Q1XPJ&#8 AQ!$0,6+M/?3V,NZZ&D^=5]J/%R,SVA&^2'/KG!%)\J
M/5?C'(S/:$;Y(<^N<"D^5'JOQCD9GM"-\D.?7.!2?*CU7XQR,SVA&^2'/KG
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M^ 9Y2-P1P70NX[8)& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MGAY?W:+K\J@?IAKGU'D7^U/ WWI_@VITW#_Q5EGV7^)9FN[GJ&6+Z7WFJ!D
M8 P"?Z4_G-T__;&N_2K7.D\I?V>X<_LK+_[M:'/X*^,L@^]Y/^+$VIR?D%_P
ME_@&>4C<$<%T+N.V"1@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & 4A&P0+F8=5YO-1*\^Q:IOGL(C(LU9=FR54!))XZC2+
M&>-VJBH@FFNLB1(YQXA3B;HP155I55U5O/WB_:9?E#[SYQ@B'FKT][$=[&Y^
M<)#SM7 C\KZS]A4,%A@# & , 8 P!@# & 0^TW:&J"\*A+G.F:>>G8,3=!2*
M.B)&6!N4Y]B8N54R*&00$Y#KBF8B0F4V$&:7-\Z7172[U=T5?,<?*,H63J,I
M0E*+:SG'Y";HY/6EII5K42ELY0>-TG390JR"Y 424*/08IO!^D!#P&*( )1
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MJ))8)+!7&XLE;>36%75JRLTVVVW\"-[;O?2\<2Y&<0Y P!@# & , 8 P!@#
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MT/\ S.Z9?L17/HQOGD+A']?RW[U;_BR-T9+^KV/V=G^Y$NGG#.0, 8 P!@#
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M/4S7KSU!+%]+[S5(R , 8!/-+3&)J50CD3,J8MOKPE3()"F.(2K784IE#$3
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M;32Q:]\3&[@TZ&6+2"?M;MQ$QL+7YV$AFHMG4G4K)9W,['/9!4ZJ,W5=--/
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MTR_8BN?1C?/(7"'Z_EOWK*/Q9&Z,E_5['[.S_<B73SAG(& , 8 P!@# & ,
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M#LW2+ O(<V<.644@J=M.CI5SU7X:EWW\Y1WS35*)JN%]5355TNZ-AG?D&48
MP!@# & , 8 P!@# & , 8 P#'#4_3Z7A9=75'3IL<\VD"1[96FQP0+:F+7I*
M]8[1*DA9XY/C&8NCB4CQ$#Q[PPI*IJ(6NE2OG+S7KYGKZ-/?P,JR;/\ Z2S>
M9:1;<)JM8O2G3&$L)+!5V6"X6&HD/>^"?:9!DZ(=55:#$0$AD#G,C,MD7!3M
MU0*LV=M5RG;/V*Q".&;HBB*A $ V_3^12KY4\#4Q65.JT_H;7#6N["^AU7"N
M4.VX)RV%I',MH6:4X5KC.SI)?1E=1WJK2J?"//4$L7TOO-9C( P!@$_TI_.;
MI_\ MC7?I5KG2>4O[/<.?V5E_P#=K0Y_!7QED'WO)_Q8FU.3\@O^$O\  ,\I
M&X(X+H7<=L$C & , 8!!M3OS=7G]E)[Z-<9FR?\ 3V/VD/WD8K?]#:_4EW&J
M>7P!^H/X9[#EB^E]YI0YR , 8 R8XKI7>#:5T/\ S.Z9?L17/HQOGD+A']?R
MW[U;_BR-T9+^KV/V=G^Y$NGG#.0, 8 P!@# & , 8 P!@# & , 8 P!@# &
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MTU"& Y#D. &*<ABB)3%,40$I@$0$! 0$0' .V , 8 P!@# & , 8 P!@# &
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MV.IX28UF$4F7+5W).(YJZ=JL6:<>R!9TB1P=)FQ1$4FC5(5!3;-R")4D2D(
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MW>&_UDG@YV\/,AS0BMD4C;7!GZADGV%B]MG%^TNCECG# & , 8 P!@# & ,
M8 P!@# & , M7KD^)&:.:FR!WS>+YG2;"X3D7<$>SMV*Z<:N9N[4KR<;,J3
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MS5Z>]B.]C<_.$AYVK@1^5]9^PJ&"P\/AP#@             V  !T   '0
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M>^Z[.U:1:V2G21XF>9+0UDCXR70!L]3,F11RR1Y8H<<A1*(#@LFFJHN?@D8
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M 8 P!@# & , 8 P#C8 B!A !, " #L#: #LV@ ^$ '8&W9X=@;?!@'. , 8
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MTXBVE=K%/7@(NM0L(SCH9)L)UUU5<>?'WIKW7!V;T/#"M=-4]+T/GOO)!;>
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MV/70AK#J2^J3-I /6;&5=2:2\"E>:U(S4D#(\(I'K2JL+)2ZD#*I-U,?9W]
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2XQA   !,(].02E1)8T]&\__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g344283gra0064.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g344283gra0064.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MM;9Y(KF- LB,JDAB_4].<F@"3X3:Q>ZUX LY[]VDFA=H1(W)=5/!)[GMGVH
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ME?\ 91_X2?R=V?W'_/?;V\S'RY^GXT 8/AW_ )+EXQ_Z]K?_ -%QT >CT %
M'G_Q3^YX4_[#MO\ ^S4 >@4 >>^+W\06'B$66E37)@\0HMLDGFDBRE4_.Z_W
M08]QX[KF@#G_ !5JE_I^JZM:IJMTEM;ZGIL(\R^DA41M"=X,@.4#8RS#ZT :
M>M:CJ>CZ'IGB+09Q>I&TEK+;0:I)?0N9#B-M[]2K[1R.,XH 9X:A\6KXKM/#
M>L7]S+!I(-]+=B5@;H. $C8]P'W\'@A<=J +7B.\\5#XEO;>'+E'V:2DC6D[
MGRFW2LN\#H&7@^X7% '/66L:[>^$K#0(=1U"[U>]U*<2SP3!9Q!$WS%2S +V
M &X#J* +JZA<ZKIOAIKN[U&VU4:JFEZG%%?S1Y*H^<JCX!;"MD?G0!:O+P67
MQ*N=,FU/99PV]OY,5YKT]KR2<E<9\UCQD-_6@"CH6J:JOCB*6ZU"Z2PEUN]M
M [WDDB/C[D)B/RH/1ASVXH J#5_$.N^'M)T/2;S4I=3)N[NXFMYP)0BRR)$"
MSNOR[L9&>B\ T ;MKXWCNO$/A6^OM373[6>QN%NXI9Q'&)U*J0P) R"#C- #
MKG6)+3XC6SG4X]8LM1FA2V@L]3=7M 4R&:%6VO&>NXCH?ID K_%#Q!J%AKNG
MVUG=7-K#;Q?:)A%,4><%PN(E!'F.H!)4DC!R0: -K7=:U#_A%=(\962/BUQ<
M7-E!<[XY8'&&!( #%<@YQQ@T 9%N]_9:AIL'B[6;NTL+JS>[DE^V/ GVEGSY
M1D!!4(F,+D G/7I0!6N7U*X\*6.H7-]J<<C:Q':6\RWDT)FM#-A6958#)!/S
M8R1CF@";Q!<KI?Q!CTR34S%IZ:4CK'>Z_<6:[S*^6W@L7;'&#V'M0!ZH,8&.
ME ' >$M6T_1+7QA>ZE=Q6MLFOW.7D; ^ZG ]3["@"4:OXE\8Y30H'T32&ZZC
M=Q_OY1W\J,]!Z,U &[X?\):5X<5I+:-YKV7_ %U[<-YD\I]68_R&!0!NT >$
M:]XX_P"$'^,7B6Z^Q_:?M$4$>-V,8B0T#-'3_CE<:IJ$%C9Z 9+B=PD:B3J3
M0(O^(_BUJ?A74%LM5\/".5T#J5ER&'3@_A0!R>J?$_\ X3?5_#FG_P!G?9O)
MU:WFW;LYPV,?^/4#/H.@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0!R.G?#K1+/7[S6KF-KZ\N+F2X03\QPECGY4Z9X'S'GCM0!UU !0 4 <#XF
M^$>@>*=>GUB\NK^&XG"AUAD0*=JA0<%3V H SK3X&^'["[BN[75M7BGA8.CK
M+&"I'?[E RYK?PATOQ%?"\U36]7N)@H0%I8^!Z#Y*!$.E?!+PUI.K6FH)=ZC
M-);2K*B22)M+*<C.%!Z^] 'I- !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
0 !0 4 % !0 4 % !0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139628280320864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XOMA CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000791908<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139628275697296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="text"><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Pay Versus Performance Table </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Section&#160;953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company. This disclosure is intended to comply with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K</div> applicable to &#8220;smaller reporting companies.&#8221; For further information concerning the Company&#8217;s compensation philosophy and how the Company seeks to align executive compensation with the Company&#8217;s performance, refer to &#8220;Executive Compensation&#8212;Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table.&#8221; </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:81%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92pt"/>
<td/>
<td/>
<td style="width:92pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:68pt"/>
<td/>
<td/>
<td style="width:68pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:130pt"/>
<td/>
<td/>
<td style="width:130pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:125pt"/>
<td/>
<td/>
<td style="width:125pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:149pt"/>
<td/>
<td/>
<td style="width:149pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:58pt"/>
<td/>
<td/>
<td style="width:58pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Summary<br/>Compensation<br/>Table&#160;Total&#160;for<br/>PEO<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually&#160;Paid&#160;to<br/>PEO<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Summary<br/>Compensation<br/>Table Total for<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Compensation<br/>Actually&#160;Paid&#160;to<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO&#160;NEOs</div><div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(4)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Initial Fixed<br/>$100 Investment<br/>Based on Total<br/>Stockholder&#160;Return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(5)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net (Loss)<br/>Income<br/>(millions)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(6)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="padding-bottom:2pt ;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(d)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(e)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(f)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(h)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,009,298</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">956,887</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">41.69</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">17.1</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,135,708</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">349,707</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">47.25</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">15.8</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (b)&#160;are the amounts of total compensation reported for Mr. Neal (our Chief Executive Officer and PEO) for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to &#8220;Executive Compensation&#8212;Summary Compensation Table.&#8221; </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (c)&#160;represent the amount of &#8220;compensation actually paid&#8221; to Mr.&#160;Neal, as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/> The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&#160;Neal during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments w<div style="letter-spacing: 0px; top: 0px;;display:inline;">ere </div>made to Mr.&#160;Neal&#8217;s total compensation for each year to determine the compensation actually paid: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:96%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:108pt"/>
<td/>
<td/>
<td style="width:108pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:44pt"/>
<td/>
<td/>
<td style="width:44pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:50pt"/>
<td/>
<td/>
<td style="width:50pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:63pt"/>
<td/>
<td/>
<td style="width:63pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation<br/>Table&#160;Total&#160;for&#160;PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity&#160;Award<br/>Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(b)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr> </table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:4%;border-bottom:1px solid #000000; width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns in the Summary Compensation Table for the applicable year. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(b)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The stock option agreement granted in 2021 to Mr.&#160;Neal provided that if Mr.&#160;Neal met certain age and service criteria, he would be eligible to </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">&#8220;retire&#8221; and his option would become fully exercisable. At the time of grant, Mr.&#160;Neal had satisfied such retirement eligibility and the service-based vesting requirements were deemed to have been met. Therefore, the same fair value is being used for the equity award adjustment as was used for the Summary Compensation Table. The amounts deducted or added in calculating the equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:86%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:213pt"/>
<td/>
<td/>
<td style="width:213pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:256pt"/>
<td/>
<td/>
<td style="width:256pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:170pt"/>
<td/>
<td/>
<td style="width:170pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:208pt"/>
<td/>
<td/>
<td style="width:208pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:218pt"/>
<td/>
<td/>
<td style="width:218pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:21pt"/>
<td/>
<td/>
<td style="width:21pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year End<br/>Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year Change<br/>in<br/>Fair&#160;Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>as of Vesting<br/>Date of<br/>Equity<br/>Awards<br/>Granted and<br/>Vested in the<br/>Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;over<br/>Year<br/>Change in<br/>Fair&#160;Value<br/>of Equity<br/>Awards<br/>Granted<br/>in Prior<br/>Years&#160;that<br/>Vested in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>at the End<br/>of the<br/>Prior Year<br/>of Equity<br/>Awards<br/>that Failed<br/>to Meet<br/>Vesting<br/>Conditions<br/>in&#160;the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/> </tr> </table>  </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (d)&#160;represent the average of the amounts reported for the Company&#8217;s named executive officers (NEOs) as a group (excluding Mr.&#160;Neal, who has served as our CEO since 2016) in the &#8220; Total&#8221; column of the Summary Compensation Table in each applicable year. Mr. Burns was the sole NEO (excluding Mr. Neal) included for purposes of calculating the average amounts in each applicable year. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(4)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (e)&#160;represent the average amount of &#8220;compensation actually paid&#8221; to the NEOs as a group (excluding Mr.&#160;Neal), as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div> The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr.&#160;Neal) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr.&#160;Neal) for each year to determine the compensation actually paid, using the same methodology described above in Note (2): </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:88%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:133pt"/>
<td/>
<td/>
<td style="width:133pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:41pt"/>
<td/>
<td/>
<td style="width:41pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:37pt"/>
<td/>
<td/>
<td style="width:37pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:110pt"/>
<td/>
<td/>
<td style="width:110pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation&#160;Table<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Total&#160;for&#160;Non-PEO&#160;NEOs</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award&#160;Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Compensation<br/>Actually Paid to<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,009,298</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">470,850</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">$418,439&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">956,887</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,135,708</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">599,719</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">($186,282)</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">349,707</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amounts deducted or added in calculating the total average equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:77%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:172pt"/>
<td/>
<td/>
<td style="width:172pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:241pt"/>
<td/>
<td/>
<td style="width:241pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:175pt"/>
<td/>
<td/>
<td style="width:175pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:256pt"/>
<td/>
<td/>
<td style="width:256pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:228pt"/>
<td/>
<td/>
<td style="width:228pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:332pt"/>
<td/>
<td/>
<td style="width:332pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:21pt"/>
<td/>
<td/>
<td style="width:21pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;End</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year&#160;Average<br/>Change in<br/>Fair Value of<br/>Outstanding<br/>and Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Fair<br/>Value&#160;as&#160;of<br/>Vesting&#160;Date<br/>of Equity<br/>Awards<br/>Granted and<br/>Vested&#160;in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year<br/>Average<br/>Change in<br/>Fair&#160;Value&#160;of<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years<br/>that Vested<br/>in the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value at the<br/>End of the<br/>Prior Year of<br/>Equity&#160;Awards<br/>that&#160;Failed to<br/>Meet Vesting<br/>Conditions&#160;in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Value of<br/>Dividends or<br/>other<br/>Earnings Paid<br/>on Stock or<br/>Option<br/>Awards not<br/>Otherwise<br/>Reflected in<br/>Fair Value or<br/>Total<br/>Compensation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">345,047</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">20,942</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">97,611</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,277</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">0</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">418,439</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">133,929</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">224,276</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">90,689</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">186,624</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">0</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">186,282</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td> </tr> </table>  </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(5)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(6)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year. Due to the fact that the Company is a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented. </div> </td> </tr> </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="text">Mr. Burns was the sole NEO (excluding Mr. Neal) included for purposes of calculating the average amounts in each applicable year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 2,344,168<span></span>
</td>
<td class="nump">$ 3,510,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 2,344,168<span></span>
</td>
<td class="nump">3,510,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (c)&#160;represent the amount of &#8220;compensation actually paid&#8221; to Mr.&#160;Neal, as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/> The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&#160;Neal during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments w<div style="letter-spacing: 0px; top: 0px;;display:inline;">ere </div>made to Mr.&#160;Neal&#8217;s total compensation for each year to determine the compensation actually paid: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:96%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:108pt"/>
<td/>
<td/>
<td style="width:108pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:44pt"/>
<td/>
<td/>
<td style="width:44pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:50pt"/>
<td/>
<td/>
<td style="width:50pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:63pt"/>
<td/>
<td/>
<td style="width:63pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation<br/>Table&#160;Total&#160;for&#160;PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity&#160;Award<br/>Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(b)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation<br/>Actually Paid<br/>to PEO</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,344,168</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,510,795</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr> </table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:4%;border-bottom:1px solid #000000; width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns in the Summary Compensation Table for the applicable year. </div> </td> </tr> </table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(b)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The stock option agreement granted in 2021 to Mr.&#160;Neal provided that if Mr.&#160;Neal met certain age and service criteria, he would be eligible to </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">&#8220;retire&#8221; and his option would become fully exercisable. At the time of grant, Mr.&#160;Neal had satisfied such retirement eligibility and the service-based vesting requirements were deemed to have been met. Therefore, the same fair value is being used for the equity award adjustment as was used for the Summary Compensation Table. The amounts deducted or added in calculating the equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:86%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:213pt"/>
<td/>
<td/>
<td style="width:213pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:256pt"/>
<td/>
<td/>
<td style="width:256pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:170pt"/>
<td/>
<td/>
<td style="width:170pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:208pt"/>
<td/>
<td/>
<td style="width:208pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:218pt"/>
<td/>
<td/>
<td style="width:218pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:21pt"/>
<td/>
<td/>
<td style="width:21pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year End<br/>Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year Change<br/>in<br/>Fair&#160;Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>as of Vesting<br/>Date of<br/>Equity<br/>Awards<br/>Granted and<br/>Vested in the<br/>Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;over<br/>Year<br/>Change in<br/>Fair&#160;Value<br/>of Equity<br/>Awards<br/>Granted<br/>in Prior<br/>Years&#160;that<br/>Vested in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value<br/>at the End<br/>of the<br/>Prior Year<br/>of Equity<br/>Awards<br/>that Failed<br/>to Meet<br/>Vesting<br/>Conditions<br/>in&#160;the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:top">$</td>
<td style="padding-bottom:2pt ;vertical-align:top;text-align:right;">2,633,242</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/> </tr> </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,009,298<span></span>
</td>
<td class="nump">1,135,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 956,887<span></span>
</td>
<td class="nump">349,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(4)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The dollar amounts reported in column (e)&#160;represent the average amount of &#8220;compensation actually paid&#8221; to the NEOs as a group (excluding Mr.&#160;Neal), as computed in accordance with Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div> The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr.&#160;Neal) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K,</div> the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr.&#160;Neal) for each year to determine the compensation actually paid, using the same methodology described above in Note (2): </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:88%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:133pt"/>
<td/>
<td/>
<td style="width:133pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:41pt"/>
<td/>
<td/>
<td style="width:41pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:37pt"/>
<td/>
<td/>
<td style="width:37pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:110pt"/>
<td/>
<td/>
<td style="width:110pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported&#160;Summary<br/>Compensation&#160;Table<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Total&#160;for&#160;Non-PEO&#160;NEOs</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reported</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value&#160;of&#160;Equity<br/>Awards</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award&#160;Adjustments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(a)</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Compensation<br/>Actually Paid to<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-PEO</div> NEOs</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,009,298</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">470,850</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">$418,439&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">956,887</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">1,135,708</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">($</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">599,719</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">($186,282)</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;">$</td>
<td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;">349,707</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;">(a)</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amounts deducted or added in calculating the total average equity award adjustments are as follows: </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto">
<tr style="font-size: 0px;">
<td style="width:77%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:172pt"/>
<td/>
<td/>
<td style="width:172pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:241pt"/>
<td/>
<td/>
<td style="width:241pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:175pt"/>
<td/>
<td/>
<td style="width:175pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:256pt"/>
<td/>
<td/>
<td style="width:256pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:228pt"/>
<td/>
<td/>
<td style="width:228pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:332pt"/>
<td/>
<td/>
<td style="width:332pt"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:21pt"/>
<td/>
<td/>
<td style="width:21pt"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Year</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;End</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/>Value&#160;of<br/>Outstanding<br/>and<br/>Unvested<br/>Equity<br/>Awards<br/>granted in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year&#160;Average<br/>Change in<br/>Fair Value of<br/>Outstanding<br/>and Unvested<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Fair<br/>Value&#160;as&#160;of<br/>Vesting&#160;Date<br/>of Equity<br/>Awards<br/>Granted and<br/>Vested&#160;in</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">the&#160;Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year over<br/>Year<br/>Average<br/>Change in<br/>Fair&#160;Value&#160;of<br/>Equity<br/>Awards<br/>Granted in<br/>Prior Years<br/>that Vested<br/>in the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value at the<br/>End of the<br/>Prior Year of<br/>Equity&#160;Awards<br/>that&#160;Failed to<br/>Meet Vesting<br/>Conditions&#160;in<br/>the Year</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Value of<br/>Dividends or<br/>other<br/>Earnings Paid<br/>on Stock or<br/>Option<br/>Awards not<br/>Otherwise<br/>Reflected in<br/>Fair Value or<br/>Total<br/>Compensation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Award</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">345,047</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">20,942</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">97,611</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">3,277</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">0</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">418,439</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:2pt ;vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">133,929</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">224,276</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">90,689</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">186,624</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">$</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">0</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:2pt ;vertical-align:bottom">($</td>
<td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;">186,282</td>
<td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom">)</td> </tr> </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="text"> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="margin-top:0pt;margin-bottom:0pt;text-align:center"/> <div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g344283g45g00.jpg"/> </div> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="text"><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Compensation Actually Paid and Net Income (Loss) </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 41.69<span></span>
</td>
<td class="nump">47.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (17,100,000)<span></span>
</td>
<td class="nump">15,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Mr. Neal<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Reported Value of Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,633,242)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,633,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,633,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,633,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Reported Value of Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (470,850)<span></span>
</td>
<td class="num">(599,719)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">418,439<span></span>
</td>
<td class="num">(186,282)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year End Fair Value of Outstanding and Unvested Equity Awards Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">345,047<span></span>
</td>
<td class="nump">133,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(20,942)<span></span>
</td>
<td class="num">(224,276)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">97,611<span></span>
</td>
<td class="nump">90,689<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(3,277)<span></span>
</td>
<td class="num">(186,624)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 418,439<span></span>
</td>
<td class="num">$ (186,282)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_ReportedValueOfEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_ReportedValueOfEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_EquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_EquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_TotalEquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_TotalEquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>d344283ddef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022q4"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xoma="http://www.xoma.com/20221231">
    <link:schemaRef xlink:href="xoma-20221231.xsd" xlink:type="simple"/>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:TotalEquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">xoma:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="P01_01_2022To12_31_2022" id="hidden73597816">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2022To12_31_2022">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2022To12_31_2022">0000791908</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P01_01_2022To12_31_2022">XOMA CORPORATION</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Pay Versus Performance Table &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;As required by Section&#160;953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K,&lt;/div&gt; we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company. This disclosure is intended to comply with the requirements of Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K&lt;/div&gt; applicable to &#x201c;smaller reporting companies.&#x201d; For further information concerning the Company&#x2019;s compensation philosophy and how the Company seeks to align executive compensation with the Company&#x2019;s performance, refer to &#x201c;Executive Compensation&#x2014;Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table.&#x201d; &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:81%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:92pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:92pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:68pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:68pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:130pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:130pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:125pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:125pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:149pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:149pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:58pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:58pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table&#160;Total&#160;for&lt;br/&gt;PEO&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(1)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually&#160;Paid&#160;to&lt;br/&gt;PEO&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(2)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table Total for&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(3)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Compensation&lt;br/&gt;Actually&#160;Paid&#160;to&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&#160;NEOs&lt;/div&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(4)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Initial Fixed&lt;br/&gt;$100 Investment&lt;br/&gt;Based on Total&lt;br/&gt;Stockholder&#160;Return&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(5)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net (Loss)&lt;br/&gt;Income&lt;br/&gt;(millions)&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(6)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(f)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="padding-bottom:2pt ;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(h)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,009,298&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;956,887&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;41.69&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;17.1&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,135,708&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;349,707&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;47.25&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;15.8&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (b)&#160;are the amounts of total compensation reported for Mr. Neal (our Chief Executive Officer and PEO) for each corresponding year in the &#x201c;Total&#x201d; column of the Summary Compensation Table. Refer to &#x201c;Executive Compensation&#x2014;Summary Compensation Table.&#x201d; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (c)&#160;represent the amount of &#x201c;compensation actually paid&#x201d; to Mr.&#160;Neal, as computed in accordance with Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K.&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&#160;Neal during the applicable year. In accordance with the requirements of Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K,&lt;/div&gt; the following adjustments w&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;ere &lt;/div&gt;made to Mr.&#160;Neal&#x2019;s total compensation for each year to determine the compensation actually paid: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:96%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:108pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:108pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:44pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:44pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:50pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:50pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:63pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:63pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&#160;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table&#160;Total&#160;for&#160;PEO&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Equity&lt;br/&gt;Awards&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&#160;Award&lt;br/&gt;Adjustments&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:4%;border-bottom:1px solid #000000; width:11%"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(a)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The grant date fair value of equity awards represents the total of the amounts reported in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns in the Summary Compensation Table for the applicable year. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(b)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The stock option agreement granted in 2021 to Mr.&#160;Neal provided that if Mr.&#160;Neal met certain age and service criteria, he would be eligible to &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:9%"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; line-height: normal;"&gt;&#x201c;retire&#x201d; and his option would become fully exercisable. At the time of grant, Mr.&#160;Neal had satisfied such retirement eligibility and the service-based vesting requirements were deemed to have been met. Therefore, the same fair value is being used for the equity award adjustment as was used for the Summary Compensation Table. The amounts deducted or added in calculating the equity award adjustments are as follows: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:86%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:213pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:213pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:170pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:170pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:208pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:208pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:218pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:218pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:21pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:21pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year End&lt;br/&gt;Fair&lt;br/&gt;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;granted in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year Change&lt;br/&gt;in&lt;br/&gt;Fair&#160;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;br/&gt;as of Vesting&lt;br/&gt;Date of&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted and&lt;br/&gt;Vested in the&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;over&lt;br/&gt;Year&lt;br/&gt;Change in&lt;br/&gt;Fair&#160;Value&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;in Prior&lt;br/&gt;Years&#160;that&lt;br/&gt;Vested in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;br/&gt;at the End&lt;br/&gt;of the&lt;br/&gt;Prior Year&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;that Failed&lt;br/&gt;to Meet&lt;br/&gt;Vesting&lt;br/&gt;Conditions&lt;br/&gt;in&#160;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (d)&#160;represent the average of the amounts reported for the Company&#x2019;s named executive officers (NEOs) as a group (excluding Mr.&#160;Neal, who has served as our CEO since 2016) in the &#x201c; Total&#x201d; column of the Summary Compensation Table in each applicable year. Mr. Burns was the sole NEO (excluding Mr. Neal) included for purposes of calculating the average amounts in each applicable year. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (e)&#160;represent the average amount of &#x201c;compensation actually paid&#x201d; to the NEOs as a group (excluding Mr.&#160;Neal), as computed in accordance with Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K.&lt;/div&gt; The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr.&#160;Neal) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K,&lt;/div&gt; the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr.&#160;Neal) for each year to determine the compensation actually paid, using the same methodology described above in Note (2): &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:88%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:133pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:133pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:41pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:41pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:37pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:37pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:110pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:110pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&#160;Summary&lt;br/&gt;Compensation&#160;Table&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&#160;for&#160;Non-PEO&#160;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Equity&lt;br/&gt;Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&#160;Adjustments&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Compensation&lt;br/&gt;Actually Paid to&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,009,298&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;470,850&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;$418,439&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;956,887&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,135,708&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;599,719&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;($186,282)&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;349,707&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(a)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The amounts deducted or added in calculating the total average equity award adjustments are as follows: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:77%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:172pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:172pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:241pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:241pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:175pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:175pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:228pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:228pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:332pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:332pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:21pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:21pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;End&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&lt;br/&gt;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;granted in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year&#160;Average&lt;br/&gt;Change in&lt;br/&gt;Fair Value of&lt;br/&gt;Outstanding&lt;br/&gt;and Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Fair&lt;br/&gt;Value&#160;as&#160;of&lt;br/&gt;Vesting&#160;Date&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;Granted and&lt;br/&gt;Vested&#160;in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year&lt;br/&gt;Average&lt;br/&gt;Change in&lt;br/&gt;Fair&#160;Value&#160;of&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;br/&gt;that Vested&lt;br/&gt;in the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Fair&lt;br/&gt;Value at the&lt;br/&gt;End of the&lt;br/&gt;Prior Year of&lt;br/&gt;Equity&#160;Awards&lt;br/&gt;that&#160;Failed to&lt;br/&gt;Meet Vesting&lt;br/&gt;Conditions&#160;in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Value of&lt;br/&gt;Dividends or&lt;br/&gt;other&lt;br/&gt;Earnings Paid&lt;br/&gt;on Stock or&lt;br/&gt;Option&lt;br/&gt;Awards not&lt;br/&gt;Otherwise&lt;br/&gt;Reflected in&lt;br/&gt;Fair Value or&lt;br/&gt;Total&lt;br/&gt;Compensation&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;345,047&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;20,942&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;97,611&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,277&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;418,439&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;133,929&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;224,276&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;90,689&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;186,624&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;186,282&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(5)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share price at the end and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of the measurement period. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(6)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable year. Due to the fact that the Company is a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">2344168</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">2344168</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1009298</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">956887</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD">41.69</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">-17100000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3510795</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3510795</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">1135708</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">349707</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD">47.25</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">15800000</us-gaap:NetIncomeLoss>
    <ecd:PeoName contextRef="P01_01_2022To12_31_2022">Mr. Neal</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="P01_01_2022To12_31_2022">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (c)&#160;represent the amount of &#x201c;compensation actually paid&#x201d; to Mr.&#160;Neal, as computed in accordance with Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K.&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr.&#160;Neal during the applicable year. In accordance with the requirements of Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K,&lt;/div&gt; the following adjustments w&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;ere &lt;/div&gt;made to Mr.&#160;Neal&#x2019;s total compensation for each year to determine the compensation actually paid: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:96%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:108pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:108pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:44pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:44pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:50pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:50pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:63pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:63pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&#160;Summary&lt;br/&gt;Compensation&lt;br/&gt;Table&#160;Total&#160;for&#160;PEO&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Equity&lt;br/&gt;Awards&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&#160;Award&lt;br/&gt;Adjustments&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation&lt;br/&gt;Actually Paid&lt;br/&gt;to PEO&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,344,168&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,510,795&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:4%;border-bottom:1px solid #000000; width:11%"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(a)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The grant date fair value of equity awards represents the total of the amounts reported in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns in the Summary Compensation Table for the applicable year. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(b)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The stock option agreement granted in 2021 to Mr.&#160;Neal provided that if Mr.&#160;Neal met certain age and service criteria, he would be eligible to &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:9%"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; line-height: normal;"&gt;&#x201c;retire&#x201d; and his option would become fully exercisable. At the time of grant, Mr.&#160;Neal had satisfied such retirement eligibility and the service-based vesting requirements were deemed to have been met. Therefore, the same fair value is being used for the equity award adjustment as was used for the Summary Compensation Table. The amounts deducted or added in calculating the equity award adjustments are as follows: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:86%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:213pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:213pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:170pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:170pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:208pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:208pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:218pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:218pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:21pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:21pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year End&lt;br/&gt;Fair&lt;br/&gt;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;granted in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year Change&lt;br/&gt;in&lt;br/&gt;Fair&#160;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;br/&gt;as of Vesting&lt;br/&gt;Date of&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted and&lt;br/&gt;Vested in the&lt;br/&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;over&lt;br/&gt;Year&lt;br/&gt;Change in&lt;br/&gt;Fair&#160;Value&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;in Prior&lt;br/&gt;Years&#160;that&lt;br/&gt;Vested in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;br/&gt;at the End&lt;br/&gt;of the&lt;br/&gt;Prior Year&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;that Failed&lt;br/&gt;to Meet&lt;br/&gt;Vesting&lt;br/&gt;Conditions&lt;br/&gt;in&#160;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top;text-align:right;"&gt;2,633,242&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:top"/&gt; &lt;/tr&gt; &lt;/table&gt; </ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">2344168</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">2344168</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3510795</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-2633242</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">2633242</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3510795</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_PeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">2633242</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_PeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">2633242</ecd:AdjToCompAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="P01_01_2022To12_31_2022">Mr. Burns was the sole NEO (excluding Mr. Neal) included for purposes of calculating the average amounts in each applicable year.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="P01_01_2022To12_31_2022">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The dollar amounts reported in column (e)&#160;represent the average amount of &#x201c;compensation actually paid&#x201d; to the NEOs as a group (excluding Mr.&#160;Neal), as computed in accordance with Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K.&lt;/div&gt; The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr.&#160;Neal) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-K,&lt;/div&gt; the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr.&#160;Neal) for each year to determine the compensation actually paid, using the same methodology described above in Note (2): &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:88%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:133pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:133pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:41pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:41pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:37pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:37pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:110pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:110pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&#160;Summary&lt;br/&gt;Compensation&#160;Table&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&#160;for&#160;Non-PEO&#160;NEOs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reported&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&#160;of&#160;Equity&lt;br/&gt;Awards&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&#160;Adjustments&lt;div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Compensation&lt;br/&gt;Actually Paid to&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-PEO&lt;/div&gt; NEOs&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,009,298&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;470,850&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;$418,439&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;956,887&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;1,135,708&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;599,719&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;($186,282)&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom: 2pt; vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;349,707&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:5%;vertical-align:top;text-align:left;"&gt;(a)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The amounts deducted or added in calculating the total average equity award adjustments are as follows: &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:91%;border:0;margin-left:auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:77%"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:172pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:172pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:241pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:241pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:175pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:175pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:256pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:228pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:228pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:332pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:332pt"/&gt;
&lt;td style="vertical-align:bottom;width:1%"/&gt;
&lt;td style="width:21pt"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width:21pt"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;End&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&lt;br/&gt;Value&#160;of&lt;br/&gt;Outstanding&lt;br/&gt;and&lt;br/&gt;Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;granted in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year&#160;Average&lt;br/&gt;Change in&lt;br/&gt;Fair Value of&lt;br/&gt;Outstanding&lt;br/&gt;and Unvested&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Fair&lt;br/&gt;Value&#160;as&#160;of&lt;br/&gt;Vesting&#160;Date&lt;br/&gt;of Equity&lt;br/&gt;Awards&lt;br/&gt;Granted and&lt;br/&gt;Vested&#160;in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;the&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year over&lt;br/&gt;Year&lt;br/&gt;Average&lt;br/&gt;Change in&lt;br/&gt;Fair&#160;Value&#160;of&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Years&lt;br/&gt;that Vested&lt;br/&gt;in the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Fair&lt;br/&gt;Value at the&lt;br/&gt;End of the&lt;br/&gt;Prior Year of&lt;br/&gt;Equity&#160;Awards&lt;br/&gt;that&#160;Failed to&lt;br/&gt;Meet Vesting&lt;br/&gt;Conditions&#160;in&lt;br/&gt;the Year&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Value of&lt;br/&gt;Dividends or&lt;br/&gt;other&lt;br/&gt;Earnings Paid&lt;br/&gt;on Stock or&lt;br/&gt;Option&lt;br/&gt;Awards not&lt;br/&gt;Otherwise&lt;br/&gt;Reflected in&lt;br/&gt;Fair Value or&lt;br/&gt;Total&lt;br/&gt;Compensation&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Equity&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Award&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustments&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;($)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;345,047&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;20,942&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;97,611&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;3,277&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;418,439&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;133,929&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;224,276&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;90,689&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;186,624&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom"&gt;($&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;vertical-align:bottom;text-align:right;"&gt;186,282&lt;/td&gt;
&lt;td style="padding-bottom:2pt ;white-space:nowrap;vertical-align:bottom"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1009298</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-470850</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">418439</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">956887</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">1135708</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_ReportedValueOfEquityAwardsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-599719</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_EquityAwardAdjustmentsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">-186282</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">349707</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">345047</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-20942</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">97611</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-3277</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2022To12_31_2022_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">418439</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">133929</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-224276</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">90689</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-186624</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMemberecdAdjToCompAxis_NonPeoNeoMemberecdExecutiveCategoryAxis"
      decimals="0"
      unitRef="Unit_USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="P01_01_2021To12_31_2021_NonPeoNeoMemberecdExecutiveCategoryAxis_TotalEquityAwardAdjustmentsMemberecdAdjToCompAxis"
      decimals="0"
      unitRef="Unit_USD">-186282</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Compensation Actually Paid and Net Income (Loss) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;As a biotech royalty aggregator, our revenue is comprised of licensing fees, milestone payments and royalties from our legacy discovery and development business and future milestone payments and royalties from our royalty aggregator business. Consequently, we did not use net income (loss) as a performance measure in our executive compensation program. Moreover, because the generation of revenues related to licensing fees, milestone payments, and royalties is dependent on the achievement of milestones or product sales by our partners, we do not believe there is any meaningful relationship between our net income and compensation actually paid to our NEOs during the periods presented.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"/&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;
&lt;img alt="LOGO" src="g344283g45g00.jpg"/&gt; &lt;/div&gt; </ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,X@T&0EHQLB4A@EY+%EGDE>*O*9J)E(Q%=*,"_MIF\2:Y3UD$%^ES&DY+VC
MQ>TO2QG &O>E#:0EI>V&)3Q ,+%<1N%$7$+K[Y^A>E' NAR$!O\"K+(0<E2^
ML]85!IU$>5"X;A"$<F(X@LIQEE 1<(4UJ8Y5])Z"7?,5^. KT@LOQ"6D><GB
MX*P0.&$99("Z)N8AQ :IAA7/(T@.# P5B.5HS^R))9,PE?YX*UTA XB*0XK9
M,U34F-. H'K2:0CSD.8@G1P.128L"F?A.(R$/F!<I(1Y"V+*)6+,@#RR-,,
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ "8*$5K),^V]4 0  Q0(
M  \   !X;"]W;W)K8F]O:RYX;6RU4M%* S$0_)60#_#:0PN67E\L:D&T6.E[
MFMOK+4VRQR9WM?UZ<SD."X+XXE.RL\ED9C:+$_%Q3W04G]8X7\@ZA&:>95[7
M8)6_H09<[%3$5H58\B'S#8,J?0T0K,GRR626685.+A<CUX:SZX("Z(#D(M@#
M.X23_^[WI>C0XQX-AG,AT]Z %!8=6KQ 6<B)%+ZFTS,Q7L@%9;::R9A"3H?&
M#CB@_@%O>Y$?:N\3$M3^744AA9Q-(F&%[$,ZD?A5U-A!/#Q4;:!'- %XI0(\
M,;4-ND-/$UUD5S92#N,ZA#CGO\1(584:5J1;"RX,.3*87J#S-39>"J<L%/*!
M.N#>3WQ@70[>0A1UE13/,39X729Y_R=EH\ZB\V(#G*X[#6*%7AOR+<.5Q/P7
MB7E*<(RMA H=E*^1WD<\CE!O6/1+LIK?WDWOXZA:8QXB]N9>2)7C%,8?M/P"
M4$L#!!0    (  F"A%:-]RQ:M    (D"   :    >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'/%DDT*@S 01J\2<H".VM)%45?=N"U>(.CX@]&$S)3J[6MU
MH8$NNI&NPC<A[WLPB1^H%;=FH*:U),9>#Y3(AMG> *AHL%=T,A:'^:8RKE<\
M1U>#546G:H0H"*[@]@R9QGNFR">+OQ!-5;4%WDWQ[''@+V!X&==1@\A2Y,K5
MR(F$46]C@N4(3S-9BJQ,I,O*4,*_A2)/*#I0B'C22)O-FKWZ\X'U/+_%K7V)
MZ]#?R>7C -[/2]]02P,$%     @ "8*$5FZG)+P> 0  5P0  !,   !;0V]N
M=&5N=%]4>7!E<UTN>&ULQ93/3L,P#,9?I<IU:C)VX(#678 K[, +A-9=H^:?
M8F]T;X_;;I- HV(J$I=&C>WOY_B+LGX[1L"L<]9C(1JB^* 4E@TXC3)$\!RI
M0W*:^#?M5-1EJW>@5LOEO2J#)_"44Z\A-NLGJ/7>4O;<\3::X N1P*+('L?$
MGE4(':,UI2:.JX.OOE'R$T%RY9"#C8FXX 2AKA+ZR,^ 4]WK 5(R%61;G>A%
M.\Y2G55(1PLHIR6N]!CJVI10A7+ON$1B3* K; #(63F*+J;)Q!.&\7LWFS_(
M3 $Y<YM"1'8LP>VXLR5]=1Y9"!*9Z2->B"P]^WS0NUU!]4LVC_<CI';P ]6P
MS)_Q5X\O^C?VL?K'/MY#:/_ZJO>K=-KX,U\-[\GF$U!+ 0(4 Q0    (  F"
MA%8'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ "8*$5AX59'3N    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ "8*$5IE<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  )@H16_D5!HW@"  #R!@  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ "8*$5D_>T^ *#@
M^E(  !@              ("!NPH  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    (  F"A%;R[WNK!@,  "T0   -              "  ?L8
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ "8*$5I>*NQS     $P(   L
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64$L%!@     *  H A (  -$@      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>22</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>10</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="d344283ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d344283ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" original="d344283ddef14a.htm">d344283ddef14a.htm</File>
    <File>xoma-20221231.xsd</File>
    <File>xoma-20221231_def.xml</File>
    <File>xoma-20221231_lab.xml</File>
    <File>xoma-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g344283g02g01.jpg</File>
    <File>g344283g02g02.jpg</File>
    <File>g344283g04g51.jpg</File>
    <File>g344283g45g00.jpg</File>
    <File>g344283gra0064.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022q4</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/ecd/2022q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d344283ddef14a.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022q4": 4,
    "http://xbrl.sec.gov/ecd/2022q4": 45
   },
   "contextCount": 22,
   "dts": {
    "definitionLink": {
     "local": [
      "xoma-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d344283ddef14a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "xoma-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xoma-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "xoma-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_def.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_lab.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_pre.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"
     ]
    }
   },
   "elementCount": 221,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 18,
   "memberCustom": 8,
   "memberStandard": 2,
   "nsprefix": "xoma",
   "nsuri": "http://www.xoma.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d344283ddef14a.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "995100 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d344283ddef14a.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d344283ddef14a.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "2",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d344283ddef14a.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 10,
   "tag": {
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the contained file.",
        "label": "Contained File Information, File Description"
       }
      }
     },
     "localname": "ContainedFileInformationFileDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_ContainedFileInformationFileName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the contained file.",
        "label": "Contained File Information, File Name"
       }
      }
     },
     "localname": "ContainedFileInformationFileName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The SEC Document Number of the contained file.",
        "label": "Contained File Information, File Number"
       }
      }
     },
     "localname": "ContainedFileInformationFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_ContainedFileInformationFileType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.).",
        "label": "Contained File Information, File Type"
       }
      }
     },
     "localname": "ContainedFileInformationFileType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentCopyrightInformation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The copyright information for the document.",
        "label": "Document Copyright Information"
       }
      }
     },
     "localname": "DocumentCopyrightInformation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentCreationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different.",
        "label": "Document Creation Date"
       }
      }
     },
     "localname": "DocumentCreationDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the document.",
        "label": "Document Description"
       }
      }
     },
     "localname": "DocumentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases.",
        "label": "Document Effective Date"
       }
      }
     },
     "localname": "DocumentEffectiveDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement",
        "label": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b).",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Text Block]"
       }
      }
     },
     "localname": "DocumentInformationTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_DocumentName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'.",
        "label": "Document Name"
       }
      }
     },
     "localname": "DocumentName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentSubtitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'.",
        "label": "Document Subtitle"
       }
      }
     },
     "localname": "DocumentSubtitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentSynopsis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'",
        "label": "Document Synopsis"
       }
      }
     },
     "localname": "DocumentSynopsis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'.",
        "label": "Document Title"
       }
      }
     },
     "localname": "DocumentTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentVersion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The version identifier of the document.",
        "label": "Document Version"
       }
      }
     },
     "localname": "DocumentVersion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAccountingStandard": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element.",
        "label": "Entity Accounting Standard"
       }
      }
     },
     "localname": "EntityAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses.",
        "label": "Entity Address, Address Description"
       }
      }
     },
     "localname": "EntityAddressAddressDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityContactPersonnelLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Contact Personnel [Line Items]"
       }
      }
     },
     "localname": "EntityContactPersonnelLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityHomeCountryISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element.",
        "label": "Entity Home Country ISO Code"
       }
      }
     },
     "localname": "EntityHomeCountryISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityLegalForm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc.",
        "label": "Entity Legal Form"
       }
      }
     },
     "localname": "EntityLegalForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'.",
        "label": "Entity Listing, Depository Receipt Ratio"
       }
      }
     },
     "localname": "EntityListingDepositoryReceiptRatio",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "pureItemType"
    },
    "dei_EntityListingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security.",
        "label": "Entity Listing, Description"
       }
      }
     },
     "localname": "EntityListingDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingForeign": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt.",
        "label": "Entity Listing, Foreign"
       }
      }
     },
     "localname": "EntityListingForeign",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityListingPrimary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity.",
        "label": "Entity Listing, Primary"
       }
      }
     },
     "localname": "EntityListingPrimary",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'",
        "label": "Entity Listing, Security Trading Currency"
       }
      }
     },
     "localname": "EntityListingSecurityTradingCurrency",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Phone Fax Numbers [Line Items]"
       }
      }
     },
     "localname": "EntityPhoneFaxNumbersLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityReportingCurrencyISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'.",
        "label": "Entity Reporting Currency ISO Code"
       }
      }
     },
     "localname": "EntityReportingCurrencyISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "currencyItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to serve as parent of six Entity related Table concepts.",
        "label": "Entity [Text Block]"
       }
      }
     },
     "localname": "EntityTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r48",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_FormerFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former end date of previous fiscal years",
        "label": "Former Fiscal Year End Date"
       }
      }
     },
     "localname": "FormerFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LegalEntityIdentifier": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI.",
        "label": "Legal Entity Identifier"
       }
      }
     },
     "localname": "LegalEntityIdentifier",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "legalEntityIdentifierItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NameChangeEventDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type.",
        "label": "Name Change Event Date [Axis]"
       }
      }
     },
     "localname": "NameChangeEventDateAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table.",
        "label": "Name Change Event [Line Items]"
       }
      }
     },
     "localname": "NameChangeEventLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period.",
        "label": "Name Change Event [Table]"
       }
      }
     },
     "localname": "NameChangeEventTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherAddressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other address for entity",
        "label": "Other Address [Member]"
       }
      }
     },
     "localname": "OtherAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_ParentEntityLegalName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity",
        "label": "Parent Entity Legal Name"
       }
      }
     },
     "localname": "ParentEntityLegalName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PhoneFaxNumberDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Phone or Fax Number",
        "label": "Phone Fax Number Description"
       }
      }
     },
     "localname": "PhoneFaxNumberDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940.",
        "label": "Registration Statement Amendment Number"
       }
      }
     },
     "localname": "RegistrationStatementAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r56",
      "r68",
      "r84",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r55",
      "r67",
      "r83",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r51",
      "r63",
      "r79",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r52",
      "r64",
      "r80",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r59",
      "r71",
      "r87",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r54",
      "r66",
      "r82",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "xoma_EquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "EquityAwardAdjustmentsMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]"
       }
      }
     },
     "localname": "FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions [Member]"
       }
      }
     },
     "localname": "FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_ReportedValueOfEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reported Value of Equity Awards [Member]"
       }
      }
     },
     "localname": "ReportedValueOfEquityAwardsMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_TotalEquityAwardAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Award Adjustments [Member]"
       }
      }
     },
     "localname": "TotalEquityAwardAdjustmentsMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year End Fair Value of Outstanding and Unvested Equity Awards Granted [Member]"
       }
      }
     },
     "localname": "YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested [Member]"
       }
      }
     },
     "localname": "YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "xoma_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted [Member]"
       }
      }
     },
     "localname": "YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedMember",
     "nsuri": "http://www.xoma.com/20221231",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 1
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r101": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r102": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r104": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r105": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r106": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r107": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r109": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r111": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r112": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r113": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r114": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r116": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r117": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r118": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r119": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r121": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r122": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r123": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r124": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r125": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r126": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r127": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r128": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r88": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r98": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r99": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-23-090874-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-090874-xbrl.zip
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MA7Z8\P*]((2?65."Q;Z>MUK\K;:WGYZVCKCJ3!6XP0Q(YUXO@O7\^9[6M_H
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MS,?XV2K?DV\7^I GK'H*+W_(4_"3R;3(@>6"_LO$.XP]?3$.!V%NKP$JL/O
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MO<U[L+X]T'5G9V$4Z8ZW"S\!TL>A\E[M/-]\>0^6]_A9;Q,T,]==[W(D9D@
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ME&CY,";8G@E?G"J4QV.-XZ':!$/"O/"HKH_902,;T7KXUT^R'):198F/OO2
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MMXXS<1(/6]$60_,#3UL[3<)V&G:-!8"=$8B4XDAA>[CKHEQCY:UAY;,'@95
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M&=\;NDBF!,6E:H]Y+EQ?SK7!W[P[KV<6OS;(WY%!'JTV['':%TU+^^,8'>1
M;-#'741DYD :G28%1055*H/4B:XH7K=^]T6N(#:(AT)J2F4+[>NN72XCD#ID
M^-)\"=WE,EQ.27[&.8KV!?9M&AAGQ93,-R))<'$:$;&-EAZW$0&CWRY=7)2,
M7)8)5^0N-$B+8S[L(\D=S>'^J#G_$A91%L,1,S2EXJ4)G5@T:XL7'<R<"CG&
M+XQX@/9"Z\C&4'P;E"D,'"<-*/Y09/E%@IM!3B,VB,C*["PW(C?]A!J6>*>=
MQ366U!2'ZX6#[L;:@.IAECNVK6J1,:N0N5&? R= Y=:1YT-BPA9 W 2>8]*
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M19[+*S"B&P5:9S3T$6)VP/$"@;>[=]AIV;](!F;SP./_O]DD^44#"T%*#T_
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M5O^IT_;:Y;WJ4D/D>=C#RS))YGJ#(HP"Z?&.N\B$YP25MJ@5]HC/!@50$9<
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MV0K%%O='R[U:U<=!QIOY=2CJ/HVYZ?%S$]V7GXH(<;+B6A))M8Z33MNV(82
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M##9P![5;SO,)E\&ZFZG&FD<S0ZT5LR5#9HE>L0L#UR-^;!%A!T4:>ZG4@95
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M/C1S#U#T>?TK6^D M;P!EIXS(S6(!35?64 GGT7S:"Q'31<[U^J"G/NZ7,L
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M2 H<P ;EV4UT#'J'4C?) 0F&C[OR!J4SP/51'JA+3G<$M*P)ATJ;A)V\U@#
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M NA,WU?9V%VRX>&M3KVY^C2;:V0V-UV3Y[?CEC_]ZAO3K+Z97GU!J+U5.6[
M422'98'26CD\2K[C TN^-@-&+(H8@8D<B_OZ_B<PI3>RCPBPJS/T;6  U%LG
M"9<=<Z;&,I?? 7=B1E&?G%'4B5',@)S-:8ZW]>;#;EAY)Z.LO&5::!,99$.V
M7+X])FW]4,1N*$PG #96E3):"4S,Q[8>!BCYQ0\1MMV(\R9/<T2]G9'.70=
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M:8O5T?'%JJM33SC1@+M467T!FET'&X+!.#BD>MP*A4N>$7S,QMP<>K?C/CP
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MC%%K3;:"?!R$09HPR)'=FF(AA4.U<#WUR=8S#?/;.X2!#Z<"UN3#\V6A/%?
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M?\0V/*2>,EHIN/Y3X&&2 :<K(0L-N;Z1RE^JJ3QM)&880PUB9'(925E)(G[
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MU3'RMJ/?P15BP4.('A9/ER(%"Z,MK#^9 TU\6$([1=>UC>"S$DL$CR2.06-
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M!7R3R",Q8^)[-&0ZFQ0WI5N^BOIECWY.<9IZ#*W'=RUA='T[NO=I861<+\/
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MQP%'[]@F+(62KF)1]G53/>@3OIVW&?PHJ#G)8X94)]05ES''3;EXLTE>:&;
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M\W3+4<>[VK'AA';"<AAMYIT@F[YV!%XI;YX:0&%7*(L-%!4=-:]BT$BK@ER
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M2O(6:,@K2** ?/3U992*6DA/Q2L0G37SJ3NQ5R\VK._$4Q4>G.;YE)W 'G#
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M'J$:F028'92+KWMZ,DHC0+XY=BQJ  %6G"[8 0^F.'PW=C?&P5"'H>X4;$C
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M#QV[M;:'P'5]$JH8'& WJ5WKZD)$?$M(AUJ"&%B EN>@+(PZG4_J[%(DM4Q
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M>7*6Y5#FNAQ$1\B>\,6<FRI+\AIIFO Y J1](4#:NVCQ,AF+#"PP#D@2Y1$
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MY$)ONGT"#I^__WA6]J_-)Q?C8?Z/_P]02P,$%     @ "8*$5C'DY++F80
MA+\  !$   !G,S0T,C@S9S R9S Q+FIP9^S]!UQ32_,'C(?>D5X$I!?I":$W
MZ;UW4# DH4,@=!00%12D=U%!I'>ITA&D%Q&D@Z)4I2E($:2\ :_EWNN]3_W_
MW]_S?EB2D[.S,_.=G9V=/>PAG*.QHS< $G5E-64 &AHZFB^:+P!PM$K[2-<.
MX8%PMT.X,@GQ"P+$Y-6T,#$!J$(;T@@'_Z@"9.G1S $8=.PJ__(G.@" >GU5
MS7ZBBR3:?OS-UE)QT#I9GOM#-B[3DS:)D[;YXW;4&^VD1N"*M'?QT/'T</7T
M0%6QCFFZ[AX&U@B$TPF'FHL''.[BZ?SM_/A3P0EY7#]S(FM@[W/,(6_O<2SS
M0R<<J0UQAALJF1I^!_LJH(M$(&P,X!Z>KCK6#E 4F1"@"T "$*@?&P 3P
M!W@ / &N)R+XKM^YOZF1=_)P^<TB0FM/>R</>Y<3E:@ZW@FW@I:9QE=O2![S
MH_/]KL=D/_58Q]7#'N'BCJ)2G_3+U</E6R=0G;1&?J_HV[IK_6A!NBC\J+AX
M_*AH6CNY?Z]HVWIX?:\H.3LI?J^@_/A#M3S4T?8W1WPU$*"O(J^ ^L X.8<Q
M,<$0GM87$&\ WXH*TN5/-'FG/_/)(V&&1BX>RJSZ3AZ GXJ\$XSI5W1]=R>/
M$[JNC],%T^]D?"\XU .!5(1X0+Y'A:ZMKONWJ#@^_^U3X<0)<!N/7ZDW1$V!
M7]$-H$Y?Z;I(Z 6S[V02*!+A:F('1PTN:KSL76R_>8SXN$$?99,\PL,#X>R$
M<+']383P6\NQ"3_1B;[1]>UM[7YN(/C6@++M._DX<C!6O]J T70HC)I<:-\^
M3Z**XZ2-^$</9*_]-ON(3JK'\]G\I$[[O7[N1.NGDSK>-SFTKU+XOU5.:IPD
M7YW^+1B^8F)LG9RK @1L;% M3J@C]F]27RGI=U.^4T G1W/4\1M%^.3(]X-R
MHO/SR3EJ7AW]LF"\.V[^[[>=]!GWJW^_]AO]PM?W;VWGOGOM:_WL\1F&W'?K
MOQ8-U+OSA&8+$$3U^?@(!'R?1+\K/],Z?Y/]2X9OY4?* +AX.AV'WG&6Q;9&
M>+K W/\P8Z$>P&\F'X?Y3R$&^$,L N1_Q.R)&?H_0O*D.^Y.]E"XN[&3YO&D
M0OL=#M9)&^J$#/7&.:FH*?ZD&\<6B?!T_1T)&X&TM[7_GB^5#(Z%=$YHJ#H1
MQ-,#H0)W@2,A'G#8B?6^KM_2/?Y7YF/*<8N:LRW3_Q_ZC^&)=/K=HG'B_-]3
MM-QM?[^P8$.</ PAMK^C$4/A*#FXCX>:NZJAEN:WU(7[C?P[9CP[!-)/SLG>
M]INGSGSMO.HW\K%W87 ;B.=)[L+S@B,]?L%N_(W\>W8":UL%A!,"^9-S2;\*
MR*M\;S@V0QOA<OR)YX%P12U0[O"?'8?OA'+DGZB$UB=)\$]T N1QJOL#^60V
M<7V50[W193\"?M!)3T[1?LM)%">UXP'%/*D3GKCTQ6\.2S@60IT^!0"LC^D5
M !H VM'8T2J 4 Z&L(9;*6@!T(_6 ,0G-0#LVK'<T23@)H 0%Q<7#Y<0#X^0
ME "?@)3R#"'A&4H:<G)*<G(:4L*3\MO'KPL:$0$!$3$1"3$Q"04Q,3'%\8&8
MXJL(Z3^CX.@I@!0797P"!AH+ )T4#8,4[>@5JJ/X1ZUHLB@KL=!.RF]NQ "@
MH6-B8>/@XN$3H/VQ$0V CO&MD02 AHF&@8Z)CH6#C8N%02B$:B3%P&0F V+)
MZ4'(6=R"0-@4,>FE\JQLE/K-UD)@Y/4!!1SV6(./;]>A[L)4C\IN<"C&&<*4
M6C(\1*@'C6;@&^4WG[WTG/VDS!F?&5R1T#HTMYE5V38\OV5LXQ62F%W5/K*P
M+:IB8NM]*RGG2<?HX@XI !T=92WFB4TXV%C")R8P \DP41:XL9!C@8)B*(XM
M:-8?^"C$9OT6>3U6P8 2Z@Y>9\<^-@"'0[AE$&5$!C5,R4C$ S[SW82_MH#S
MAPE'$P!"C!-,4H L8,LP5HW]/%NLFKH:>[_G$:!83)JKCHZ>L/YM1@$VK=D1
MH(XJ="?P:?EFT[K]BYO9/M:\1?=G<==5;T=1^TTZ9#^Q<)R\Y$2V6!]2<89:
MO"=E*7 6(],ZMI=#4J:YY^Y*KLJ^=)K&8>6EPHMQTULWEHT1F1IEJ8-GLJ63
M-V\\NR_=:WO@/MQ5ZOF*>DE NV4R4#=\);U0+"#XUB%QW/["]&92X!OUKF=W
M2 Z<JK,.7?@@]_@1"QG-9S[%'0%J[B1%C<K4>WZ2!N5_7'_0KMP)8_Q\-<U@
MY CPP@E><FO+(D_LCD2)15_#'KFQ=.2CIJ4TG<W(PXY'M8KQH#X_>>"UC^=*
MUL<SPBKCLX1F_&5G5 9OD!/?EVC@]D[L[4N4&24_ M!>*2P_C)50XPIM&$?Y
MB2T+Y:?S:FRQZOJH0]K1BRTC ]F\68\C@,XJW<PX$9^]:TPA0_Y$QLCC2%OM
MLBJ\RK3,@KV^4<3VY!ZX-T2>3'#WVN  SULIR9(;(X+E*_ZF\Y-C+V;H!\<Q
M5Q.[JQ>%(_C=B!P5:SHN -9,* =!##IZ'54-"J%GZ ,BGFV6>*^5I2U:'2@I
M+.N,W-HRN2\E2K6Y\$ '>T96^@BP8[%#>TB^VT/Z.9 13!3V5OA\P!W+BT.0
M\.XKKQ3/ $[+:3DMI^6TG);3<EI.RVDY+:?E?Z<<O=4OL//P<)40$'!QYX<<
M;UCP0Q'. CX05P$@OZ  0$K6QQ4"=81[,%G#;>U=I%D^U#6Q,-G#I%E,A+4$
MM5P5X';VJGY(N(&?MB'4SQ$J#F.1E<&7\I'P<79UAGM F'R<G5S<)7RD64Z4
M2Z#.C\D"+$PG+!Z.TBPGVR1,IEJZ3 H())Q)A%^0#RHH"&(2%><'BH#!8F*\
M3"!!D*" H*@ 4) /!)(0%)$0%F+ZK;#(X*..4DB8C82^HO)O<*B:-,MO_?+V
M]N;W%N)'(&T%@.+BX@*"( $0B _%P>?NZ^(!\>%S<6?]JN2;'D6X.Q1I?W)W
MA.FX#K%&>'I(L[#@,_U4?NN7L^MWH%\Z\%=",.AW&5=/I-.):3"H -P)[@QW
M\7!'R0%_*8<"T]+Z>SAGYU]*NGLH>7G\O:3[\3:<@#[<'>&)A,*5O%"6L/Y:
ME3[<YE]1A6+_I2+7;[<&?ZWL>_-?NA'E#D-=V[\WQ4/ U?8O/*)H[_S/= /%
M!G=Q/[Y1]LM>H(Q0^7LUO\:W=W+R=/= 0CP0R%^+_\3P=QXXN:GC_O<6G.R&
MN@M\#_+C.$>)2B@@X<?J#1$()YFOD_#'[5H% Q$F+A-[%QC"V_V\E, ?V7^E
M":Z(>LN !(&B?()"?() 0R!00A D 1;A$Q26$!3\2<E7SC_HT$*E!1C$ _*;
M%I#0L18AE!8A"9"H!$B8!Z5%Z#<MO^/]HQX$S-[&]Y_2\H/S)QTPJ(0- ND,
M\9"Q=X;8P@7@KNXV4@(_J+^'T]*24'-Q]X"X'-^-D$$1^.WM81)B-C (""((
MY8.("XFC4A88S"<NA,HX@M:B<#@<* 02AHB<V/![\3^I5D1 /8]S JKM:_J$
M(: H]=_GA@0(+ 06%1$%\T%%X")\UA"P#9^UD+4-GPT$+&H-A(%$1:&@;T _
M*?L3T->;(A"GGWB.^P)#@8'!"LHBHB**8@HB("5A(%!.2$Y044Q,7E1>24@9
MK/A=_2]4_ E&'^X"LS_.JPI.$'=WF9,;UA*N,)MO.O[0_B=Y57MW5 3ZROQN
M+ISD; .XV^^IWQJ<[$]RN"L$Z7YR-T>:Y5MB8OF3P+',2:J4@$"/K9"!GD0K
M3$K@=]2_%K/_<RC\8_?]2?2O]7O;P5V.9Y@PGR JK, G42TD 03RH);$XQGV
M$]=?*W%'V'AX0Y!P.5O4*/VCB?\KD3_Y6>"KH_]_, #N$*__S/T@,65199"2
MB#A(1.C$_2(*<F+RBD"0L(@\""0L_Q^X7]A04%1"2%0"=8XZ^:^Y'\STF_?_
M.>?_4 RU@[C8PF$R M\$OQ'^E\9+& 04!8'%H7S"(!MK/C#01H1/'"PBR@>!
MBH. 4'$X7- &]F^-V1\6)=%OB]*_/69J/Q9H)@4%IF,()BXM"-3>Y7@H_\FI
M\W]K]* (E^-[N__""*)P(*CK>3C27<8&B7!F@KBZ.ME#(<=2 JB\SN2!^!W)
MRP7VV_7)]R7L&]1/FOZ7XA4(MX%9"UM#^, P(2@?6% 8PB<.%['A@XE:HRX"
MH,(P<6&1?S]>@2*&0-'C> 6)\0F"_VLYYC1:_S):OU[S.;C";?_?#4P8'&G_
MKX3F3U9^]PO3GSKYB_GW?ZG3__%LM('9@.$0&) /;@T10ZT>(L)\XD!!.!]0
M& (3M 8+ :%"XJ>S\?_FV(D)BXN !>7%P<I"HDIBJ"LU84$Q<06@B" 0*":G
MH"#Z;XW;\4"AALY04 PU7!+'U?_BE=J_?*'\?VO$_O/\^2-O_)]?Z/][^?1_
MJ-/_^9P4.9V3_UM9% B"BX!!UM9\,$%AU**%&CT^:QN0*!\4!!&"B8J+BX!@
M_];UZ%]NI/T71@T$XA?\WQZV_^ZEZ-]>I7W=COS_1BK]'^KT?YY*_ZDMX=.)
M^0?J[_=UO^T3_WD?^-N&^=?85#Z.KG]NL*5.;FC])ZGT#^*_T@[[1_OX-N)B
M$&$8V)H/"(%#^8!@%):XM:@H'U@0!A4&PJ%0L)#H-RS8KS;8?V A_I.M_+]4
M\2LDY%_NYO^R_<_#^--H_=SZPRV:<%L(U%=-UU!!T=X6[NXAHZ"HH*PL)ZHH
M)Z: ,EI0'#4R@J(B<DIRRH+""D)@)2F!OQ'^)<3)5Q"T$#"X#/AGX1_DW\>8
MH:ZMA+8N*B>YRP!/NO$3X<^<JA!W8WMW>VLGN"$2XN*.BD:X"]171AGBY [_
M+OT73'^G30>514^^R?>7JGYP_%F/%L3GV& #>S_X/S])%.V=);QE1/E!@L?E
M>(B_4G[%9R<#XA<5%$*5;WQVO^3S=+'WD%%S@=K!W;\QGI#^$"E_L/D7/=)U
M@GC C[]Q^8<UX1_=&I)1\(6X_*-50T8+<ISI(/^0SPSNY(3P_H=L\DX0J.._
MF//^LI/?/&#@#?& VJD<?P7J7_3!O[8H'M_OECCYIM6Q)3**7[_FP_05GND$
M_\3@GYG^7L\QJHS@ST(GE/]PD?@;GTC]=&M=X@3K6YZ3$OA3T^\]_?5N.RH8
MD8ZH=>S'W/L]'?]GVW[Z8Y*3AJ]4?45E&7R4Z+<_D_F5C_[[Y13D%.04Y!3D
M%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04
MY!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3D%.04Y!3DOPR"_^,?
M3\)=8-(LWBRR,D>3  4 VG]8CI7\ISK0OCY'0P/0B8%&^NTY&JT 1@  '0.
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M)0Z;S^7<(B.T _(<(EJK0U?45@B]-:H;C114C74HLS9=KG7T. 1+!9S%_XA
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M4NUCL%&M1)^9^QPY/5W":]MV"<\BTE9I^J'HE]E/E$B5J)*KM@41]%62JW.
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M&UB6W1CO+,2FMX7KH0HMTB4I6%P(K>?S3DU*@."XWJH#UEKN>%9FRC.M7,D
M3)6.^@*//34%GZF.CL<\EJFO#TUW"Y4N'I*SWZP5S4O(XJ.-:GJH'0Q]X,7M
M.YK4(4'B#X:ZY#/PI-5E"9_CT9O=V:WGEV_8U X 2KEV*N5'OCY?W8',T#'6
MRH"VZRNWNH!59F7D^C8Z&-[N2C("XS:F@N+3QW2[(9A&_I8A9<+WE2F;?;''
MF2GB,1]G##^-%T([[*>+$0].:)]X-K=!<R\7^B2BQB;A)E-$=A%/RQP2$&]]
M/Z9J+[K@C*+GV$5C[51;VJB>V7FS=W/OC9OT8<R)ZMMOU=Y>-HRI4;G4?ACY
MY@L#1U3Q)'MYTXXC^[D@ 4(WB^6$=W,JBO:5&$+!&P<)H=)E*?.VZ_*L,8%)
M39'3SW;()ZM]#MK_GP",'7/B=RHDVV_GX5BN^WY\97[^]OMZVZY\_%,=NYJ!
MMN1TCBVC!^YC%[*AB/SQ\FX.WKE_?K@O0ZY(RW'??W.PM3,BUZ<H\:[7C+-S
M)A&@CIK9TO.ZFHKD.3V$V7>!RT^JK0N>U\RQ/&A ^<B2$1/?O[C;>1[>3-4C
M:3]+RE+*6D0;M\G&EJI+)Q!W*0M;CED(!\<:O(VR*Q&N^%W*4\;W3,5N58FS
M.G;^(I%E;BUUI\?DHXC)Q\<;2P8VPL0=E\LO&)-Y'17>"\0[KI-UUO8[+*<>
MY:^V^ZT=-D<?EZR3<Z+2Z&QC55+2U<-BDDSK&PF$%&C1Q-3V5Y")\GN8-B.(
M]C79-.G;R%J"C1K36[EJ58:]:O&TLTTKG98XXT!9F)_ 'H;D[ $]8URY5Q]6
MQ>O68*=.I#)8M6K,J0UZ\$2EY)II9"J1QHH+,[,% &Y/2"WJ@=X7=Z.R,C:9
MM+&)PUQY62,3PU6607Q9,ZE?,25?;Z? ,QAZ^RW=B"/)CPY(P38&:K,_!G#2
M8.4GC[=K=#_\#:<%2UXGS.1E6YF)(F++'*JE:^/20$I+'1C9@SH61[,L[(Q3
MCUSB[R=Q(^XFJ([-#S#3^'@EIX19XTC><2NK7,J8F06(&R#1PK%%,R.M.O6:
M2&*621>I[>@)TSG\D\SV?;W953F\?<)K9YGC19\5_P!&GY;N:]\"WMX"'"2/
M+K^.\W-E1WRFJ(@M5HH#H)B&HYB!KWOYK*/'XB/2-.4&_F#':R7C<;UL7#)Y
M(89.)Y+)?L(CA=]C5KN)%VG7>T/AJT'+;R,FNK\++2QD=BCA1+%(GS&2G!CM
MW(68JLD%*J\E4,8W1[-J0Q2AJI!]-_$J\S)*T?6GKQ!D)\*JMU7-&F T_P T
M<>Q,F'QC31V_^V0(HNV,,A557,,GUM1/=SM1\.>'*Q:CU ZGZVK8>NW'8;*/
MF[FSG^;<M3!5?0(!;?< ;GXJLZ%K:7TTAB)DFLYRRI<^5!$IH4F"#[*YGOCF
MQ&YC*C<<AU#[\/AQ"N_[W3^190!OK>#.)-3I!$*'[6II-P6+A*88W*US!2/T
M>?JI0WJK7HD1_P!?[K[I+._V6^1T7!CE9A+F<I6B(4[!JU)#;E+>QN!,M9=M
MB"6]_;J%?"]A#=UCE<U(D;0X7%R+$S#>2.[DI%KQLGHA>52.\C-N#LVP!!;:
M4?XF>A>#D;J!J4&OUV.0YASCR^WLU'U5MA+4;/E_ERMM"N^/[?%$5?W]_;R(
M_#M,IH:LKD_4EG$3@?U$B78V/^WC'4]^)V.06=#SA=XF74,#M_W7"XJ6,'_S
M 2;>Q_*?OU4QU%[UVG4/JQW>X\P\RR@<O]D'\1Y3C^W@L:@LAGX$+D*!RCLR
MR2!>@+:'G;JOI,HR.4$IE]<ANF%9^@M'(LK5VBDU5J31]VVL;XK!+E+&01VV
M-B9WI/CJBJ">223Q22S\E*&&(Q'_ !MUK'0?<,Z+TEK>G6E9<WF+&-BPBJC/
MX%,%J+(Y"0DI%&*L31B \VD>V\6\3HNQZYZ8?1^?WH[0Y#C"1$DAXAPXH>^Y
MQMHY4C?E<#636!BY6-*>GNMUR%:_5G(S0_9,!5OO[WZ2 J9"I^=R=7)H_3MF
MXC*<G>#4<1&P+[V74&2PR\@1%2B!DW8,AE$4)V9U/7UVCT2VL]1U$G3?#8=H
M\AF&#</(H=VJTAM$ZLUZPI,RAH'^62Q(C[[ L/\ XD/F&MXTZE<*=:LL&OI1
M\L\@Q)9:2J_+U\.OXYX8JXL\=3'IX;1"C5*Z.UQ@((A"## RK6,!G^VC1T3V
M)Q3Y#4^2SD_DE&+I-M,^[EKV2=HP[RN22YA2US.[.WDW;T2>F&^(3-IC=%P8
M:-H5ESMZ&#PL>+&CC^-N9H8U'LQV%I+N0(T#C<ABG5#WH<<(.YK]1_AJ1)B2
M)5!PO#TW.%Z0(E>.(?)0AU>/))(K'#"QVYT&>(-7.:\CH[FC7W152W^\.7_2
M]#Y")659<K+!C(MVV)69C+8"J&!;>K#,&]$+R&X]CJD>P>'&3US!;?EXL+1M
M7V7Q<HVD?:I &E*E8W26<2HH99'\;<?I5^FV_5Q]1"JZ"]<IDS,3ZZ1V%Y7%
M9Y;A'/R6#E+!G# )E]R/:PB(YCZ'!1)D>8P<@9@VNCET%,2.6',L#1%H[=Z,
MFUAG(X94D7$4F2?*3J"!X]R8ZBOZVEM%&7T04B660'DJ!FO[@:TIZ)P-B_))
M"V1G22+%4I) LEJR  65 &=HJ_-'E8+P!,:2/&) XS]N,^)^:^S7)A\=Q;C]
MES'RMJGW^MGUU.)]QH[@@G$M=+H[:9+.-GR)(E.DS["PEC^^;+&)"$DR!#>X
M.0R6(TYCTFOV8,=CX%AJPER$1?\ )%%&BCWLH&RHNP4$@!5])7A<5J#6^8N"
MC7DR&3M--?N2EF6).;;EYII"Y16*B*(R%W=@ S%B6,GG>D[ZDOLOMTUYI3]_
M?]J:M_PY5_\ C;+_ '_;_E?V_?R,MW)T223^O4SOZVW;;[;>]P/S_;J8Q]F]
M>A #C:ZD;[_QB'<<MQ]E.^X] ?WVZ_&3TFO4H>Y?;IIS5^Z^R>]+ 1$54]O=
M%6T^*(JI[JJJB)_=5_X\CW'T6/\ WY4^^YV;[CWZV^^WO;^_XZR/^3FNFVWH
MU1Z4?5;^WH#\1';;\]0&WV)UO&VPU/'^]H+'*[7&7-EF]5FK<* M**^J9*Q+
M*KGB:Y[&2HDD;Q%1A",^2?Q>Y/W\EE2[5R%2O<IS)/6L1B:&5#NKQR .C#_5
M6!']CU <IB;V#OW,9DH3!;JETD7V4;B_'R1,0.<3%6"OL-]B" 00'H/PS/(D
M?4="-AA'2GEL.+N?MI7I%>Y')&I=70Y74USAI\W.:,]K-T2>WP8U2!(Y%<]Q
M/BJW>2FU?5BSD#C=Q\$NX_[Z2SQD'T-B(EA.W]&&WK;IQ^TE]+VBZ")&T:T7
M>@-UV$AKQP^213_F#3-*"=R>:MO[ZM\[A=O^+.F7$T[DGD68R;;35D5?'V!A
MS8T70\A:I H^/35?YCYMA5L52!E:31R DK\Y5.=+D,DRS5U;81S0>A,UW SD
M6'Q,9CB3C-D\G)&[U<72W/.Q-PV,DKA66I41A+;F'C0HBRRQ9_<;N+I_MGIN
MSJ#.SIR :'&8U9HXK66OL!XJE<OZ1.3*UJTRF*I!RED#'A'(C?V [![[LGRG
MI^8>6-)$M]=IB-"T0)"@H,MG89RDI\9DH4D[_P!)R= ,CUCC(]9=G.)-T5])
MF75C+E+T>TSI;%:0PM/!82H\%&DK,6=0UJY:= +.0O2(H\]^SL [ <((@E2J
MD=:*./KDGK37.7[@Y_):@SEY+60R$B11()>-6E325OE,5C89)"M3%T^1,<>_
MDL3O-D<A+-=L33=72^DMZ8PN2"9WM5V*SCW<>1)$6[X6XVO8:L;OY@"-D0.2
M]?62F(]</$*T<C#9Z:)$U\A@]5;!3-#IH=^N??#N\V-:WHS2UL#).KU\_E*T
MFYQJ$<9,33E0[?J+C=<C8C;^ 7>G"QN&P]1N/AN[&I>AQ_<#5U(M03Q6=+XN
MW%L,DR[-%G[4$JAQC0P#X:"55.0V7*2)\FU$6&9>1L)0\H<?[?C?41F2\YO<
MGH,?>1WB&9"5>CJI53-^(RHX:E8"6\@5<G\"M8]%1S45%&Q>1LXC)8_*TW*6
ML=<K7J[ E=IJLR31^U((!9 &V/L$CIXLIC:F8QF0Q-^))Z.3I6L?<AD5726M
M<@>O/&Z,"K*\<C*000=_?6<UR#C;;B;=[CBS6$'%U'&VPT.&NQF7\N1T_+7$
MFI=+097J[ZIXHHK #VN>,@)0B#(YCD7SJ-C,A!FL5C\O3^NIE*=*_ 5(<".U
M$LP0LH +1ES&X(!#JP(!'7''+8J;2V?R^GLC(L=O"9&YC)6>-J8E-*Q) EB*
M*9V80V$C6:%UDDC>-U:.1E(/34?H&=EHN^X$VG6ZVM&2-%P1?.M\H(DO[B2>
M+][+EV<*/#&]'%?'RNL;?51WH<K(T2QH@(P WA:]-OB+TJ^-U'1U/#$5K:AK
M>&X0@4+EL<JPR,^QV#7*?R\R[HI=X[#;L0Q#^?"SK.+-Z-NZ5DL&6YI*X5KE
MI9IBV'RCRVZBK-,7,@IV3;J%$ED%>!:B$1(\2=?7UO>A.]["YO&=B^%<Y8;+
MD/BBBLLMM<-2A67HM5QL>86\AS\I7#&Z1<:''W1K&5_3\;YS[ZHNK 56PEG!
MB0I_EV([A4--6[NFLW9CI8W,6(K=*_.W"M4R:QBNR7)2P2&M<@$:?,O^W7F@
MC,NT4CO'[?$?VOR.L<71U-I^I)?S&!KV:MW'UD5[M_#3'Y@FC%XVDM7<?90S
M0T8WCDMP3VHH&:SX89D^2ED0+)1,))@6U3/]WC1TJNMZFRKI"*USAK^6LZFR
M@S (]BO9$GPY(FN;])F(J.@1'/ "0DL$T8&YXR0RQ3(QVW^J.6.2-Q]BZ.K?
MD'KGB1<QF2+*)JUVE,0I'FKV*]JG,$8@#Q6()H)HC]Q'*C+[ (/5D6)]7[U%
M^/:,.=K>Q$K2P0 &.-,Y$Q6*W6@ UK6L17Z6WI?URR)[,3Y&NIMH<CG/>4KR
M.5_E49'LWVWR$\EE].BI(7;DF-O7:-=MV_%:*8P1#V=E@CB4#8!0 !U?V'^(
M/NGC:PK'/0Y)%CC2*3*XZG;M)Q0*2;21P33ER.3/::Q*6))<[C:*/83N-V4[
M-F$G8/G+7<@5P)RV$'(3ID&BQ$2<GO\ 5+K\#FXM/FGS0HOU1)):J7."U5:
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MD4'BN_V&T</_ $BO3@]VJO5/".5J^Z(ZVV[V_M_A6NU*M<G_ $Y%3_KR1_\
M-[N3_P#%F0_IZCIC[_W%7?J-#LYVO7;;1&"]'?\ [,Q]^_OO(=_N?1W'4@>*
M^E?4GA&2&?Q7URX>QEM&*(\>^K<+1&T@#!_]H@=)81)E\)PU7Y-5EBWV?_/_
M ,OW\CV5UIJW.*8\MJ/,78BI4P2WYQ7*M_,#61T@._YWC]_GJ28?16D-/N9<
M)IG!8N=N/*Q2QE.&RP7?B&LK$)R%))4&0@$D@;DDR=\C'4GZ/#HZBW+Z/=,Y
M\N;83NJ77:;/LIDRQL)LOASC^3+G6%C*+.L)TN0:@>:3+FS#GERY)GO-(DF*
M8KW$>YRR5=9ZN1$C34^?2.-$CC1,O?5$CB4)'&BK.%5(T551  JJ    !U&W
MT=I&222632^G7EFEEGFD?"XYI)9IY&EFFD=JQ9Y9I6:261B7DD9G<EB2?<L!
MQU@.*<O Q'&.)RG'F-JR3"UN5Q6?J\QGH!;"6:?/+$IZ:+#@ +-G2#S)9!@:
M^1),4Y7/(]SETU[(7\I:DNY*Y:OW)0@EM7)Y;-B01HL:!YIF>1@B*J("Q"HH
M5=@ .MQ0QV/Q52*ABZ-/&T8.?@IT*T-.K#Y':1_%7KI'#'SD=Y'XH.3LSMNS
M$GA.3N%N'^:ZZKI^8N+>/>4ZJCL76]+6\A8^@V$*IM7Q307V5;&OX$\,&<^%
M(D1'RHS!&?&,4#GJ-[FKZ8[+Y7$22RXK)7L;+-'X9I*-J>H\L7)7\<C0.A=.
M:J_%B5Y*#MN >O/(8G%Y:.*+*XW'Y.*"86((LA3KW8X9Q&\0GB2S'*L<PBEE
MC$B .(Y'3EQ=@?,*+I3T\R]]2:G-]6.O5#I<U:1+S.W]1P]@*^XH[FO)]L"V
MJ;&+0"EU]E",B&B38I12(Q6M*$C"-:Y-C/JW5-F":M8U'G)Z]B-H9X)<I=DB
MFB<;/%+&TQ22-AZ9&!5A]P>L&'2NF*\\%FOIS P6:LHGK6(<1CXIZ\RJR++!
M+'762*0([*'1E8*S+OL2.I.>1[K?=1BT/2CIYK=!>ZS5=6NONEU.GM9=[I-)
M?\0X.XO;^ZGD^V=;7-M844B?9V,LGLZ1-F'-(*J-1Y%1K43?0:JU-6@AK5]0
M9F"O7C6&""')6XX88D]+'%&DP2-%_"J !N3MN3UI9M-:=LSS6K& PMBS8?RV
M+$^+HRSSR<53R32R0-)(_!$3F[,W!$7?BJ@=B=U6ZT.XS7A?_0#AUG$#K]-4
M3BX7'64%Q\?2)-2Q2\DX\54R@E6GZ@UDY9DB 4RS!!DJ]3!$]GA^OYSY_P#5
M#F,F<EXO ,@UVRUT0\/'XEM&0S*GC^CBK@<"5^Q(/N,)AA0.*&)Q@QA<R'&B
MA5% R&;YDN:8B^7+FQ^^6,9)F_=)Y_5UT>/T)Z01)42=&Z@]:03($R)80I(^
M$N.6FBSH,@<N%+ ],[\AR(LH(I$<K51XC#81BH]K53);5FJ&5T;46<99$='5
MLK>(9'4HZL#/L5="58'[J2#Z)'6.NFM.(R.F PBO')'+&ZXJBK1RQ.LD4B,(
M 5>.15DC<$,CJKJ0R@B6?D?ZW?1X='1X='4=.0^H/5+ES5S=WRGULX*Y'VUE
M%@0;#6[CBK$:G23H=4#\K619EU=4DVPD@KXWM'A"-(>R,!&A"C!M:U-K5SN:
MHP+6I9?)5*ZLSK!6NV8(59SN["..14#,?;$#<GV=^L"QBL7;E\]O&T+4W$)Y
M;-.M/)P4DJG.6-VXJ22%WV!)('L]<KQ;U=ZV<'WMAJ.&> N'.*-);5*T%I?\
M=<;Y'&W%E1K,CV*U$ZQSU37RY=:L^)%F_DCE?'_-1PG^O[1M<GQ=S&6R,:0Y
M#)W[L4;^5(K=N>Q&DG$KY%261U5^)*\@ >)(WVZ^JV-Q])WDIT*=2210DCUJ
ML$#NBDLJNT2(656)*AB0"20 2>O_V5!+ P04    "  )@H160(WVE(\.   X
M5@  $0   &<S-#0R.#-G,#)G,#(N:G!G[5QY6!-G_I\ 40%/"JY%T31(T4+N
M Y*&*"0$4,.M>)6:S$Q"),F$F0F'ZU%MM=B*%E;TT2K6HU814$1IZT$/K=4J
M7FWQJ%9MB[INJ5>IKG7E-S,A(8&PC_O8WSZ[^\P7DKS?\_-^O^^1]YT_TG&^
MXRHP>((F10,P&#Z,$D8) '2T#6A*ST-P!,M#;"P1EP_$)J1H_?P @@9L:A*_
MT\4"@T8PI@.^PR.21O@  /'O,(V@=(.;3SV:M^W+)G^FK;!N)_-0*J634[I6
M4D^\&!07:$--5CS-CMOL.,$R25DZAF?I$<1,6:18<1BVVBW.-OFI,J,D/XCR
MS3(5DQ8))ISTZ8H)HZDZ"YR=.#7;!>9P2$<1Q) %XW9;FGXV2(C[ ^D "B#$
MGP%@ 5D #." ';!1+@$VE[4S3((9MW;VJ+_>;C+C)BL5DN#]*6N5=MI$1S5>
M)NU].!X9![EEG&;#38@5(Z1_HO*RX59G$D22>M3%9!HQ;9<&M:JZ&"O>Q4S2
MFS$7DVK$"UU,HL6L=C%$';M")X#YQLY".#H(9"8EJ(@/7ZH-L5@08M>/1ZX"
M3DI"K3UD">:>=@DHE#W9BFO",\TXX$8)9HCE39Z)F7%*GEYL'F_**)_E$ <4
MPB".H&H=KG/-BG1C.N:<%62[\U-%%0$VX-["9Q-3VIL\"S0[Y.DH.'Z:2SP8
M1!%;3AY,#"XQ7B:KT5FQ@:0BD^A3 H+CB,6,6(V=+OV=&K(+;O(!3GFFR9CG
MK@AT*HB^N<3DS/%M<_3!]Y,G$F)Q,9R?U*QZD=(-[,I@W&N=JV\ Q9+K<R3%
M/^_)^]ZG>'^G'X/RBASL*+-S^!THOK]2[2! 0AF2<[B/F_8!U1Y!;!E>R?=F
M9X_Z.?*@8@ ^XQVO3MU(5^\<?"C9\HUW(3DHCG@=IV1&@ \(.]]=D]6#W&7'
M.WU[-7!2U]($K'8S.<3D;M9'C]BM$-9M98"XP-EE<CJY#270;<R!A*ZY074C
MLVOHJ70PLPF$L2GF2>3D97C@,"D=0%8? /I23(K:+79?(XK8;1ZB/@AJ,II<
M^U)B%NF41LD(?H#.CB-)L!5&=3@,4;TOL3FWU0"',2DA-2D6(^O?D+^O'35[
M;,Y4\3TE6LSHN8'WT9GQ;)W10S80A D_N!A/P9*SM9.<6T0_I]C#V#\/0>?$
MFTU&9Z5HHHDFFFBBZ;^?.J[%?Y^'XS8YCV?%N#H(T<-<$+'PBG4VGH#+YP&*
M<<4V'9@/XRP]3!P-XMBW]W_"9IF@.':.1,O7VE1PGBEY#@IGS4G-!N?D@S*(
M/4X9H"B6%UML%AC7L8HM9BLF+XYC4\'E1)L4\]@LR@3/CV/'DPK65&TZ2X6@
M,$O*Y7- /E_(BI%Q!5*Q.#8VFB7D"_D\?@Q/P.<(A7*^5"X1L3J)K0P@WA4H
M9)!GJC6=< 07Q^[,JZBHB%LDXB*HD2>0R60\OI G%'(("PY68L5UQ1PK%NX(
MXHRCAC$0-5$W+1;)$[<(.Q['9@>PW*@S+XO-!>2U@-Z<;&Z]\W B%(23R*L3
M!+I\;,1)B,H' GFP&;; 5APC_ 3>P9RW\UX@G>I>>TNDJ-7^\R0M%J^>&)Y8
MB/]S3XP\1/(R80RQHR"<6$BD$NX]5";<2]&\AR+,NT:5'%@B#;D*A77$Q3";
M./$IXS$;@L&L23C$5?"Z*[OY:1'(9"@A[I.PDIB)(@Y?Q!$)L@4BN5@H%_&C
M^!+BW1'$S=(;-MPCAD NYLN%4O<8;I;=^T&L'(BXU3Y53]QMW>(0<TR>CB*0
M'831SB)PTXF%8T!0%C<U,9LE)&8@EPCB8>@6  +EA*U%ARM-%IT1YL$VS*#@
M=4G=L9R32ZY"S A*% =6"A0\;V*O7BDJ%=$#@\D,*[',I 162J)**I!)I1PA
MUR.,FYUGQ;1:>8H5PW56\CZD) 1<DPF2RV+$ H->RN=(]3HI1R(6PQR]2"?D
M2&/U GV,2!(K "54$3W=>X16(Z"=7'R$SK&Y00A(A._JEQ "I3$&/L012"0&
MCD$G%G%B15(9!X+%@AA(*I)*I$(GD%NP'D".:YG.[&9#Y@(18!)I+&B($0@X
M(ADDXX 2,<21Q>HA#@0)88/   OT?($3PDN8'E#))HQ8!"5*CS5([8I9<(&G
MU*DPFZA=TJ9#,>I.&,=V+D)V#P?2A]H6Y#J0W%^5F*X0AA0\#UGO3J:>@_ET
M!>CAWCM&41YL[;FX!#'.Q>5FU7L0##'@13H4CC<2=58ZON&ZGI,*A5P^:TR.
MR0HA1=A89TA/G]YC@WDZJQ&&E#RGHU/08W1XCN'Y?Q@V$+$6PBC^+PP=@:,C
MOOEA%%,:4,3"TMEL9A.H([W(K8:%(QZB0BO4N<>[EI,3RBW2OS%C"$9-_\I4
M=>NEJUBL_\K,GWF)@B+(P(?U(HZ8'PMQ8F"QC*.32$ .Q)>",*2+!<52';U$
M_^.&32J4BF$X)H8CY<L@C@06BSDZ$<'&2/4Q4AD("D4BZ1\P;%W'%GK8_O"=
MU<MF0NXW[B>W_[U-]3\\Z6=>F$]W?J479C>IYP'6>2CN>>!UGNX=<U-#SJZG
M&VP%=4M]EJVTF[NWZ%#/.\#3?K]V<_<6'7G6FT:O87I6WJW KL<OO&[/7QP/
M=WB=3W>4 82O\\F2M^GRQQ,-0H/0(#0(#4*#T" T" U"@] @- @-0H/0(#0(
M#4*#T" T" U"@] @- @-0H/0(#0(#4*#T" T" U"@] @- @-0H/0(#0(#4*#
MT" T" U"@_S!( %=O]4 6Z$X=A%[G++C.T %,)Z1.CX% OL!8< L!F,(T'&8
M: $^#";#_:>Q^O9A^/CZ,?L%$.K(P0"#"3#\?'P9CI^$ _P();-/7V!(T O/
M!8>P!?V&)F1T7 3ZD2'& ;\_O/G7:0W73W(^?3(ECOOYON>V1RW]\,,/JDLO
MA[7;9Q4\WE)E&8C/F+%0O7C#GC=.!MLD(2%GV;R9R;(LX[S0YN77XH[I4H*S
M? L:ZD_,JCX);8D><_TU^]Y5IS6-?JK)T8+/DZ^M:]D=$U0MGQV4]HCUV<K[
M ==2Q4!VPL];(B[^,G%NR.G/1K^I5(U>_=9XYIWBQT<GE?$-"5\^;E8G%J6K
M;O^VZKRVZ>('ZU,S"LY,CWI7=;B]9 _KZK;%C<')/UP>M+'J1&!L3?6)FH;:
M[(&?9FU\%!ET[O'2ORHJ[5]H9LAR-N[?,''>*TE30EI*RQ/]WCZ>L6C)\$#3
M(O_R):-7,869Z_@U>7>B=P1K-9*#^M.6@H_'G+5,^5"T9O$ILV5U_+S)VM"C
MOWW\<]DH_=3FG(/+L+7?O!HIJ4/9FR=G!D<J[K3^I77YAO+=#^[%LQ-%HL(!
M9_;)0G)+STF7-@:L;XG9Q+N_/^SVV?95N;-_/+J@,=0_YR([\/4KPVX49B?>
MS5NS]%(','O]@8P_/_AE_=<U%=A0V=+0]V8N9D\,WS3[T.&YM>SP=_\Q35'P
M5OV1I@/P'&GD@F__=B[S@XJ&F$C_F=&AU[Z2)ZG'M7YT?X%&>+ FIWK"O)-0
MZ-WRZ=_>*8A(N!#V2#"S SA7QWS 61QRX:/'$2$K1ENBJH[6YH]I?4/QF]XT
M-Z3VPL_-:9^G-X] ->H]K^_[+O?J3\MVW>\3'SZR=>/'\^>?.:^XW&:=T+(H
M%F:/4(97MLO>NG$J8/3F/J8A=R^_4K?^WL&W9/[8UMH3PT<<7'9"TU+=/C]W
M?]C1^K)EIWY<>.AN54!;19O0]F;.A"7W."$KDQ*7*EY*B:B1U[W6>,ZT)[%T
M6N4^]MNG^AV*SK\R)[IIM7U]OGK,@ZF+3L?_/@X_-U3>;]39G(T;\BK_<FW4
MK6@D87Y.P]4I<1%W[N8>;5-N2M4\'A:K:%_R=1SSP)15C=C)QRU!W\O;U[^W
M5+JL4?'NQ=*VZ7$;!==O_EKYV[*=I6SX$73R6*9\CC7I=,'6%1EP_?93W]Q#
M(O6OQFG28@5PA'WK ^:7[YW_[/T+G/-#&=I5[^_<S:@[U")NK-CY(M/<MGS,
M.5Y@9</QC_SVW@C<W@%<ERF:?@<_:?JI?Q,65MGT?<Y/^*KC&5'WUA6 LQ(G
MEY6NO/[-#?/"VN>;SYX_-JRR+?/*\_K8-%E4V.$#41$5Z\IW7M\U<RJ3,^W$
MR*)!ST?MVO\GD38_. T]/B3\TKJ&0>R5X:6+7V6GY<!?,2>$O_1PUCL_K$WS
MV?KM;6%E\G.*2B7RMK!MQ['9D;_4E$UO3TNN>D6Z.6?'L-U[:\JG?EM>@QXL
MF[.I9.\*+!R[N/R7,O3(%RC[I?KJIK$+DJ;JAA54:%;XA3=.>Y^=O>1%=47Y
MRY7WT]B:ELW7U]S:N2JG:.[RR=BE';>W#8HJ_W"X[_PG\CKVJ1GA0##C\[75
M@6/4TM,O<&O&MOSZU:,4[JWMD?6[MXZ\=&U':4/PU$GEI^/N'JT^T@&\:SL+
MO>=;(;1/#T\]T/!U6#QD6AL0^G?SPDW;@TKWR-I>?_7AVIF-N2\'U@+PQ 4[
MMH?/WKS8D!\J^6A^7-65M.JZ[ZZ&K?D2JMM_MT5:U__32UFZ:0+FGGFBO]VL
M:7UY\JZQ/HM:SA2NE(1<,*75U35G5^I#ZG:WU1\;JHG7<-'5^W+;5KP=F7WS
M^_.7<V6GFR-:;_TY[5Q<U<B3%Z61$.LS%7,GM/C(01-JR!4^W)Q8M64Y:\OV
M4^HI!65E.P9+9>-J"]9-$<P*;_#;M8TQXYI?A:1^T^$KY:';@V[,3%S-+8!>
M,/PX\JN2B+Z:"$%2TO0!-RI3[K:,WAKD7Z_6AI65S3]2YA\:._J,<>SFZ-?>
MQ+](:!_T\S_BY_^@_EJY9Y1E5]'#P1N6?B)7M?X^-X6W-NG*E3>M3QZ=O^F@
M6^(U"T?5OK)0=#+C3L83GRTE<].GVXYR/I@Y8?@0Q<K]QX[LL+QQ+ZHR:6O=
MHCZ'6][9DC)Y2$9&UC[>^XE/7EKP0[MF;^ULR;:R_(S0EKU#0ELV%:K5:<FE
M5>7/G8W<<NM@&$$+.B[\'U!+ P04    "  )@H16:PMD8881   G6   $0
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MA1C: W!=L3+-("%0H@:=3IL0$B%10S'!<3$=8$8%+ A8+H90O392.A?$V Y
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M H0 (4 ($ *$ "% "! "A  A0 @0 H0 (4 ($ *$ "% "! "A  A0 @0 H0
M(4 (D'\9Q+[SIP @C<S?(]5C,K^M&0@$K/XAM1T!^MD"+L!**ZN!0-LQ8#@
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M#1^=WKK_TX7RYTYWGKP#-Q]>H?QJI/O53_Q%DU[,T)!;,QNK0Q)1YB*7ZC:
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M,# N:G!G[+P%0)1;UR\^='>7PM -0Z=T=X>(Q !#,PRI( )*(XVTTHVT@*2
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M(>-"!,#+E0 (WVH# LZ]CWV"DOG70I&TH]ZF!>H</<V\7"XYOKYK+3$U=[S
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MDI\&8$%3L#;S<MLB[TL)OH.U,85A6T!B@TN;[U^JVVA0/_0)%IIW@L6(>'=
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MKD:XA(5_[]A#7C][WUY:H>%AMTA4=D_2I[4J,^LHL^TY@1R@N=4B3<]3ZX'
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MW7S:+>)T+?K:*U-MC1Y+X9[[_V_1K%[@OS\@>3D-U2F5(F'90>U!8[(ETU
MIX<MY9?EY=]!G[^#3=B!<D]&. @_0#G>[02PX4M#,)$=VCXWLR$>>$[5W<AD
M_)IB04.[*I[+6YW),BF9O=,$PT@/CS]MP;J@P@(=?;Y,P#OL=05]L1%1P$ ]
MTF)Q6B24YCD_KCY&*"I&D;CVZ0KD=L3+<P5T1<GS/>\25]BN-XY+OF[=C$=%
M1RB^GOR=&_AIIK+G@@@PHX;B/XF]$F]SB?)H3#(DV^^\6L)-^V2[Q?S8Y@3
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MHV]L-R/@(7MOIJH^:AKRM$LO[&)4<PW$.3(UJ+17<\9Y0G4M?!,-*O<@EU^
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MWWH[UIL8G5#66K[C/TJ3:E_8F*,%*&"7N<&N)I>$K0< D&(CW<-& TRA =8
M@"FDX5H[V=O+ &R 7A"2S)>7.J%<!@!@I[\8,NA(0[_NDNZ9-17^?]2]=5A;
MZ[XM'$J+5+ BQ=VMN!>WX!+<6MS=2I$BQ=V#%0F!X.ZE0*&X)+A3W"G%];9K
MK[7/.N>LO;_]/?O<YSDW_V6^<\[,^=K/QAB!J[/-VN#A<2>VB$/Z6DWH488.
M7IJMDNK0[V)]P)TO=-Y4P_P"54M<0Y!_=<A/PJ]G MN _7HN;Q<8G(Y+L_1Z
MJAPX500Y0:5F)?+,EW<X\(RF:A7(;"*Q=Z@8,*]8GH*ISFUB&PG](1DW%G4/
M#NL7*?W^*M%O0I+68;E>Y7.D6@/8XJ'1C#+)>BTV^9ZO!KGSFNC4-_6)C8,<
M'[WU4G)9*6>W*2/2_/3U5\C ]RMD8)MZE?,?(4-XUST SSS'_(XVO?S@[0>=
M3ZF+-N_C?KX>_94&HKC9O^'.^3]*^XY_E/;9?Y7V/<@CG]NX^(G[=QHO$ZY3
M.\D^&FV)F:;YK7_0>*%^#A6BU8E+,HV#,Z+;>WYP\M8HK7M ;MU5P@&/"GN
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MN]5\.:4ZB80B-,^'"N=?/B1DQWA#,^,^_DA=A79E8:S*&A'DSHA*MV UP;#
M^!8BQ)[?1DWW[9\F!8-J(FO)7N1%'BC1BB75S95@C<C.\;@,):GPFBVN4)M
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M;;S!^FF]AFFI^T]U;=H<;4G^=J#[YW>=DLFSJH'8#LQ3$G7A"E#$K]:FML^
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M%('7(+FS!9ABXCY8-< F_4@,H 6?A,7*C/@[-F71)]7>+*XT__1%C@\/SK+
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M10(@D=1EJ&;2+64P].],;F0GESCK2PMTJJKF)]B4%29[)]L>CKYSPCPSM;D
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MM;MGSIB)T]),H"!G2Z/O?[W_#U!+ P04    "  )@H16J'OUQ, +  "X#
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M[E^35#T?<).1B9>/7T!02EI&5NZ(FKJ&IA8:8VATW-CDA.E)F],_V=K9GW'
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M,7)6P^W%&VF@G&S8)G@KNJ%P_,R$TUBK']^8-.<IJP5XRZP4?4A"#M=IXK$
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M\F(36E+[-\A_'U"T#W\%4$L#!!0    (  F"A%8H,N-' @0  + 4   1
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M+&&0Q(VE,.#C&1C2K]JM(W$]NK8VH _X3UB:#5#C&=4%E;>DK<:D7Z(MC5.
M.\(HQM\E1IV# <2 !**QN +0Y?Q^$BA_^Z?3?R2U8U)OWL(Q?G\E;^ HVX/'
M/L5YQ6WFPS]02P,$%     @ "8*$5J=W#C%3 P  /Q0  !4   !X;VUA+3(P
M,C(Q,C,Q7V1E9BYX;6S-F%UOVC 4AN\G[3]DZ;5) FVWHM**]6-":D?%*.HT
M395)3L";8U/;*533_OOLD$1DRUI:7(DK\G'\GN><UW82#H\7"77N04C"6<<-
M&K[K  MY1-BDXZ8J1A_<XZ.W;P[?(?0)& BL('+&#\[I>>^S<_-Q<.'TF%28
MA>"<\C!-@"D'.5.E9FW/F\_GC2@F3'*:*IU -D*>>/K^:)G0&;0:OC[51WX+
M=6>"4-3TFRWG6Q"T]UIM?_^[\ZM[^1LA@T )^SG&$AR-S&3'74FR& O:X&+B
M-7V_Y16![C*RO9"D$CUO%;&!=W-Y\26<0H(1R>LH1QF9NG'!P<&!E]W5H9*T
M93;^@H=894U\DLOY;X0Y0T48,I=0T$2MH+&04<FE8R)5IED5V/.6-UW3+L$I
M#"!V,M*V>IA!QY4DF5%3879M*B!>ZLA"2$+8F/![#\)("S:;=[OF$"T/#<7.
MU?VL&_U(I3)6RSZC#ZYC4ET/>E6F52D3X-6-] PI%F$!FQ_^(V8*)$QY$4F\
M/,;#E+IK55?3ZJ)3IL=[65V9VB8X^AB8F=4H@ABG5%F$J]&VA,H33-CKD.;2
M&X%F&BB!9 S")F55=Q/$J:8183H&5)9N$;16?1-<QE77ZKHI!#,H/3L)(V8;
MO-!2E22P4, BB(HTAN;Y&T;V'.!A19F:G9>+C78U?7JKR]#IAOR$)[/+RHRC
M> RTX]8%>&L3+?2<RU(&S>6&OF.NW Y@QH5^J(XP3:$?G]VE1#UTYUA$LA9B
MC?B_K.B**IV>"H5F/BM>N!!CP9/ZKN3I^%JX7$0@]+N'[UMHYTJ"E;E3V\G'
M0[>IB8^3EOT++/3O*V!QQJ)S3$1N63]5YL7(O!%V673-[D%J/U>-_"0PTY=J
MFVQ!;YN<L%!.:5?3DEU]_?IN?D^FF$V@QZQZ9U-\VXRT65OI:LN"JR5(5_;C
MD4ZM,4[UEU=U_\P)--\HH^NQX11,/;5F6M+<)@\ME51:M_OZ"[(&K,>N!.'9
M #F<8K6D?,F"?+;X-IEIN[;2U3VK"U+IR:,? /U8_Y;IJWB&10^@$ WY)8#*
M9^8)U]M)]B_($^O39HIM<OAU*BQ]WK?@\Y K3)_Q"KE&_#8YL 9NV<[W.;I7
M_:;++A7_4!W] 5!+ P04    "  )@H16]M]C7O$#  !;'0  %0   'AO;6$M
M,C R,C$R,S%?;&%B+GAM;-U978_:.!1]7VG_@S=]#B&@K18T,Q7;:2LDIE3,
MA[JJJLHD-T-V@\W:IC!:[7_?:R>!A&&8 )Y0[5-"\+GW^.8<7V/.WBRG"?D.
M0L:<G3M^H^D08 $/8W9_[LQ5Y/[FO+GX^:>S7USW S 05$%(Q@_D\GW_(_G\
M^VA ^DPJR@(@ESR83X$IXI*)4K.NYRT6BT88Q4SR9*XP@6P$?.KA]W=I0C)J
M-YKX$>^:;;<W$W'BMIJM-OGB^]U?V]WFZZ_DG][5OZZK*20Q^VM,)1"DS.2Y
M4TBR'(NDP<6]UVHVVUX^T$E'=I<R+HU>M/.QOO?Y:G =3&!*W3B;QPJEPVS#
M^9U.QS/?XE 9=Z7!#WA E2GBL[S(DR/T)S<?YNI'KM]RVWYC*4-'UT#P!$80
M$9.^JQYF<.[(>#I+-&WS;"(@VLXA$<+3>(_!O7Z-.GY'Q_=?Z_BOLL<#.H;$
M(7KD[:C_Y'0ZI5@9R*N)XR<0,0_?L</(;J+K97VMJ%!'\"[BZV)^PQ5-#N)<
M1-;%]B,<5M\UKK:ZXCH(A]6U@+3)5CUFNG<Q2U5,]/T \Y>8P5(!"R',N6GD
MCI73!#8KK@G)@U*P1"^]7)3GN>2XIF,S:?FM=/U\I9]\&\&,"ZS?'4WF,(S>
M_3V/U4-O044HKV ZAE44P]O$_E85N)YOB9X R><B@+WFFE:P3(6.*U/!%H8P
MW<.!N;?7SD6.(09$>$12&$EQY$N*_'J6IE[-I"?*M:8BR&GA[3-3R49X <>^
M.E-N:5:1X-/]ZIOQX/N5PCM6,H6@O?#/N51ZD_.,6G9CZA+*,\PW-5)4!"D
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M8%U>J#*'36$;3$FS/];I4>7W4A)9U9?BK4ZXTT_9OW<7_P%02P,$%     @
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M63CZ"U!+ 0(4 Q0    (  F"A%833L4^=S(!  I<"0 2              "
M 0    !D,S0T,C@S9&1E9C$T82YH=&U02P$"% ,4    "  )@H16,>3DLN9A
M  "$OP  $0              @ &G,@$ 9S,T-#(X,V<P,F<P,2YJ<&=02P$"
M% ,4    "  )@H160(WVE(\.   X5@  $0              @ &\E $ 9S,T
M-#(X,V<P,F<P,BYJ<&=02P$"% ,4    "  )@H16:PMD8881   G6   $0
M            @ %ZHP$ 9S,T-#(X,V<P-&<U,2YJ<&=02P$"% ,4    "  )
M@H162==T0IZ;  #H"@$ $0              @ $OM0$ 9S,T-#(X,V<T-6<P
M,"YJ<&=02P$"% ,4    "  )@H16J'OUQ, +  "X#   $@
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H82TR,#(R,3(S,5]P<F4N>&UL4$L%!@     *  H A (  /]K @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
